ACYP1
acylphosphatase 1, erythrocyte (common) type
ACYP1; acylphosphatase 1, erythrocyte (common) type; acylphosphatase-1; erythrocyte isozyme; organ-common type isozyme; Acylphosphatase 1; Acylphosphatase 1 erythrocyte (common) type; Acylphosphatase 1 erythrocyte type; Acylphosphatase; Acylphosphatase erythrocyte isozyme; Acylphosphatase organ common type isozyme; Acylphosphatase1; Acylphosphate phosphohydrolase 1; ACYP 1; ACYP1_HUMAN; ACYPE; Erythrocyte acylphosphatase 1; OTTHUMP00000246802; OTTHUMP00000246804; OTTHUMP00000246805; acylphosphatase, erythrocyte isozyme; acylphosphatase, organ-common type isozyme;
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
ADAMTS1; ADAM metallopeptidase with thrombospondin type 1 motif, 1; C3-C5; METH1; A disintegrin and metalloproteinase with thrombospondin motifs 1; METH-1; ADAM-TS1; ADAMTS-1; ADAM-TS 1; human metalloproteinase with thrombospondin type 1 motifs; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1;
ADAMTS4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
ADAMTS4; ADAM metallopeptidase with thrombospondin type 1 motif, 4; ADMP-1; ADAMTS-2; ADAMTS-4; A disintegrin and metalloproteinase with thrombospondin motifs 4; ADAM-TS4; ADAM-TS 4; aggrecanase-1; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 4;
ADAMTS5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
ADAMTS5; ADAM metallopeptidase with thrombospondin type 1 motif, 5; ADMP-2; ADAM-TS5; ADAMTS-5; ADAMTS11; ADAM-TS 5; ADAMTS-11; ADAM-TS 11; A disintegrin and metalloproteinase with thrombospondin motifs 5; aggrecanase-2; a disintegrin and metalloproteinase with thrombospondin motifs 11; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2);
AKT1
RAC-alpha serine/threonine-protein kinase
AKT 1; AKT 2; AKT 3; AKT1; AKT2; AKT3; C AKT; CAKT; DKFZP434N0250; v-akt murine thymoma viral oncogene homolog 1; Murine thymoma viral (v akt) homolog 2; murine thymoma viral (v akt) oncogene homolog 1; Murine thymoma viral (vakt) oncogene homolog 1; PKB Akt; PKB alpha; PKB; PKB beta; PKBalpha; PKBBETA; PKBG; PRKBA; PRKBB; PRKBG; Protein kinase Akt 2; Protein kinase Akt 3; Protein kinase B; Protein kinase B beta; Protein kinase B gamma; RAC alpha; RAC alpha serine/threonine protein kinase; RAC; RAC beta; RAC beta serine/threonine protein kinase; RAC gamma; RAC gamma serine/threonine protein kinase; RAC PK alpha; RAC PK beta; RAC PK gamma; Rac protein kinase alpha; Rac protein kinase beta; RAC Serine/Threonine Protein Kinase; Serine threonine protein kinase Akt 3; STK 2; STK2; V AKT Murine Thymoma Viral Oncogene Homolog 1; v akt murine thymoma viral oncogene homolog 2; v akt murine thymoma viral oncogene homolog 3; VAKT Murine Thymona Viral Oncogene 1;
BMPR2
bone morphogenetic protein receptor, type II (serine/threonine kinase)
BMPR2; bone morphogenetic protein receptor, type II (serine/threonine kinase); PPH1, primary pulmonary hypertension 1; bone morphogenetic protein receptor type-2; BMPR II; BMPR3; BRK 3; T ALK; BMPR-2; BMP type-2 receptor; BMP type II receptor; type II ac;
BRSK2
BR serine/threonine kinase 2
BRSK2; BR serine/threonine kinase 2; C11orf7, chromsosome 11 open reading frame 7 , STK29; serine/threonine-protein kinase BRSK2; PEN11B; serine/threonine kinase 29; protein kinase SAD1B; brain-selective kinase 2; serine/threonine-protein kinase 29; BR s;
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
BUB1; BUB1 mitotic checkpoint serine/threonine kinase; BUB1A; BUB1L; hBUB1; mitotic checkpoint serine/threonine-protein kinase BUB1; mitotic spindle checkpoint kinase; putative serine/threonine-protein kinase; budding uninhibited by benzimidazoles 1 homolog; BUB1 budding uninhibited by benzimidazoles 1 homolog;
C12orf5
chromosome 12 open reading frame 5
C12ORF5; chromosome 12 open reading frame 5; FR2BP; TIGAR; fructose-2,6-bisphosphatase TIGAR; transactivated by NS3TP2 protein; fructose-2,6-bisphosphate 2-phosphatase; probable fructose-2,6-bisphosphatase TIGAR; TP53-induced glycolysis and apoptosis regulator;
C19orf10
chromosome 19 open reading frame 10
C19ORF10; chromosome 19 open reading frame 10; IL27, IL27w, interleukin 27 working designation; UPF0556 protein C19orf10; IL 25; IL 27; IL25; R33729_1; SF20; CS010_HUMAN; EUROIMAGE1875335; IL-25; IL27; IL27w; Interleukin 25; Interleukin 27 working designation; Interleukin-25; Interleukin25; R33729 1; R337291; Stromal cell derived growth factor; Stromal cell derived growth factor SF20; Stromal cell-derived growth factor SF20; Uncharacterized protein C19orf10 precursor; stromal cell-derived growth factor;
C4orf7
chromosome 4 open reading frame 7
C4orf7; chromosome 4 open reading frame 7; FDC-SP; MGC71894; follicular dendritic cell secreted peptide;
C6orf108
chromosome 6 open reading frame 108
C6ORF108; chromosome 6 open reading frame 108; deoxyribonucleoside 5-monophosphate N-glycosidase; dJ330M21.3; rcl; putative c-Myc-responsive; c-Myc-responsive protein Rcl; RP3-330M21.3;
Cd36
CD36 molecule (thrombospondin receptor)
CD36; CD36 molecule (thrombospondin receptor); FAT; GP4; GP3B; GPIV; CHDS7; PASIV; SCARB3; BDPLT10; platelet glycoprotein 4; GPIIIB; PAS IV; PAS-4 protein; glycoprotein IIIb; cluster determinant 36; fatty acid translocase; platelet glycoprotein IV; scavenger receptor class B, member 3; leukocyte differentiation antigen CD36; CD36 antigen (collagen type I receptor, thrombospondin receptor);
CHGA
chromogranin A (parathyroid secretory protein 1)
CHGA; chromogranin A (parathyroid secretory protein 1); chromogranin-A; SP-I; pituitary secretory protein I; parathyroid secretory protein 1; betagranin (N-terminal fragment of chromogranin A); CGA; CgA; Pancreastatin;
CHGB
chromogranin B (secretogranin 1)
CHGB; chromogranin B (secretogranin 1); secretogranin-1; Secretogranin I; CCB peptide; Cg B; CgB; Chromogranin-B; ChromograninB; GAWK peptide; SCG1; SCG1_HUMAN; Secretogranin 1; Secretogranin B; Secretogranin I precursor; SgI;
CLTB
clathrin, light chain B
CLTB; clathrin, light chain B; clathrin, light polypeptide (Lcb); clathrin light chain B; Lcb; clathrin, light chain (Lcb);
COX15
COX15 homolog, cytochrome c oxidase assembly protein (yeast)
COX15; COX15 homolog, cytochrome c oxidase assembly protein (yeast); COX15 (yeast) homolog, cytochrome c oxidase assembly protein; cytochrome c oxidase assembly protein COX15 homolog; COX15_HUMAN; cytochrome c oxidase subunit 15;
COX17
COX17 cytochrome c oxidase assembly homolog
COX17; COX17 cytochrome c oxidase assembly homolog (S. cerevisiae); COX17 (yeast) homolog, cytochrome c oxidase assembly protein , COX17 homolog, cytochrome c oxidase assembly protein (S. cerevisiae) , COX17 homolog, cytochrome c oxidase assembly protei;
CYB5A
cytochrome b5 type A (microsomal)
CYB5A; cytochrome b5 type A (microsomal); CYB5, cytochrome b 5 , cytochrome b5 (microsomal); cytochrome b5; type 1 cyt-b5; CYB5; MCB5;
CYC1
cytochrome c-1
CYC1; cytochrome c-1; cytochrome c1, heme protein, mitochondrial; UQCR4; heme protein; mitochondrial; Complex III subunit 4; Complex III subunit IV; CY1_HUMAN; Cytochrome b c1 complex subunit 4; Cytochrome b-c1 complex subunit 4; Cytochrome bc1 complex subunit 4; Cytochrome c 1; Cytochrome c1; Ubiquinol cytochrome c reductase complex cytochrome c1 subunit; Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit;
CYP2C19
cytochrome P450, family 2, subfamily C, polypeptide 19
CYP2C19; cytochrome P450, family 2, subfamily C, polypeptide 19; CYP2C, cytochrome P450, subfamily IIC (mephenytoin 4 hydroxylase), polypeptide 19; cytochrome P450 2C19; CPCJ; P450IIC19; CYPIIC17; CYPIIC19; cytochrome P450-11A; cytochrome P450-254C; cyto;
CYP2C9
cytochrome P450, family 2, subfamily C, polypeptide 9
CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9; CPC9; CYP2C; CYP2C10; CYPIIC9; MGC88320; P450IIC9; MGC149605; cytochrome P450 2C9; OTTHUMP00000020135; cytochrome P-450MP; cytochrome P450 PB-1; microsomal monooxygenase; xenobiotic monooxygenase; flavoprotein-linked monooxygenase; cytochrome P-450 S-mephenytoin 4-hydroxylase;
CYP2D6
Cytochrome P450, Family 2, Subfamily D, Polypeptide 6
CPD6; CYP2D; CYP2DL1; CYPIID6; P450C2D; P450DB1; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; P450-DB1; MGC120389; MGC120390; CYP2D6; cytochrome P450, family 2, subfamily D, polypeptide 6; cytochrome P450 2D6; OTTHUMP00000198705; OTTHUMP00000198706; cytochrome P450-DB1; microsomal monooxygenase; xenobiotic monooxygenase; debrisoquine 4-hydroxylase; flavoprotein-linked monooxygenase; cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2; cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing)-like 1; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6; cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2; cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2; Debrisoquine 4 hydroxylase; EC 1.14.14.1; Flavoprotein linked monooxygenase; P450 DB1;
CYP2E1
cytochrome P450, family 2, subfamily E, polypeptide 1
CYP2E1; cytochrome P450, family 2, subfamily E, polypeptide 1; CPE1; CYP2E; P450-J; P450C2E; cytochrome P450 2E1; CYPIIE1; cytochrome P450-J; microsomal monooxygenase; xenobiotic monooxygenase; 4-nitrophenol 2-hydroxylase; flavoprotein-linked monooxygenase; cytochrome P450, subfamily IIE (ethanol-inducible), polypeptide 1;
CYP3A4
cytochrome P450, family 3, subfamily A, polypeptide 4
CYP3A4; cytochrome P450, family 3, subfamily A, polypeptide 4; HLP; CP33; CP34; CYP3A; NF-25; CYP3A3; P450C3; CYPIIIA3; CYPIIIA4; P450PCN1; MGC126680; cytochrome P450 3A4; OTTHUMP00000210308; cytochrome P450 3A3; cytochrome P450 HLp; cytochrome P450-PCN1; cytochrome P450 NF-25; quinine 3-monooxygenase; albendazole monooxygenase; P450-III, steroid inducible; glucocorticoid-inducible P450; taurochenodeoxycholate 6-alpha-hydroxylase; cytochrome P450, subfamily IIIA, polypeptide 3; cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4;
DDT
D-dopachrome tautomerase
DDT; D-dopachrome tautomerase; D-dopachrome decarboxylase; D dopachrome decarboxylase; DDCT; D dopachrome tautomerase; DOPD_HUMAN; Phenylpyruvate tautomerase II; OTTHUMP00000198527; OTTHUMP00000198528;
DSTYK
dual serine/threonine and tyrosine protein kinase
DSTYK; dual serine/threonine and tyrosine protein kinase; receptor interacting protein kinase 5 , RIPK5; DustyPK; KIAA0472; RIP5; Dusty PK; Dusty protein kinase; HDCMD38P; Receptor interacting protein 5; Receptor interacting protein kinase 5; Receptor interacting serine/threonine protein kinase 5; RIP homologous kinase; SGK496; Sugen kinase 496; OTTHUMP00000035175; OTTHUMP00000035299; RIP-homologous kinase; receptor-interacting s; RIPK5;
Efna1
ephrin-A1
EFNA1; ephrin-A1; EPLG1, TNFAIP4; ECKLG; LERK1; TNF alpha-induced protein 4; ligand of eph-related kinase 1; immediate early response protein B61; eph-related receptor tyrosine kinase ligand 1; tumor necrosis factor alpha-induced protein 4; tumor necrosis; B61; EFL1; EPLG1; LERK-1; TNFAIP4;
Efna2
ephrin-A2
EFNA2; ephrin-A2; EPLG6; ELF 1; LERK6; EFNA 2; EFNA2_HUMAN; ELF1; Eph related receptor tyrosine kinase ligand 6; EPH-related receptor tyrosine kinase ligand 6; EphrinA2; HEK7 L; HEK7 ligand; HEK7-L; HEK7L; LERK-6; Ligand of eph related kinase 6; ELF-1;
EFNA3
ephrin-A3
EFNA3; ephrin-A3; EPLG3; Ehk1 L; LERK3; EFL-2; LERK-3; EHK1 ligand; ligand of eph-related kinase 3; eph-related receptor tyrosine kinase ligand 3; EFL2; Ehk1-L;
EFNA4
ephrin-A4
EFNA4; ephrin-A4; EPLG4; LERK4; LERK-4; ligand of eph-related kinase 4; eph-related receptor tyrosine kinase ligand 4; EFL4; FLJ57652; MGC125826;
EFNA5
ephrin-A5
EFNA5; ephrin-A5; EPLG7; AF1; LERK7; AL-1; LERK-7; eph-related receptor tyrosine kinase ligand 7; EFL5; RAGS; GLC1M;
EFNB1
ephrin-B1
EFNB1; ephrin-B1; CFNS, craniofrontonasal syndrome (craniofrontonasal dysplasia) , EPLG2; Elk L; LERK2; CFND; CFNS; Craniofrontonasal syndrome (craniofrontonasal dysplasia); EFL 3; EFL-3; EFL3; EFNB1_HUMAN; ELK ligand; ELK-L; Eph related receptor tyrosine kinase ligand 2; EPH-related receptor tyrosine kinase ligand 2; EPLG2; LERK 2; LERK-2; Ligand of eph related kinase 2; MGC8782; OTTHUMP00000023456; ligand of eph-related kinase 2;
Efnb2
Ephrin-B2
EPHB2; EPH receptor B2; DRT; EK5; ERK; CAPB; Hek5; PCBC; EPHT3; Tyro5; MGC87492; ephrin type-B receptor 2; EPH-like kinase 5; eph tyrosine kinase 3; elk-related tyrosine kinase; protein-tyrosine kinase HEK5; tyrosine-protein kinase TYRO5; renal carcinoma antigen NY-REN-47; tyrosine-protein kinase receptor EPH-3; developmentally-regulated Eph-related tyrosine kinase; EphB2; EC=2.7.10.1; Developmentally-regulated Eph-related tyrosine kinase; CAPB; PCBC; EFN B2; EFNB 2; EFNB2; Eph related receptor tyrosine kinase ligand 5; EPH-related receptor tyrosine kinase ligand 5; Ephrin-B2; EphrinB2; EPLG 5; EPLG5; Htk L; HTK ligand; HTK-L; HTKL; LERK 5; LERK-5; LERK5; Ligand of eph related kinase 5 antibody; MGC126226; MGC126227; MGC126228; OTTMUSP00000024973; Htk-L; ELF-2; NLERK-1;
EFNB3
ephrin-B3
EFNB3; ephrin-B3; EPLG8; LERK 8; Ephrin B3; eph-related receptor tyrosine kinase ligand 8; EPH-related receptor transmembrane ligand ELK-L3; EFL6; LERK8;
EHMT2
EHMT2 euchromatic histone-lysine N-methyltransferase 2
EHMT2; euchromatic histone-lysine N-methyltransferase 2; BAT8, C6orf30, chromosome 6 open reading frame 30 , HLA B associated transcript 8; histone-lysine N-methyltransferase EHMT2; Em:AF134726.3; G9A; KMT1C; NG36/G9a; protein G9a; H3-K9-HMTase 3; G9A histone methyltransferase; HLA-B associated transcript 8; HLA-B-associated transcript 8; lysine N-methyltransferase 1C; ankyrin repeat-containing protein; histone H3-K9 methyltransferase 3; histone-lysine N-methyltransferase, H3 lysine-9 specific 3; BAT8; GAT8; NG36; C6orf30; FLJ35547; DKFZp686H08213;
EIF1AX
eukaryotic translation initiation factor 1A, X chromosome
EIF1AX; eukaryotic translation initiation factor 1A, X chromosome; EIF1A; EIF4C;
ERBB2
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
ERBB2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 19 protein; neuro/glioblastoma derived oncogene homolog; tyrosine kinase-type cell surface receptor HER2; neuroblastoma/glioblastoma derived oncogene homolog; v-erb-b2 avian erythroblastic leukemia viral oncoprotein 2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog;
ERBB3
ERBB3 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian); LCCS2, lethal congenital contracture syndrome 2; receptor tyrosine-protein kinase erbB-3; HER3; proto-oncogene-like protein c-ErbB-3; tyrosine kinase-type cell surface receptor HER3; LCCS2; ErbB-3; c-erbB3; erbB3-S; MDA-BF-1; c-erbB-3; p180-ErbB3; p45-sErbB3; p85-sErbB3; MGC88033;
ERBB4
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
ERBB4; v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian); v erb a avian erythroblastic leukemia viral oncogene homolog like 4; receptor tyrosine-protein kinase erbB-4; proto-oncogene-like protein c-ErbB-4; tyrosine kinase-type cell surface receptor HER4; avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4; HER4; p180erbB4; MGC138404;
ETS1
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
ETS1; v-ets erythroblastosis virus E26 oncogene homolog 1 (avian); EWSR2, v ets avian erythroblastosis virus E26 oncogene homolog 1; protein C-ets-1; Avian erythroblastosis virus E26 (v ets) oncogene homolog 1; ets protein; ETS 1; FLJ10768; p54; v-ets avian erythroblastosis virus E2 oncogene homolog 1; Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1; ETS-1; EWSR2;
F3
coagulation factor III (thromboplastin, tissue factor)
F3; coagulation factor III (thromboplastin, tissue factor); TF; TFA; CD142; tissue factor;
F7
coagulation factor VII (serum prothrombin conversion accelerator)
F7; coagulation factor VII; SPCA; eptacog alfa; proconvertin; OTTHUMP00000018733; OTTHUMP00000018734; FVII coagulation protein; serum prothrombin conversion accelerator; factor VII;
FASTK
Fas-activated serine/threonine kinase
FASTK; Fas-activated serine/threonine kinase; FAST; Fas activated serine threonine kinase; Fas activated serine threonine kinase isoform 1; Fas activated serine threonine kinase isoform 4; FAST kinase; FLJ13079;
GHRH
Ghrh growth hormone releasing hormone
GHRH; growth hormone releasing hormone; somatoliberin; GRF; growth hormone-releasing factor; growth hormone-releasing hormone; GHRF;
GHRL
Ghrelin/Obestatin Prepropeptide
Ghrelin/obestatin prepropeptide; obestatin; ghrelin,growth hormone secretagogue receptor ligand; Growth hormone-releasing peptide; appetite-regulating hormone; Motilin related peptide; ghrelin/obestatin preprohormone; Growth hormone secretagogue; proteinM46; ghrelin; MTLRP; OTTHUMP00000207791; OTTHUMP00000207792; OTTHUMP00000207790; OTTHUMP00000207793; OTTHUMP00000207794; OTTHUMP00000207795; OTTHUMP00000207796; OTTHUMP00000207797; OTTHUMP00000207798; OTTHUMP00000226986; GHRL;
HFE2
hemochromatosis type 2 (juvenile)
HFE2; hemochromatosis type 2 (juvenile); hemojuvelin; haemojuvelin; HFE2A; HJV; JH; repulsive guidance molecule c; RGMC; RGM domain family member C; hemochromatosis type 2 protein; MGC23953;
KIR3DL1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; KIR; killer cell immunoglobulin-like receptor 3DL1; AMB11; CD158e1; CD158e1/2; CD158e2; cl 2; cl 11; nkat3; NKB1; NKB1B; CD158 antigen-like family member E; CD158E; CD158e antigen; CL11; CL2; HLA-BW4-specific inhibitory NK cell receptor; killer cell immunoglobulin like receptor; Killer cell immunoglobulin like receptor three domains , short cytoplasmic tail, 1; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 1; KIR antigen 3DL1; KIR G1; KIR3DS1; Kirl1; Kirl2; Krl1; MGC119726; MGC119728; MGC126589; MGC126591; MHC class I NK cell receptor; Natural killer associated transcript 3; Natural killer cell inhibitory receptor; NK receptor; NK-associated transcript 10; NK-associated transcript 3; NK-associated transcript 3delIg1; NKAT10; p70 killer cell inhibitory receptor; p70 natural killer cell receptor clones CL 2/CL 11; NKAT-3; NK-receptor; OTTHUMP00000068687; OTTHUMP00000068688; OTTHUMP00000081758; killer Ig receptor; p70 NK receptor CL-2/CL-11; p70 ki; KIR3DL1/S1;
MKNK1
MAP kinase interacting serine/threonine kinase 1
MKNK1; MAP kinase interacting serine/threonine kinase 1; MAP kinase-interacting serine/threonine-protein kinase 1; MNK1; MAPK signal-integrating kinase 1; MAP kinase signal-integrating kinase 1;
MKNK2
MAP kinase interacting serine/threonine kinase 2
MKNK2; MAP kinase interacting serine/threonine kinase 2; G protein coupled receptor kinase 7 , GPRK7; MAP kinase-interacting serine/threonine-protein kinase 2; MNK2; Putative map kinase interacting kinase; MAP kinase signal integrating kinase 2; G protein coupled receptor kinase 7; GPRK7; MAP kinase interacting serine threonine kinase 2; MAP kinase interacting serine threonine kinase; MAP kinase interacting serine threonine protein kinase 2; MAP kinase signal-integrating kinase 2; MAPK interacting kinase 2; Mitogen activated protein kinase interacting serine threonine kinase 2; MKNK2_HUMAN; G protein-coupled receptor kinase 7;
MST4
serine/threonine protein kinase MST4
RP6-213H19.1; MASK; serine/threonine-protein kinase MST4; OTTHUMP00000024034; OTTHUMP00000215131; OTTHUMP00000215132; OTTHUMP00000215133; OTTHUMP00000215134; STE20-like kinase MST4; mammalian sterile 20-like 4; Mst3 and SOK1-related kinase; serine/threonine-protein kinase MASK; mammalian Ste20-like protein kinase 4;
NHP2L1
NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae)
NHP2L1; NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae); non histone chromosome protein 2 (S. cerevisiae) like 1 , sperm specific antigen 1 , SSFA1; NHP2-like protein 1; 15.5K; FA 1; small nuclear ribonucleoprotein 15.5kDa (U4/U6.U5); SNRNP15 5; SNU13; SPAG12; [U4/U6.U5] tri snRNP; High mobility group like nuclear protein 2 homolog 1; hSNU13; NHP2 non histone chromosome protein 2 like 1 (S. cerevisiae); NHP2L 1; NHPX; OTK27; sperm specific antigen 1; U4/U6.U5 tri-snRNP 15.5 kDa protein; non-histone chromosome protein 2-like 1; [U4/U6.U5] tri-snRNP 15.5 kD RNA binding protein; high mobility group-like nuclear protein 2 homolog 1; FA1; FA-1; SSFA1; SNRNP15-5;
PASK
PAS domain containing serine/threonine kinase
PASK; PAS domain containing serine/threonine kinase; PAS domain-containing serine/threonine-protein kinase; KIAA0135; PASKIN; STK37; per-arnt-sim (PAS) domain kinase; DKFZp434O051; DKFZp686P2031;
RCC1
regulator of chromosome condensation 1
RCC1; regulator of chromosome condensation 1; CHC1, chromosome condensation 1; regulator of chromosome condensation; cell cycle regulatory protein; SNHG3-RCC1 readthrough transcript; guanine nucleotide-releasing protein; CHC1; RCC1-I; SNHG3-RCC1; rcc1-a; CHC 1; Chromosome condensation 1; Chromosome condensation protein 1; Guanine nucleotide releasing protein; HERC2; Ran GEF; RanGEF; RCC 1; RCC1 I; RCC1_HUMAN; SHEP1; SNHG3 RCC1; SNHG3 RCC1 readthrough transcript; xrcc1; chc1-a;
RIPK2
receptor-interacting serine-threonine kinase 2
RIPK2; receptor-interacting serine-threonine kinase 2; CCK; RICK; RIP2; CARD3; GIG30; CARDIAK; receptor-interacting serine/threonine-protein kinase 2; RIP-2; CARD-carrying kinase; growth-inhibiting gene 30; tyrosine-protein kinase RIPK2; receptor-interacting protein 2; CARD-containing IL-1 beta ICE-kinase; CARD-containing interleukin-1 beta-converting enzyme (ICE)-associated kinase; receptor-interacting protein (RIP)-like interacting caspase-like apoptosis regulatory protein (CLARP) kinase;
SCO1
SCO cytochrome oxidase deficient homolog 1
SCO1; SCO cytochrome oxidase deficient homolog 1 (yeast); SCO (cytochrome oxidase deficient, yeast) homolog 1 , SCOD1; protein SCO1 homolog, mitochondrial; SCOD1;
SCO2
SCO cytochrome oxidase deficient homolog 2
SCO2; SCO cytochrome oxidase deficient homolog 2 (yeast); SCO (cytochrome oxidase deficient, yeast) homolog 2; protein SCO2 homolog, mitochondrial; SCO1L; cytochrome oxidase deficient homolog 2; MGC125823; MGC125825;
SEMA5A
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
SEMA5A; sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A; semF; SEMAF; semaphorin-5A; sema F; semaphorin F; semaphorin-F; semaphorin 5A;
SERPINC1
serpin peptidase inhibitor, clade C (antithrombin), member 1
SERPINC1; serpin peptidase inhibitor, clade C (antithrombin), member 1; AT3; ATIII; MGC22579; antithrombin (aa 375-432); antithrombin III; coding sequence signal peptide antithrombin part 1; signal peptide antithrombin part 1; serine (or cysteine) proteinase inhibitor, clade C (antithrombin), member 1; Antithrombin-III; Serpin C1; PRO0309; OTTHUMP00000035393; serine-cysteine proteinase inhibitor clade C member 1;
SMARCA4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
SMARCA4; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4; BRG1; SNF2; SWI2; MRD16; RTPS2; BAF190; SNF2L4; SNF2LB; hSNF2b; BAF190A; transcription activator BRG1; SNF2-beta; SNF2-like 4; protein BRG-1; nuclear protein GRB1; brahma protein-like 1; BRM/SWI2-related gene 1; homeotic gene regulator; protein brahma homolog 1; BRG1-associated factor 190A; sucrose nonfermenting-like 4; ATP-dependent helicase SMARCA4; mitotic growth and transcription activator; global transcription activator homologous sequence;
SPTA1
spectrin, alpha, erythrocytic 1 (elliptocytosis 2)
SPTA1; spectrin, alpha, erythrocytic 1 (elliptocytosis 2); spectrin alpha chain, erythrocyte; EL2; alpha-I spectrin; erythroid alpha-spectrin; HPP; HS3; SPH3; SPTA;
SPTAN1
spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)
SPTAN1; spectrin, alpha, non-erythrocytic 1 (alpha-fodrin); spectrin alpha chain, brain; alpha-II spectrin; fodrin alpha chain; spectrin, non-erythroid alpha chain; NEAS; EIEE5; SPTA2; FLJ17738; FLJ44613;
STK10
serine/threonine kinase 10
STK10; serine/threonine kinase 10; serine/threonine-protein kinase 10; LOK; PRO2729; lymphocyte-oriented kinase;
STK16
serine/threonine kinase 16
STK16; serine/threonine kinase 16; serine/threonine-protein kinase 16; MPSK; PKL12; hPSK; TSF-1; protein kinase PKL12; TGF-beta-stimulated factor 1; tyrosine-protein kinase STK16; protein kinase expressed in day 12 fetal liver; myristoylated and palmitoyl;
STK24
serine/threonine kinase 24
STK24; serine/threonine kinase 24; serine/threonine kinase 24 (Ste20, yeast homolog); serine/threonine-protein kinase 24; MST 3; MST3; MST3B; STE20; STE20 like kinase 3; sterile 20 like kinase 3; STK3; STE20-like kinase 3; STE20-like kinase MST3; sterile;
STK3
serine/threonine kinase 3
STK3; serine/threonine kinase 3; serine/threonine kinase 3 (Ste20, yeast homolog); serine/threonine-protein kinase 3; KRS1; MST2; MST-2; STE20-like kinase MST2; mammalian STE20-like protein kinase 2; serine/threonine-protein kinase Krs-1; serine/threonine;
STK33
serine/threonine kinase 33
STK33; serine/threonine kinase 33; serine/threonine-protein kinase 33;
STK4
serine/threonine kinase 4
STK4; serine/threonine kinase 4; KRS2; MST1; YSK3; TIIAC; serine/threonine-protein kinase 4; MST-1; STE20-like kinase MST1; mammalian sterile 20-like 1; kinase responsive to stress 2; mammalian STE20-like protein kinase 1; serine/threonine-protein kinase Krs-2; dJ211D12.2 (serine/threonine kinase 4 (MST1, KRS2));
TACO1
translational activator of mitochondrially encoded cytochrome c oxidase I
TACO1; translational activator of mitochondrially encoded cytochrome c oxidase I; CCDC44; clone HQ0477 PRO0477p; coiled-coil domain containing 44;
TARS
threonyl-tRNA synthetase
TARS; threonyl-tRNA synthetase; threonine--tRNA ligase, cytoplasmic; threonine tRNA ligase 1; cytoplasmic; threonine tRNA ligase 1, cytoplasmic; threonyl-tRNA synthetase, cytoplasmic; ThrRS; MGC9344;
THBD
thrombomodulin
THBD; thrombomodulin; CD141; fetomodulin; CD141 antigen; TM; THRM; AHUS6; BDCA3; THPH12;
THBS1
thrombospondin 1
THBS1; thrombospondin 1; TSP; THBS; TSP1; TSP-1; THBS-1; thrombospondin-1; thrombospondin-1p180;
THPO
thrombopoietin
THPO; thrombopoietin; ML; TPO; MGDF; MKCSF; MPLLG; THCYT1; MPL ligand; c-mpl ligand; prepro-thrombopoietin; megakaryocyte stimulating factor; megakaryocyte colony-stimulating factor; megakaryocyte growth and development factor; myeloproliferative leukemia virus oncogene ligand;
THRB
THRB thyroid hormone receptor, beta
THRB; thyroid hormone receptor, beta; ERBA2, pituitary resistance to thyroid hormone , PRTH, thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v erb a) oncogene homolog 2) , thyroid hormone receptor, beta (erythroblastic leukemia viral (v erb a) oncogene homolog 2, avian); thyroid hormone receptor beta; avian erythroblastic leukemia viral (v erb a) oncogene homolog 2; ERBA BETA; generalized resistance to thyroid hormone; GRTH; NR1A2; oncogene ERBA2; THR1; THRB1; THRB2; thyroid hormone receptor beta 1; nuclear receptor subfamily 1 group A member 2; thyroid hormone nuclear receptor beta variant 1; thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian); PRTH; ERBA2; C-ERBA-2; C-ERBA-BETA; MGC126109; MGC126110;
F2
coagulation factor II (thrombin)
F2; coagulation factor II (thrombin); prothrombin; serine protease; prothrombin B-chain; PT; THPH1;
Thsd1
thrombospondin, type I, domain containing 1
THSD1; thrombospondin, type I, domain containing 1; thrombospondin, type I, domain 1; thrombospondin type-1 domain-containing protein 1; TMTSP; 4833423O18Rik; transmembrane molecule with thrombospondin module; UNQ3010; MGC74971;
TREX2
three prime repair exonuclease 2
TREX2; three prime repair exonuclease 2; 3-5 exonuclease TREX2 long form;
TSSK2
testis specific serine threonine kinase 2
TSSK2; testis specific serine threonine kinase 2; DGS-G;
UQCRC2
ubiquinol-cytochrome c reductase core protein II
UQCRC2; ubiquinol-cytochrome c reductase core protein II; cytochrome b-c1 complex subunit 2, mitochondrial; QCR2; UQCR2; mitochondrial; Complex III subunit 2; Core protein II; Cytochrome b-c1 complex subunit 2; EC 1.10.2.2; QCR2_HUMAN; Ubiquinol cytochrome c reductase complex core protein 2 mitochondrial; Ubiquinol cytochrome c reductase core protein II; Ubiquinol-cytochrome-c reductase complex core protein 2;
SMC1B
structural maintenance of chromosomes 1B
SMC1B; structural maintenance of chromosomes 1B; SMC1 (structural maintenance of chromosomes 1, yeast) like 1 , SMC1 structural maintenance of chromosomes 1 like 2 (yeast) , SMC1L2; structural maintenance of chromosomes protein 1B; bK268H5; SMC protein 1B; SMC-1-beta; SMC-1B; SMC1 beta; SMC1B_HUMAN; SMC1beta; SMC1beta protein; Smc1l2; Structural maintenance of chromosomes 1-like 2; OTTHUMP00000199851; OTTHUMP00000199852; SMC1 structural maintenance of chromosomes 1-like 2; SMC1 (structural maintenance of chromosomes 1, yeast)-like 1; mitosis-specific chrom; bK268H5.5;
ATR
Anthrax Toxin Receptor
ANTXR1; ATR; TEM8; FLJ10601; FLJ11298; FLJ21776; anthrax toxin receptor 1; OTTHUMP00000159975; OTTHUMP00000202140; OTTHUMP00000202171; tumor endothelial marker 8; 2310008J16Rik; 2810405N18Rik; anthrax toxin receptor; tumor endothelial marker 8 precursor;
Cry1
cryptochrome 1 (photolyase-like)
CRY1; cryptochrome 1 (photolyase-like); PHLL1; cryptochrome-1; photolyase-like cryptochrome 1;
MTOR
mechanistic target of rapamycin (serine/threonine kinase)
MTOR; mechanistic target of rapamycin (serine/threonine kinase); FRAP; FRAP1; FRAP2; RAFT1; RAPT1; serine/threonine-protein kinase mTOR; rapamycin target protein 1; mammalian target of rapamycin; rapamycin and FKBP12 target 1; FKBP-rapamycin associated protein; rapamycin associated protein FRAP2; FKBP12-rapamycin complex-associated protein 1; FK506 binding protein 12-rapamycin associated protein 2; FK506-binding protein 12-rapamycin complex-associated protein 1;
SMC1A
structural maintenance of chromosomes 1A
SMC1A; structural maintenance of chromosomes 1A; SMC1 (structural maintenance of chromosomes 1, yeast) like 1 , SMC1 structural maintenance of chromosomes 1 like 1 (yeast) , SMC1L1; structural maintenance of chromosomes protein 1A; DXS423E; KIAA0178; SB1;
STRAP
serine/threonine kinase receptor associated protein
STRAP; serine/threonine kinase receptor associated protein; serine-threonine kinase receptor-associated protein; MAWD; pt wd; Unr interacting protein; UNRIP; unr-interacting protein; WD-40 repeat protein PT-WD; MAP activator with WD repeats; PT-WD;
CBX1
CBX1 chromobox homolog 1
CBX1; chromobox homolog 1; chromobox homolog 1 (Drosophila HP1 beta); chromobox protein homolog 1; CBX; HP1 beta homolog (Drosophila ); HP1 BETA; HP1Hs beta; M31; MOD1; HP1 beta homolog; modifier 1 protein; heterochromatin protein 1-beta; heterochromatin protein p25 beta; heterochromatin protein 1 homolog beta; chromobox homolog 1 (HP1 beta homolog Drosophila ); p25beta; HP1-BETA; HP1Hsbeta; HP1Hs-beta;
CYorf15B
chromosome Y open reading frame 15B
CYORF15B; chromosome Y open reading frame 15B; Lipopolysaccaride-specific response 5-like protein;
ADAMST8
ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 8
ADAM metallopeptidase with thrombospondin type 1 motif, 8; METH2; ADAM-TS8; FLJ41712; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 8; ADAMTS-8; METH-2; METH-8; ADAM-TS 8; A disintegrin and metalloproteinase with thrombospondin motifs 8; EC 3.4.24.; EC 3.4.24; EC 3.4.24.14; EC 3.4.24.82; ADAMTS8; OTTHUMP00000230650;
ADAMTS13
ADAM metallopeptidase with thrombospondin type 1 motif, 13
ADAMTS13; ADAM metallopeptidase with thrombospondin type 1 motif, 13; VWFCP; C9orf8; vWF-CP; ADAM-TS13; ADAMTS-13; A disintegrin and metalloproteinase with thrombospondin motifs 13; vWF-cleaving protease; von Willebrand factor-cleaving protease; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 13;
ADAMTS17
ADAM metallopeptidase with thrombospondin type 1 motif, 17
ADAMTS17; ADAM metallopeptidase with thrombospondin type 1 motif, 17; A disintegrin and metalloproteinase with thrombospondin motifs 17; ADAM-TS17; ADAMTS-17; ADAM-TS 17; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 17;
ADAMTS2
ADAM metallopeptidase with thrombospondin type 1 motif, 2
ADAMTS2; ADAM metallopeptidase with thrombospondin type 1 motif, 2; NPI; PNPI; PCINP; PCPNI; PCI-NP; PC I-NP; ADAM-TS2; ADAMTS-2; ADAMTS-3; A disintegrin and metalloproteinase with thrombospondin motifs 2; procollagen I N-proteinase; procollagen N-endopeptidase; procollagen I/II amino propeptide-processing enzyme; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 2;
ADAMTS8
ADAM metallopeptidase with thrombospondin type 1 motif, 8
ADAMTS8; ADAM metallopeptidase with thrombospondin type 1 motif, 8; METH2; ADAM-TS8; A disintegrin and metalloproteinase with thrombospondin motifs 8; METH-2; METH-8; ADAMTS-8; ADAM-TS 8; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 8;
ALS2CR8
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8
ALS2CR8; amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8; amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein; calcium response factor; CaRF; FLJ21579; NYD SP24; calcium-response factor; testis development;
ASPSCR1
alveolar soft part sarcoma chromosome region, candidate 1
ASPSCR1; alveolar soft part sarcoma chromosome region, candidate 1; tether containing UBX domain for GLUT4; ASPL; ASPS; UBX domain protein 9; UBXD9; UBXN9; UBX domain-containing protein 9; alveolar soft part sarcoma locus; renal cell carcinoma, papillary,;
C11orf30
chromosome 11 open reading frame 30
C11ORF30; chromosome 11 open reading frame 30; protein EMSY; EMSY; EMSY protein; FLJ90741; GL002; OTTHUMP00000229238; OTTHUMP00000229239; OTTHUMP00000229240; OTTHUMP00000229241; OTTHUMP00000229242; OTTHUMP00000229289;
C17orf75
chromosome 17 open reading frame 75
C17ORF75; chromosome 17 open reading frame 75; protein Njmu-R1; NJMU R1; Protein kinase Njmu R1; Protein Njmu R1; spermatogenesis-related protein; NJMU-R1;
C1orf38
chromosome 1 open reading frame 38
C1ORF38; chromosome 1 open reading frame 38; protein THEMIS2; ICB 1; Basement membrane induced; ICB1; Induced by contact to basement membrane 1 protein; Protein ICB 1; THEMIS2; Thymocyte expressed molecule involved in selection protein 2; protein ICB-1; basement membrane-induced; thymocyte-expressed molecule involved in selection protein 2; ICB-1;
C20orf30
chromosome 20 open reading frame 30
C20ORF30; chromosome 20 open reading frame 30; UPF0414 transmembrane protein C20orf30; HSPC274; dJ1116H23.2.1; OTTHUMP00000030184; OTTHUMP00000030185; OTTHUMP00000030186; OTTHUMP00000030187; CT030_HUMAN; Hypothetical protein LOC29058; OTTHUMP00000030179; OTTHUMP00000030181; OTTHUMP00000030182; OTTHUMP00000030183; RP5-1116H23.2;
C21orf33
chromosome 21 open reading frame 33
C21ORF33; chromosome 21 open reading frame 33; ES1 protein homolog, mitochondrial; D21S2048E; ES1; GT335; HES1; KNP I; KNP Ia; KNPH; KNPI; Keio novel protein I; human HES1 protein, homolog to E.coli and zebrafish ES1 protein;
C5orf32
chromosome 5 open reading frame 32
C5ORF32; chromosome 5 open reading frame 32; UPF0467 protein C5orf32; ORF1 FL49; Hypothetical protein LOC84418; OTTHUMP00000159548; Putative nuclear protein ORF1 FL49; putative nuclear protein ORF1-FL49; ORF1-FL49;
C6orf115
chromosome 6 open reading frame 115
C6ORF115; chromosome 6 open reading frame 115; costars family protein C6orf115; HSPC280; PRO2013; Hypothetical protein LOC58527; Uncharacterized protein C6orf115; OTTHUMP00000017303; RP11-501K14.2;
C9orf86
chromosome 9 open reading frame 86
C9ORF86; chromosome 9 open reading frame 86; putative GTP-binding protein Parf; bA216L13.9; FLJ10101; FLJ13045; Parf; pp8875; Rab like protein 1; RBEL1; Hypothetical protein LOC55684; KIAA1984; OTTHUMP00000022608; OTTHUMP00000022610; OTTHUMP00000022612; OTTHUMP00000022613; OTTHUMP00000022614; OTTHUMP00000022615; Partner of ARF; Putative GTP binding protein Parf; Rab like GTP binding protein 1; Rab like GTP binding protein 1C; RP11-216L13.9; Rab-like protein 1; Rab-like GTP-binding protein 1; Rab-like GTP-binding protein 1C;
C9orf96
chromosome 9 open reading frame 96
C9ORF96; chromosome 9 open reading frame 96; protein kinase-like protein SgK071; MGC43306; Hypothetical protein LOC169436; Protein kinase like protein SgK071; RP11 244N20.8; SGK 071; SGK071; sugen kinase 071; OTTHUMP00000022465; Sk521; RP11-244N20.8;
CBX2
chromobox homolog 2
CBX2; chromobox homolog 2; M33; CDCA6; SRXY5; chromobox protein homolog 2; modifier 3; Pc class homolog; cell division cycle associated 6; chromobox homolog 2 (Pc class homolog, Drosophila);
CBX3
chromobox homolog 3
CBX3; chromobox homolog 3; HECH; HP1-GAMMA; HP1Hs-gamma; chromobox protein homolog 3; HP1 gamma homolog; modifier 2 protein; heterochromatin-like protein 1; heterochromatin protein HP1 gamma; heterochromatin protein 1 homolog gamma; chromobox homolog 3 (HP1 gamma homolog, Drosophila);
CBX5
chromobox homolog 5
CBX5; chromobox homolog 5; HP1; HP1A; HEL25; chromobox protein homolog 5; HP1-ALPHA; HP1Hs alpha; antigen p25; HP1 alpha homolog; epididymis luminal protein 25; heterochromatin protein 1-alpha; heterochromatin protein 1 homolog alpha; chromobox homolog 5 (HP1 alpha homolog, Drosophila);
CHAF1A
chromatin assembly factor 1, subunit A (p150)
CHAF1A; chromatin assembly factor 1, subunit A (p150); chromatin assembly factor 1 subunit A; CAF 1; CAF1; CAF1B; CAF1P150; chromatin assembly factor I (150 kDa); MGC71229; P150; hp150; CAF-I p150; CAF-1 subunit A; CAF-I 150 kDa subunit; chromatin assembl;
CHD3
chromodomain helicase DNA binding protein 3
CHD3; chromodomain helicase DNA binding protein 3; ZFH; Mi-2a; Mi2-ALPHA; chromodomain-helicase-DNA-binding protein 3; hZFH; CHD-3; zinc finger helicase; ATP-dependent helicase CHD3; mi-2 autoantigen 240 kDa protein; zinc-finger helicase (Snf2-like);
CHD4
chromodomain helicase DNA binding protein 4
CHD4; chromodomain helicase DNA binding protein 4; chromodomain-helicase-DNA-binding protein 4; Mi 2b; Mi2 BETA; CHD-4; ATP-dependent helicase CHD4; Mi-2 autoantigen 218 kDa protein; Mi-2b; Mi2-BETA; DKFZp686E06161;
CHD8
chromodomain helicase DNA binding protein 8
CHD8; chromodomain helicase DNA binding protein 8; helicase with SNF2 domain 1 , HELSNF1; chromodomain-helicase-DNA-binding protein 8; DUPLIN; KIAA1564; axis duplication inhibitor; ATP-dependent helicase CHD8; helicase with SNF2 domain 1; HELSNF1;
CHRAC1
chromatin accessibility complex 1
CHRAC1; chromatin accessibility complex 1; chromatin accessibility complex protein 1; CHRAC15; histone fold protein CHRAC15; YCL1; histone-fold protein CHRAC15; DNA polymerase epsilon subunit p15; chromatin accessibility complex 15 kDa protein; CHARC1; CH;
CHTF18
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)
CHTF18; CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae); C16orf41, chromosome 16 open reading frame 41; chromosome transmission fidelity protein 18 homolog; C321D2.4; CHL12; Ctf18; MGC38008; 6030457M03Rik; C16orf41; C321D2.2; C321D2.3; chromosome transmission fidelity factor 18 homolog (S. cerevisiae); RUVBL; hCTF18; OTTHUMP00000045506; OTTHUMP00000208409; homolog of yeast CHL12; C321D2.3 (novel protein); C321D2.4 (novel protein); some homology with holliday junction DNA helicase RUVB like;
CLINT1
clathrin interactor 1
CLINT1; clathrin interactor 1; CLINT; ENTH; EPNR; KIAA0171; epsinR; epsin 4; enthoprotin; epsin-related protein; clathrin interacting protein localized in the trans-Golgi region; EPN4; FLJ46753;
COX4I2
cytochrome c oxidase subunit IV isoform 2 (lung)
COX4I2; cytochrome c oxidase subunit IV isoform 2 (lung); COX4L2, cytochrome c oxidase subunit IV isoform 2; cytochrome c oxidase subunit 4 isoform 2, mitochondrial; COX4 2; COX4B; COXIV 2; cytochrome c oxidase subunit IV like 2; dJ857M17.2; COX IV-2; cy;
COX5B
cytochrome c oxidase subunit Vb
COX5B; cytochrome c oxidase subunit Vb; cytochrome c oxidase subunit 5B, mitochondrial; mitochondrial; COX 5B; COX5B_HUMAN; COXVB; Cytochrome c oxidase polypeptide Vb; Cytochrome c oxidase polypeptide VB mitochondrial; Cytochrome c oxidase subunit 5B; Cytochrome c oxidase subunit 5B mitochondrial; OTTHUMP00000161109; cytochrome c oxidase polypeptide VB, mitochondrial;
COX6B1
cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous)
COX6B1; cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous); COX6B, cytochrome c oxidase subunit Vib , cytochrome c oxidase subunit Vib polypeptide 1 (ubiquitous); cytochrome c oxidase subunit 6B1; COXG; COX VIb-1; COX6B; COXVIb1;
COX6C
cytochrome c oxidase subunit VIc
COX6C; cytochrome c oxidase subunit VIc; cytochrome c oxidase subunit 6C; cytochrome c oxidase polypeptide VIc; cytochrome c oxidase subunit VIc preprotein;
CSE1L
CSE1 chromosome segregation 1-like
CSE1L; CSE1 chromosome segregation 1-like (yeast); chromosome segregation 1 (yeast homolog) like; exportin-2; CAS; CSE1; XPO2; exp2; importin-alpha re-exporter; chromosome segregation 1-like protein; cellular apoptosis susceptibility protein; MGC117283; M;
CYB5R4
cytochrome b5 reductase 4
CYB5R4; cytochrome b5 reductase 4; NADPH cytochrome B5 oxidoreductase , NCB5OR; b5+b5R; dJ676J13.1; b5b5r; C79736; cb5/cb5R; Cb5cb5r; Cytochrome b type NAD(P)H oxidoreductase; Flavohemoprotein b5+b5R; Flavohemoprotein b5/b5R; N terminal cytochrome b5 and cytochrome b5 oxidoreductase domain containing protein; N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein; NADPH cytochrome B5 oxidoreductase; NB5R4_HUMAN; NCB5OR; RP4 676J13.1; OTTHUMP00000016802; cytochrome b-type NAD(P)H oxidoreductase; RP4-676J13.1;
CYP1B1
cytochrome P450, family 1, subfamily B, polypeptide 1
CYP1B1; cytochrome P450, family 1, subfamily B, polypeptide 1; CP1B; GLC3A; CYPIB1; P4501B1; cytochrome P450 1B1; microsomal monooxygenase; xenobiotic monooxygenase; aryl hydrocarbon hydroxylase; flavoprotein-linked monooxygenase; cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile);
CYP24A1
cytochrome P450, family 24, subfamily A, polypeptide 1
CYP24A1; cytochrome P450, family 24, subfamily A, polypeptide 1; CYP24, cytochrome P450, subfamily XXIV (vitamin D 24 hydroxylase); 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial; CP24; P450 CC24; mitochondrial; 1 25 @dihydroxyvitamin D3 24 hydroxylase; 1 25 dihydroxyvitamin D(3) 24 hydroxylase; 1; 24 ohase; 24-OHase; 25-dihydroxyvitamin D(3) 24-hydroxylase; CP 24; CP24A_HUMAN; CYP 24; CYP24; Cytochrome P450 24A1; Cytochrome P450 24A1 mitochondrial; Cytochrome P450 family 24; Cytochrome P450 family 24 subfamily A polypeptide 1; Cytochrome P450 subfamily XXIV; Cytochrome P450, subfamily XXIV (vitamin D 24-hydroxylase); Cytochrome P450-CC24; EC 1.14.13.n4; Exo mitochondrial protein; MGC126273; MGC126274; Vitamin D 24 hydroxylase; Vitamin D(3) 24 hydroxylase; Vitamin D(3) 24-hydroxylase; OTTHUMP00000031314; OTTHUMP00000165939; OTTHUMP00000165940; vitamin D 24-hydroxylase; exo-mitochondrial protein; 1,25-@dihyd; HCAI; P450-CC24;
CYP2J2
cytochrome P450, family 2, subfamily J, polypeptide 2
CYP2J2; cytochrome P450, family 2, subfamily J, polypeptide 2; CPJ2; cytochrome P450 2J2; CYPIIJ2; microsomal monooxygenase; arachidonic acid epoxygenase; flavoprotein-linked monooxygenase; cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2;
CYP46A1
cytochrome P450, family 46, subfamily A, polypeptide 1
CYP46A1; cytochrome P450, family 46, subfamily A, polypeptide 1; CYP46, cytochrome P450, subfamily 46 (cholesterol 24 hydroxylase); cholesterol 24-hydroxylase; CH24H; cytochrome P450 46A1; cytochrome P450, subfamily 46 (cholesterol 24-hydroxylase); CP46;
CYP7B1
cytochrome P450, family 7, subfamily B, polypeptide 1
CYP7B1; cytochrome P450, family 7, subfamily B, polypeptide 1; cytochrome P450, subfamily VIIB (oxysterol 7 alpha hydroxylase), polypeptide 1 , spastic paraplegia 5A (autosomal recessive) , SPG5A; 25-hydroxycholesterol 7-alpha-hydroxylase; cytochrome P45;
EHMT1
euchromatic histone-lysine N-methyltransferase 1
EHMT1; euchromatic histone-lysine N-methyltransferase 1; euchromatic histone methyltransferase 1; histone-lysine N-methyltransferase EHMT1; bA188C12.1; Eu HMTase1; FLJ12879; KIAA1876; KMT1D; H3-K9-HMTase 5; G9a like protein; G9a-like protein 1; lysine N-m;
EPB41
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked)
EPB41; erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked); EL1; protein 4.1; 4.1R; P4.1; EPB4.1; band 4.1; erythrocyte surface protein band 4.1; HE;
EPB41L3
erythrocyte membrane protein band 4.1-like 3
EPB41L3; erythrocyte membrane protein band 4.1-like 3; band 4.1-like protein 3; erythrocyte protein band 4.1-like 3; Epb4.1l3; Kiaa0987;
ERG
v-ets avian erythroblastosis virus E26 oncogene homolog
ERG; v-ets avian erythroblastosis virus E26 oncogene homolog; p55; erg-3; transcriptional regulator ERG; ets-related; TMPRSS2/ERG fusion; v-ets erythroblastosis virus E26 oncogene like; v-ets erythroblastosis virus E26 oncogene homolog; v-ets avian erythroblastosis virus E26 oncogene related; transcriptional regulator ERG (transforming protein ERG);
ERMAP
erythroblast membrane-associated protein (Scianna blood group)
ERMAP; erythroblast membrane-associated protein (Scianna blood group); erythroblast membrane associated protein , erythroblast membrane associated protein (RD and SC blood groups) , Radin blood group , RD, SC, Scianna blood group; erythroid membrane-associated protein; ERMAP_HUMAN; Erythroblast membrane associated protein; Erythroid membrane associated protein; hERMAP; MGC118810; MGC118811; MGC118812; MGC118813; PRO2801; Radin blood group (Rd); Radin blood group antigen; RD; SC; Scianna blood group (Sc); Scianna blood group antigen; OTTHUMP00000008916; OTTHUMP00000008917; OTTHUMP00000008918;
F2RL3
coagulation factor II (thrombin) receptor-like 3
F2RL3; coagulation factor II (thrombin) receptor-like 3; proteinase-activated receptor 4; PAR4; proteinase activated receptor 4; PAR-4; thrombin receptor-like 3; protease-activated receptor-4; proteinase-activated receptor-4; coagulation factor II recepto;
KLF1
Kruppel-like factor 1 (erythroid)
KLF1; Kruppel-like factor 1 (erythroid); Krueppel-like factor 1; EKLF; erythroid Kruppel like factor; monoclonal A3D8; erythroid Kruppel-like factor; erythroid krueppel-like transcription factor; erythroid-specific transcription factor EKLF; INLU; HBFQT;
MASTL
microtubule associated serine/threonine kinase-like
MASTL; microtubule associated serine/threonine kinase-like; serine/threonine-protein kinase greatwall; FLJ14813; THC2; 2700091H24Rik; C88295; GW; GWL; GWL_HUMAN; hGWL; MAST-L; MGC117975; microtubule associated serine/threonine kinase like; Microtubule-associated serine/threonine-protein kinase-like; RP11 85G18.2; greatwall protein kinase; GREATWALL; RP11-85G18.2;
MCM2
minichromosome maintenance complex component 2
MCM2; minichromosome maintenance complex component 2; CCNL1, CDCL1, MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae) , minichromosome maintenance deficient (S. cerevisiae) 2 (mitotin); DNA replication licensing factor MCM2; BM28; cdc;
MCM3
minichromosome maintenance complex component 3
MCM3; minichromosome maintenance complex component 3; MCM3 minichromosome maintenance deficient 3 (S. cerevisiae) , minichromosome maintenance deficient (S. cerevisiae) 3; DNA replication licensing factor MCM3; p102; RLF subunit beta; hRlf beta subunit;
MCM5
minichromosome maintenance complex component 5
MCM5; minichromosome maintenance complex component 5; CDC46, MCM5 minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) , minichromosome maintenance deficient (S. cerevisiae) 5 (cell division cycle 46); DNA replication licensing;
MCM7
minichromosome maintenance complex component 7
MCM7; minichromosome maintenance complex component 7; MCM2, MCM7 minichromosome maintenance deficient 7 (S. cerevisiae) , minichromosome maintenance deficient (S. cerevisiae) 7; DNA replication licensing factor MCM7; CDC47; CDC47 homolog; homolog of S.;
MT-CO2
mitochondrially encoded cytochrome c oxidase II
MT-CO2; mitochondrially encoded cytochrome c oxidase II; cytochrome c oxidase II , MTCO2; cytochrome c oxidase subunit II; CO2; COX2; COII; COX2_HUMAN; COXII; Cytochrome c oxidase II; Cytochrome c oxidase polypeptide II; Cytochrome c oxidase subunit 2; MS405; MS419; MT CO2; MTCO2;
NFE2
nuclear factor (erythroid-derived 2), 45kDa
NFE2; nuclear factor (erythroid-derived 2), 45kDa; nuclear factor (erythroid derived 2), 45kD; transcription factor NF-E2 45 kDa subunit; NF E2; erythroid-derived 2 45 kDa subunit; Leucine zipper protein NF-E2; Leucine zipper protein NFE2; NFE2_HUMAN; Nuclear factor (erythroid derived 2), 45kDa; Nuclear factor; Nuclear factor, erythroid derived 2 45 kDa subunit; p45; p45 NF-E2; p45 NFE2; Transcription factor NFE2 45 kDa subunit; OTTHUMP00000242012; OTTHUMP00000242013; OTTHUMP00000242015; nuclear factor, erythroid-derived 2 45 kDa subunit; NF-E2;
NFE2L2
nuclear factor, erythroid 2-like 2
NFE2L2; nuclear factor, erythroid 2-like 2; NRF2; nuclear factor erythroid 2-related factor 2; HEBP1; NFE2-related factor 2; NF-E2-related factor 2; nuclear factor erythroid-derived 2-like 2; nuclear factor (erythroid-derived 2)-like 2; nuclear factor, erythroid derived 2, like 2;
NPHS1
nephrosis 1, congenital, Finnish type (nephrin)
NPHS1; nephrosis 1, congenital, Finnish type (nephrin); CNF; NPHN; nephrin; nephrin; renal glomerulus-specific cell adhesion receptor;
OPHN1
oligophrenin 1
OPHN1; oligophrenin 1; mental retardation, X linked 60 , MRX60; oligophrenin-1; ARHGAP41; OPN1; OTTHUMP00000023451; mental retardation, X-linked 60; oligophrenin-1, Rho-GTPase activating protein; MRX60;
SLC4A1
solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)
SLC4A1; solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group); AE1, DI, EPB3, Waldner blood group , WD; band 3 anion transport protein; CD233; FR; Froese blood group; RTA1A; SW; Swann blood group; WR; Wright blood group; Solute carrier family 4 anion exchanger member 1; Solute carrier family 4 member 1; AE 1; AE1; Anion exchange protein 1; Anion exchanger 1; B3AT_HUMAN; BND3; DI; Diego blood group; EMPB3; EPB3; Erythrocyte membrane protein band 3; Erythroid anion exchange protein; Waldner blood group; WD; WD1; OTTHUMP00000210781; solute carrier fa;
SMARCB1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
SMARCB1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1; RDT; INI1; SNF5; Snr1; BAF47; MRD15; RTPS1; Sfh1p; hSNFS; SNF5L1; SWNTS1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1; hSNF5; SNF5 homolog; BRG1-associated factor 47; integrase interactor 1 protein; malignant rhabdoid tumor suppressor; SWI/SNF-related matrix-associated protein; sucrose nonfermenting, yeast, homolog-like 1;
SMARCD2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2
SMARCD2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2; BAF60B; chromatin remodeling complex BAF60B subunit;
SMARCD3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
SMARCD3; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3; 60 kDa BRG 1/Brm associated factor subunit C; 60 kDa BRG-1/Brm-associated factor subunit C; BAF60C; BRG1 associated factor 60C; BRG1-associated factor 60C; CRACD3; MGC111010; Rsc6p; SMRD3_HUMAN; SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily d member 3; mBAF60c; 1500001J14Rik; 2210409C08Rik;
SMC6
structural maintenance of chromosomes 6
SMC6; structural maintenance of chromosomes 6; SMC6 structural maintenance of chromosomes 6 like 1 (yeast) , SMC6L1; structural maintenance of chromosomes protein 6; FLJ22116; SMC protein 6; SMC6 structural maintenance of chromosomes 6-like 1; SMC-6; hSMC;
STK17B
serine/threonine kinase 17b
STK17B; serine/threonine kinase 17b; DRAK2; serine/threonine-protein kinase 17B; death-associated protein kinase-related 2; DAP kinase-related apoptosis-inducing protein kinase 2;
STK32A
serine/threonine kinase 32A
STK32A; serine/threonine kinase 32A; serine/threonine-protein kinase 32A; MGC22688; YANK1; A930015B13Rik; Serine/threonine protein kinase 32A; STK 32A; YANK 1; OTTHUMP00000223848; OTTHUMP00000223877;
STK38
serine/threonine kinase 38
STK38; serine/threonine kinase 38; serine/threonine-protein kinase 38; NDR; NDR1 protein kinase; nuclear Dbf2-related 1; nuclear Dbf2-related kinase 1; Ndr Ser/Thr kinase-like protein; serine threonine protein kinase; NDR1;
STK40
serine/threonine kinase 40
STK40; serine/threonine kinase 40; serine/threonine-protein kinase 40; MGC4796; SgK495; 2310004N11Rik; sugen kinase 495; Ser/Thr-like kinase; SINK-homologous serine/threonine-protein kinase; SHIK; RP11-268J15.4;
STON1-GTF2A1L
STON1-GTF2A1L readthrough
STON1-GTF2A1L; STON1-GTF2A1L readthrough; STON1-GTF2A1L protein; SALF; stoned B/TFIIA alpha/beta like factor; SBLF; STN 1; Stoned B like factor; Stonin 1; OTTHUMP00000159452; OTTHUMP00000200508; OTTHUMP00000201180; stoned B/TFIIA-alpha/beta-like factor;
STYK1
serine/threonine/tyrosine kinase 1
STYK1; serine/threonine/tyrosine kinase 1; tyrosine-protein kinase STYK1; DKFZp761P1010; NOK; SuRTK106; Novel oncogene with kinase domain; Protein kinase STYK1; Protein PK unique; Protein PK-unique; Styk 1; STYK1_HUMAN; SuRTK 106; Tyrosine protein kinase STYK1; OTTHUMP00000238727;
D4S234E
DNA segment on chromosome 4 (unique) 234 expressed sequence
D4S234E; DNA segment on chromosome 4 (unique) 234 expressed sequence; neuron-specific protein family member 1; Brain neuron cytoplasmic protein 1; NSG1; NSG1_HUMAN; OTTHUMP00000217301; OTTHUMP00000217302; OTTHUMP00000217303; OTTHUMP00000217305; carboxyterminally EE-tagged neuron-enriched endosomal 21 kDa protein; P21; D4S234; NEEP21;
C18orf1
chromosome 18 open reading frame 1
C18ORF1; chromosome 18 open reading frame 1; uncharacterized protein C18orf1; clone 22; CR001_HUMAN; hypothetical protein LOC753;
RIPK1
receptor (TNFRSF)-interacting serine-threonine kinase 1
RIPK1; receptor (TNFRSF)-interacting serine-threonine kinase 1; receptor-interacting serine/threonine-protein kinase 1; RIP; RIP-1; cell death protein RIP; receptor interacting protein; receptor-interacting protein 1; serine/threonine-protein kinase RIP;
COX6A1
cytochrome c oxidase subunit VIa polypeptide 1
COX6A1; cytochrome c oxidase subunit VIa polypeptide 1; COX6A; cytochrome c oxidase subunit 6A1, mitochondrial; mitochondrial; COX VIa L; COX VIa-L; COX6AL; CX6A1_HUMAN; Cytochrome c oxidase polypeptide VIa liver; Cytochrome c oxidase polypeptide VIa-liver; Cytochrome c oxidase subunit 6A1; Cytochrome c oxidase subunit 6A1 mitochondrial; Cytochrome C oxidase subunit VIa homolog; Cytochrome c oxidase subunit VIA liver; Cytochrome c oxidase subunit VIA-liver; MGC104500; MS412;
C17orf28
chromosome 17 open reading frame 28
C17ORF28; chromosome 17 open reading frame 28; protein hid-1 homolog; DMC1; downregulated in multiple cancer 1; down-regulated in multiple cancers 1; UPF0663 transmembrane protein C17orf28; FLJ43526;
CRY2
cryptochrome 2 (photolyase-like)
CRY2; cryptochrome 2 (photolyase-like); cryptochrome-2; growth-inhibiting protein 37; HCRY2; PHLL2; FLJ10332; KIAA0658;
CYB5R2
cytochrome b5 reductase 2
CYB5R2; cytochrome b5 reductase 2; NADH-cytochrome b5 reductase 2; b5R.2; Cytochrome b5 reductase b5R.2; NADH cytochrome b5 reductase 2; NB5R2_HUMAN;
COX6B2
cytochrome c oxidase subunit VIb polypeptide 2 (testis)
COX6B2; cytochrome c oxidase subunit VIb polypeptide 2 (testis); cytochrome c oxidase subunit 6B2; cancer/testis antigen 59; COXVIB2; CT59; cytochrome c oxidase subunit VIb; testes specific; FLJ32865; testis-specific isoform; COX VIb-2; COXVIb-2; CX6B2_HUMAN; Cytochrome c oxidase subunit VIb isoform 2; Cytochrome c oxidase subunit VIb, testis-specific isoform; FLJ46422; MGC119094; cytochrome c oxidase subunit VIb, testes specific; cytochrome c oxidase subunit VIb, testes-specific;
PKMYT1
protein kinase, membrane associated tyrosine/threonine 1
PKMYT1; protein kinase, membrane associated tyrosine/threonine 1; membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase; membrane associated tyrosine and threonine specific cdc2 inhibitory kinase; MYT1; myt1 kinase; FLJ20093; DKFZp5;
TBXAS1
thromboxane A synthase 1 (platelet)
TBXAS1; thromboxane A synthase 1 (platelet); thromboxane A synthase 1 (platelet, cytochrome P450, subfamily V); thromboxane-A synthase; CYP5; CYP5A1; cytochrome P450; family 5; subfamily A; polypeptide 1; THAS; TS; TXAS; TXS; Cytochrome P450 5A1; FLJ52771; GHOSAL; THAS_HUMAN; Thromboxane A synthase 1 platelet cytochrome P450 subfamily V; TXA synthase; OTTHUMP00000211927; OTTHUMP00000211928; OTTHUMP00000211929; OTTHUMP00000211930; OTTHUMP00000211931; platelet, cytochrome P450, subfamily V; cytochrome P450, family 5, subfamily A, polypeptide 1; thromboxane; BDPLT14;
CYP1A2
cytochrome P450, family 1, subfamily A, polypeptide 2
CYP1A2; cytochrome P450, family 1, subfamily A, polypeptide 2; CP12; P3-450; P450(PA); cytochrome P450 1A2; P450 form 4; cytochrome P450 4; cytochrome P(3)450; cytochrome P450-P3; dioxin-inducible P3-450; microsomal monooxygenase; xenobiotic monooxygenase; aryl hydrocarbon hydroxylase; flavoprotein-linked monooxygenase; cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2;
STK39
serine threonine kinase 39
STK39; serine threonine kinase 39; STE20/SPS1-related proline-alanine-rich protein kinase; DCHT; SPAK; STE20/SPS1 homolog (yeast); STE20/SPS1 homolog; ste-20-related kinase; Ste20-like protein kinase; small intestine SPAK-like kinase; serine/threonine-pro;
TASP1
taspase, threonine aspartase, 1
TASP1; taspase, threonine aspartase, 1; C20orf13, chromosome 20 open reading frame 13; threonine aspartase 1; dJ585I14.2; FLJ20212; taspase 1; taspase-1; C20orf13; MGC39159;
POR
P450 (cytochrome) oxidoreductase
POR; P450 (cytochrome) oxidoreductase; CPR; CYPOR; P450R; NADPH--cytochrome P450 reductase; NADPH-dependent cytochrome P450 reductase;
CYB5R3
cytochrome b5 reductase 3
CYB5R3; cytochrome b5 reductase 3; DIA1, diaphorase (NADH) (cytochrome b 5 reductase); NADH-cytochrome b5 reductase 3; B5R; Cytochrome b5 reductase; DIA1; Diaphorase 1; Diaphorase-1; NADH cytochrome b5 reductase 3; NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form; NB5R3_HUMAN; OTTHUMP00000028761; OTTHUMP00000198435; OTTHUMP00000198574; OTTHUMP00000198662; OTTHUMP00000198665;
C21orf59
chromosome 21 open reading frame 59
C21ORF59; chromosome 21 open reading frame 59; C21orf48, chromosome 21 open reading frame 48; uncharacterized protein C21orf59; FLJ20467; C21orf48; CU059_HUMAN; FLJ37137; FLJ40247;
C10orf82
chromosome 10 open reading frame 82
C10ORF82; chromosome 10 open reading frame 82; uncharacterized protein C10orf82; Em:AC016825.4; MGC33547; CJ082_HUMAN; FLJ40268;
C15orf40
chromosome 15 open reading frame 40
C15ORF40; chromosome 15 open reading frame 40; UPF0235 protein C15orf40; MGC29937; FLJ33606;
C16orf72
chromosome 16 open reading frame 72
C16ORF72; chromosome 16 open reading frame 72; UPF0472 protein C16orf72; FLJ41272; PRO0149;
C1orf50
chromosome 1 open reading frame 50
C1ORF50; chromosome 1 open reading frame 50; uncharacterized protein C1orf50; MGC955; CA050_HUMAN; OTTHUMP00000008833;
C2orf40
chromosome 2 open reading frame 40
C2ORF40; chromosome 2 open reading frame 40; augurin; ECRG4; esophageal cancer related gene 4 protein; esophageal cancer-related gene 4 protein;
C9orf41
chromosome 9 open reading frame 41
C9ORF41; chromosome 9 open reading frame 41; UPF0586 protein C9orf41; FLJ25795;
MCM3AP
minichromosome maintenance complex component 3 associated protein
MCM3AP; minichromosome maintenance complex component 3 associated protein; MCM3 minichromosome maintenance deficient 3 (S. cerevisiae) associated protein , minichromosome maintenance deficient (S. cerevisiae) 3 associated protein; 80 kDa MCM3-associated protein; GANP; KIAA0572; Map80; MCM3 import protein; germinal center-associated nuclear protein; minichromosome maintenance deficient 3-associated protein; MCM3 minichromosome maintenance deficient 3 associated protein; FLJ44336; FLJ45306;
ILKAP
integrin-linked kinase-associated serine/threonine phosphatase
ILKAP; integrin-linked kinase-associated serine/threonine phosphatase; integrin linked kinase associated serine/threonine phosphatase 2C; integrin-linked kinase-associated serine/threonine phosphatase 2C; DKFZP434J2031; FLJ10181; protein phosphatase 2c, d;
ANK1
ankyrin 1, erythrocytic
ANK1; ankyrin 1, erythrocytic; ANK; ankyrin-1; SPH1; ANK-1; ANK1_HUMAN; Ankyrin 1; Ankyrin R; Ankyrin-R; Erythrocyte ankyrin; SPH2;
ANTXR1
anthrax toxin receptor 1
ANTXR1; anthrax toxin receptor 1; anthrax toxin receptor; ATR; FLJ10601; FLJ21776; TEM8; tumor endothelial marker 8 precursor; 2310008J16Rik; 2810405N18Rik; tumor endothelial marker 8; FLJ11298;
C10orf2
chromosome 10 open reading frame 2
C10ORF2;chromosome 10 open reading frame 2;infantile onset spinocerebellar ataxia (autosomal recessive), IOSCA;twinkle protein, mitochondrial;FLJ21832;PEO;PEO1;twinkle;TWINKLE;TWINL;ataxin 8;mitochondrial twinkle protein;T7-like mitochondrial DNA helicase;progressive external ophthalmoplegia 1 protein;T7 gp4-like protein with intramitochondrial nucleoid localization;SCA8;ATXN8;IOSCA;PEOA3;SANDO;MTDPS7;
C13orf15
chromosome 13 open reading frame 15
C13ORF15; chromosome 13 open reading frame 15; response gene to complement 32 protein; bA157L14.2; response gene to complement 32; RGC 32; RGC32; KIAA0564; MGC87338; RGC-32;
C15orf29
chromosome 15 open reading frame 29
C15ORF29; chromosome 15 open reading frame 29; uncharacterized protein C15orf29; FLJ22557; Hypothetical protein LOC79768; MGC117356; OTTHUMP00000159730;
C20orf7
chromosome 20 open reading frame 7
C20ORF7; chromosome 20 open reading frame 7; probable methyltransferase C20orf7, mitochondrial; dJ842G6.1; mitochondrial; CT007_HUMAN; Probable methyltransferase C20orf7; bA526K24.2;
C2orf28
chromosome 2 open reading frame 28
C2ORF28; chromosome 2 open reading frame 28; apoptosis-related protein 3; apoptosis related protein 3; APR3; HSPC013; p18; apoptosis related protein APR-3; APR-3; APR--3; PRO240;
C4orf6
chromosome 4 open reading frame 6
C4ORF6;chromosome 4 open reading frame 6;uncharacterized protein C4orf6;aC1;expressed in neuroblastoma;
C7orf10
chromosome 7 open reading frame 10
C7ORF10; chromosome 7 open reading frame 10; caiB/baiF CoA-transferase family protein C7orf10; dermal papilla derived protein 13; DERP13; FLJ11808; ORF19; Russel Silver syndrome candidate; Hypothetical protein LOC79783; Russel-Silver syndrome candidate; Uncharacterized protein C7orf10; dermal papilla-derived protein 13;
C7orf16
chromosome 7 open reading frame 16
chromosome 7 open reading frame 16; GSBS; G-substrate; OTTHUMP00000158793; OTTHUMP00000202600;
C9orf95
chromosome 9 open reading frame 95
C9ORF95; chromosome 9 open reading frame 95; nicotinamide riboside kinase 1; bA235O14.2; FLJ20559; NRK1; Nicotinic acid riboside kinase 1; NmR-K 1; Ribosylnicotinamide kinase 1; Ribosylnicotinic acid kinase 1; RNK 1; NRK 1; RP11-235O14.2;
CDY2A
chromodomain protein, Y-linked, 2A
CDY2A; chromodomain protein, Y-linked, 2A; CDY2, chromodomain protein, Y chromosome, 2 , chromodomain protein, Y linked, 2; testis-specific chromodomain protein Y 2; Y chromosome chromodomain protein 2A; chromodomain protein, Y chromosome, 2; testis-spe;
CDYL
chromodomain protein, Y-like
CDYL; chromodomain protein, Y-like; chromodomain protein, Y chromosome like; chromodomain Y-like protein; CDY like; autosomal; CDYL1; DKFZP586C1622; testis specific chromodomain Y like protein; CDY-like, autosomal; testis-specific chromodomain Y-like prot;
CECR1
cat eye syndrome chromosome region, candidate 1
CECR1; cat eye syndrome chromosome region, candidate 1; IDGFL; adenosine deaminase CECR1; ADGF; Cat eye syndrome chromosome region candidate 1; Cat eye syndrome critical region protein 1; Cat eye syndrome critical region protein 1 precursor; CECR 1; adenosine deaminase 2; ADA2;
CHAF1B
chromatin assembly factor 1, subunit B (p60)
CHAF1B; chromatin assembly factor 1, subunit B (p60); chromatin assembly factor 1 subunit B; CAF 1; CAF1; CAF1A; CAF1P60; Chromatin assembly factor I; p60 subunit; human chromatin assembly factor I p60 subunit; M phase phosphoprotein 7; MPHOSPH7; MPP7; CA;
CHD1
chromodomain helicase DNA binding protein 1
CHD1; chromodomain helicase DNA binding protein 1; chromodomain-helicase-DNA-binding protein 1; CHD-1; ATP-dependent helicase CHD1; DKFZp686E2337;
CHRNB3
CHRNB3 cholinergic receptor, nicotinic, beta 3
CHRNB3; cholinergic receptor, nicotinic, beta 3; neuronal acetylcholine receptor subunit beta-3; OTTHUMP00000229136; cholinergic receptor, nicotinic, beta polypeptide 3; acetylcholine receptor, neuronal nicotinic, beta-3 subunit;
CLTA
clathrin, light chain A
CLTA;clathrin, light chain A;clathrin, light polypeptide (Lca);clathrin light chain A;Lca;LCA;
CLTC
clathrin, heavy chain (Hc)
CLTC; clathrin, heavy chain (Hc); Hc; CHC; CHC17; CLH-17; CLTCL2; clathrin heavy chain 1; clathrin, heavy polypeptide (Hc); clathrin, heavy polypeptide-like 2; clathrin heavy chain on chromosome 17;
COX4I1
cytochrome c oxidase subunit IV isoform 1
COX4I1; cytochrome c oxidase subunit IV isoform 1; COX4; COXIV; COX4-1; cytochrome c oxidase subunit 4 isoform 1, mitochondrial; COX IV-1; cytochrome c oxidase polypeptide IV;
COX5A
cytochrome c oxidase subunit Va
COX5A; cytochrome c oxidase subunit Va; cytochrome c oxidase subunit 5A, mitochondrial; cytochrome c oxidase polypeptide Va; mitochondrial cytochrome c oxidase subunit Va; cytochrome c oxidase polypeptide, mitochondrial; VA; COX; COX-VA;
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
CYP19A1; cytochrome P450, family 19, subfamily A, polypeptide 1; ARO; ARO1; CPV1; CYAR; CYP19; CYPXIX; P-450AROM; aromatase; estrogen synthase; estrogen synthetase; cytochrome P-450AROM; cytochrome P450 19A1; microsomal monooxygenase; flavoprotein-linked monooxygenase; cytochrome P450, subfamily XIX (aromatization of androgens);
CYP26A1
cytochrome P450, family 26, subfamily A, polypeptide 1
CYP26A1; cytochrome P450, family 26, subfamily A, polypeptide 1; cytochrome P450, subfamily XXVIA, polypeptide 1; cytochrome P450 26A1; CP26; CYP26; P450RAI; P450RAI1; hP450RAI; cytochrome P450RAI; retinoic acid 4-hydroxylase; P450, retinoic acid-inactiva;
CYP26B1
cytochrome P450, family 26, subfamily B, polypeptide 1
CYP26B1; cytochrome P450, family 26, subfamily B, polypeptide 1; cytochrome P450 26B1; P450RAI 2; CP26; CYP26A2; Cytochrome P450 26A2; Cytochrome P450 family 26 subfamily B polypeptide 1; Cytochrome P450 retinoic acid-inactivating 2; Cytochrome P450 retinoid metabolizing protein; Cytochrome P450RAI-2; DKFZp686G0638; EC 1.14.; MGC129613; P450 26A2; P450 retinoic acid inactivating 2; Retinoic acid metabolizing cytochrome; OTTHUMP00000160175; cytochrome P450 CYP26B1 variant 2; retinoic acid-metabolizing cytochrome; P450RAI-2;
CYP2A6
cytochrome P450, family 2, subfamily A, polypeptide 6
CYP2A6; cytochrome P450, family 2, subfamily A, polypeptide 6; CYP2A3, cytochrome P450, subfamily IIA (phenobarbital inducible), polypeptide 6; cytochrome P450 2A6; CPA6; CYP2A; cytochrome P450(I); cytochrome P450 IIA3; coumarin 7-hydroxylase; xenobiotic;
CYP3A5
cytochrome P450, family 3, subfamily A, polypeptide 5
CYP3A5; cytochrome P450, family 3, subfamily A, polypeptide 5; cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 5; cytochrome P450 3A5; CP35; P450PCN3; PCN3; cytochrome P-450; niphedipine oxidase; cytochrome P450 HLp2; cytochrome P450-PC;
CYP3A7
cytochrome P450, family 3, subfamily A, polypeptide 7
CYP3A7; cytochrome P450, family 3, subfamily A, polypeptide 7; cytochrome P450, subfamily IIIA, polypeptide 7; cytochrome P450 3A7; CP37; P450 HFLA; cytochrome P450-HFLA; microsomal monooxygenase; xenobiotic monooxygenase; aryl hydrocarbon hydroxylase; fl;
CYP4F11
cytochrome P450, family 4, subfamily F, polypeptide 11
CYP4F11; cytochrome P450, family 4, subfamily F, polypeptide 11; cytochrome P450, subfamily IVF, polypeptide 11; cytochrome P450 4F11; CYPIVF11;
CYP4F3
cytochrome P450, family 4, subfamily F, polypeptide 3
CYP4F3; cytochrome P450, family 4, subfamily F, polypeptide 3; cytochrome P450, subfamily IVF, polypeptide 3 (leukotriene B4 omega hydroxylase) , LTB4H; leukotriene-B(4) omega-hydroxylase 2; CYP4F; CP4F3_HUMAN; CPF3; CYPIVF3; Cytochrome P450 4F3; Cytochrome P450 LTB omega; Cytochrome P450, subfamily IVF, polypeptide 3 (leukotriene B4 omega hydroxylase); Cytochrome P450-LTB-omega; Leukotriene B(4) 20 monooxygenase; Leukotriene B(4) omega hydroxylase; leukotriene B4 omega hydroxylase; Leukotriene-B(4) 20-monooxygenase 2; leukotriene-B4 20-monooxygenase; LTB4H; cytochrome P-450; cytochrome P450, subfamily IVF, polypeptide 3;
CYP7A1
cytochrome P450, family 7, subfamily A, polypeptide 1
CYP7A1; cytochrome P450, family 7, subfamily A, polypeptide 1; CP7A; CYP7; CYPVII; cholesterol 7-alpha-monooxygenase; cytochrome P450 7A1; cholesterol 7-alpha-hydroxylase; cytochrome P450, subfamily VIIA polypeptide 1;
EPB41L1
erythrocyte membrane protein band 4.1-like 1
EPB41L1; erythrocyte membrane protein band 4.1-like 1; band 4.1-like protein 1; KIAA0338; neuronal protein 4.1; neuron-type nonerythroid protein 4.1; 4.1N; MRD11; MGC11072; DKFZp686H17242;
EPB42
erythrocyte membrane protein band 4.2
EPB42; erythrocyte membrane protein band 4.2; Erythrocyte surface protein band 4.2; MGC116735; MGC116737; PA; EPB42_HUMAN; Erythrocyte protein 4.2; P4.2; SPH5; OTTHUMP00000161294;
F2R
Coagulation factor II (thrombin) receptor
Coagulation factor II receptor; CF2R; Coagulation factor II (thrombin) receptor; F2R; HTR; PAR 1; PAR-1; PAR1; Protease activated receptor 1; Proteinase activated receptor 1; Proteinase-activated receptor 1; Thrombin receptor; TR;
FRAP1
MTOR mechanistic target of rapamycin (serine/threonine kinase)
FRAP; FRAP1; FRAP2; RAFT1; RAPT1; FLJ44809; serine/threonine-protein kinase mTOR; OTTHUMP00000001983; rapamycin target protein 1; mammalian target of rapamycin; rapamycin and FKBP12 target 1; FKBP-rapamycin associated protein; rapamycin associated protein FRAP2; FKBP12-rapamycin complex-associated protein 1; FK506 binding protein 12-rapamycin associated protein 1; FK506 binding protein 12-rapamycin associated protein 2; FK506-binding protein 12-rapamycin complex-associated protein 1;
HAAO
3-hydroxyanthranilate 3,4-dioxygenase
HAAO; 3-hydroxyanthranilate 3,4-dioxygenase; HAD; 3-hydroxyanthranilate oxygenase; 3-hydroxyanthranilic acid dioxygenase; HAO; 3-HAO;
HCCS
holocytochrome c synthase
HCCS; holocytochrome c synthase; holocytochrome c synthase (cytochrome c heme lyase); cytochrome c-type heme lyase; CCHL; cytochrome c heme lyase; OTTHUMP00000022904; OTTHUMP00000022905; DKFZp779I1858; EC 4.4.1.17; Holocytochrome c type synthase; MCOPS7; OTTHUMP00000022903; OTTMUSP00000021173; OTTMUSP00000021174; RGD1563855; RP23-37L2.1; cytochrome c heme-lyase; holocytochrome c-type synthase;
HFE
hemochromatosis
hemochromatosis; HFE; HH; HFE1; HLA-H; MVCD7; TFQTL2; hereditary; hemochromatosis protein; high Fe; MHC class I-like protein HFE; hereditary hemochromatosis protein HLA-H;
JMJD7-PLA2G4B
JMJD7-PLA2G4B readthrough
JMJD7-PLA2G4B;JMJD7-PLA2G4B readthrough;JMJD7-PLA2G4B protein;jumonji domain containing 7-phospholipase A2, group IVB (cytosolic) read-through;HsT16992;cPLA2-beta;
MAST2
microtubule associated serine/threonine kinase 2
MAST2; microtubule associated serine/threonine kinase 2; microtubule-associated serine/threonine-protein kinase 2; KIAA0807; MAST205; EC 2.7.11.1 3; FLJ39200; MAST 2; MAST 205; Microtubule associated testis specific serine/threonine protein kinase; MTSSK; OTTHUMP00000009697 2; OTTHUMP00000046616; RP4 533D7.1; RP4-533D7.1 2; OTTHUMP00000009697; RP4-533D7.1;
MCM4
minichromosome maintenance complex component 4
MCM4; minichromosome maintenance complex component 4; CDC21, MCM4 minichromosome maintenance deficient 4 (S. cerevisiae); DNA replication licensing factor MCM4; CDC54; hCdc21; MGC33310; P1 Cdc21; CDC21 homolog; minichromosome maintenance deficient 4; hom;
MCM6
minichromosome maintenance complex component 6
MCM6; minichromosome maintenance complex component 6; MCM6 minichromosome maintenance deficient 6 (MIS5 homolog, S. pombe) (S. cerevisiae) , minichromosome maintenance deficient (mis5, S. pombe) 6 , minichromosome maintenance deficient 6 homolog (S. cer;
MCM8
minichromosome maintenance complex component 8
MCM8; minichromosome maintenance complex component 8; C20orf154, chromosome 20 open reading frame 154; DNA replication licensing factor MCM8; dJ967N21.5; MGC4816; MGC12866; MGC119522; MGC119523; REC; REC homolog (Drosophila); REC homolog; minichromosome;
NPHP4
nephronophthisis 4
NPHP4; nephronophthisis 4; nephrocystin-4; KIAA0673; nephrocystin 4; nephroretinin; POC10; POC10 centriolar protein homolog (Chlamydomonas); SLSN4; NPHP4_HUMAN; POC10 centriolar protein homolog;
PCDH24
CDHR2 cadherin-related family member 2
PCLKC; PCDH24; FLJ20124; FLJ20383; MGC163154; cadherin-related family member 2; protocadherin 24; protocadherin-24; OTTHUMP00000223383; OTTHUMP00000223384; OTTHUMP00000223385;
PSTPIP1
proline-serine-threonine phosphatase interacting protein 1
PSTPIP1; proline-serine-threonine phosphatase interacting protein 1; proline-serine-threonine phosphatase-interacting protein 1; CD2 antigen binding protein 1; CD2 cytoplasmic tail binding protein; CD2BP1; CD2BP1L; CD2BP1S; H PIP; PAPAS; PEST phosphatase interacting protein 1; PSTPIP; CD2 binding protein 1; HPIP; Proline serine threonine phosphatase interacting protein 1; CD2-binding protein 1; CD2 antigen-binding protein 1; CD2 cytoplasmic tail-binding protein; PEST phosphatase-interacting protein 1; H-PIP;
PXK
PX domain containing serine/threonine kinase
PXK; PX domain containing serine/threonine kinase; PX domain-containing protein kinase-like protein; FLJ20335; K-ATPase; Modulator of Na; Modulator of Na K ATPase; Modulator of Na K ATPase long form; MONaKA; PX domain containing protein kinase like protein; PX ser/thr kinase v2; PX serine/threonine kinase; PXK_HUMAN; OTTHUMP00000214170; OTTHUMP00000214171; OTTHUMP00000214173; OTTHUMP00000214175; OTTHUMP00000214179; modulator of Na,K-ATPase long form;
RCBTB1
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1
RCBTB1; regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1; GLP; CLLD7; CLLL7; RCC1 and BTB domain-containing protein 1; CLL deletion region gene 7 protein; GDP/GTP exchange factor (GEF)-like protein; chronic lymphocytic leukemia deletion region gene 7 protein; regulator of chromosome condensation and BTB domain-containing protein 1;
RCBTB2
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2
RCBTB2; regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2; CHC1L, chromosome condensation 1 like; RCC1 and BTB domain-containing protein 2; CHC1 L; CHC1L; Chromosome condensation 1 like; RCBT2; RCC1 and BTB domain containing protein 2; RCC1 like G exchanging factor; RCC1 like G exchanging factor RLG; Regulator of chromosome condensation (RCC1) and BTB domain containing protein 2; Regulator of chromosome condensation and BTB domain containing protein 2; RLG; CHC1-L; RCC1-like G exchanging factor RLG; regulator of chromosome condensation and BTB domain-containing protein 2;
RIPK3
receptor-interacting serine-threonine kinase 3
RIPK3; receptor-interacting serine-threonine kinase 3; receptor-interacting serine/threonine-protein kinase 3; RIP3; RIP-3; RIP-like protein kinase 3; receptor interacting protein 3; receptor-interacting protein 3;
RIPK4
receptor-interacting serine-threonine kinase 4
RIPK4; receptor-interacting serine-threonine kinase 4; ANKRD3, ankyrin repeat domain 3; receptor-interacting serine/threonine-protein kinase 4; ANKK2; DIK; PKC delta interacting protein kinase; PKK; protein kinase C associated kinase; RIP4; protein kinas;
RP6-213H19.1
MST4 serine/threonine protein kinase MST4
MASK; serine/threonine-protein kinase MST4; OTTHUMP00000024034; OTTHUMP00000215131; OTTHUMP00000215132; OTTHUMP00000215133; OTTHUMP00000215134; STE20-like kinase MST4; mammalian sterile 20-like 4; Mst3 and SOK1-related kinase; serine/threonine-protein kinase MASK; mammalian Ste20-like protein kinase 4;
SIT1
signaling threshold regulating transmembrane adaptor 1
SIT1; signaling threshold regulating transmembrane adaptor 1; suppression inducing transmembrane adaptor 1; signaling threshold-regulating transmembrane adapter 1; SHP2 interacting transmembrane adaptor; SIT; gp30/40; suppression-inducing transmembrane ad;
SMARCA2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
SMARCA2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2; SNF2L2; probable global transcription activator SNF2L2; BAF190; BRM; hBRM; hSNF2a; SNF2; SNF2LA; Sth1p; SWI2; BAF190B; SNF2-alpha; protein brahma h;
SMARCA5
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
SMARCA5; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5; hISWI; hSNF2H; ISWI; sucrose nonfermenting-like 5; sucrose nonfermenting protein 2 homolog; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5; SNF2H; WCRF135;
SMARCE1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
SMARCE1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1; BAF57; BRG1-associated factor 57; chromatin remodeli;
SMC2
structural maintenance of chromosomes 2
SMC2; structural maintenance of chromosomes 2; SMC2 (structural maintenance of chromosomes 2, yeast) like 1 , SMC2 structural maintenance of chromosomes 2 like 1 (yeast) , SMC2L1; structural maintenance of chromosomes protein 2; CAP E; hCAP E; SMC-2; SMC;
SMC3
structural maintenance of chromosomes 3
SMC3; structural maintenance of chromosomes 3; BAM; BMH; HCAP; CDLS3; CSPG6; SMC3L1; structural maintenance of chromosomes protein 3; SMC protein 3; chromosome-associated polypeptide; chondroitin sulfate proteoglycan 6 (bamacan); basement membrane-associated chondroitin proteoglycan;
SPTB
spectrin, beta, erythrocytic
SPTB; spectrin, beta, erythrocytic; spectrin beta chain, erythrocyte; spherocytosis; clinical type I; beta-I spectrin; membrane cytoskeletal protein; EL3; HS2; SPH2; HSPTB1;
SPTBN2
spectrin, beta, non-erythrocytic 2
SPTBN2; spectrin, beta, non-erythrocytic 2; SCA5, spinocerebellar ataxia 5; spectrin beta chain, brain 2; beta-III spectrin; spectrin, non-erythroid beta chain 2; glutamate transporter EAAT4-associated protein 41; SCA5; GTRAP41;
SS18
synovial sarcoma translocation, chromosome 18
SS18; synovial sarcoma translocation, chromosome 18; SSXT; protein SSXT; SYT; MGC116875; Protein SYT; SSXT/SSX4v fusion; SSXT_HUMAN; Synovial sarcoma translocated to X chromosome; Synovial sarcoma translocated to X chromosome protein; Synovial sarcoma translocation chromosome 18; SYT SSX1; SYT SSX2; SYT/SSX4v fusion protein; SYTSSX1; SYTSSX2; synovial sarcoma, translocated to X chromosome;
STK11
serine/threonine kinase 11
STK11; serine/threonine kinase 11; PJS; LKB1; hLKB1; serine/threonine-protein kinase STK11; liver kinase B1; polarization-related protein LKB1; renal carcinoma antigen NY-REN-19; serine/threonine-protein kinase 11; serine/threonine-protein kinase LKB1;
STK17A
serine/threonine kinase 17a
STK17A; serine/threonine kinase 17a; DRAK1; serine/threonine-protein kinase 17A; death-associated protein kinase-related 1; serine/threonine kinase 17a (apoptosis-inducing); DAP kinase-related apoptosis-inducing protein kinase 1;
STK19
serine/threonine kinase 19
STK19; serine/threonine kinase 19; serine/threonine-protein kinase 19; D6S60; G11; RP1; MHC class III HLA-RP1; nuclear serine/threonine protein kinase; D6S60E; HLA-RP1; MGC117388;
STK31
serine/threonine kinase 31
STK31; serine/threonine kinase 31; serine/threonine-protein kinase 31; SgK396; TDRD8; sugen kinase 396; tudor domain containing 8; serine/threonine-protein kinase NYD-SPK; FLJ16102;
STK32C
serine/threonine kinase 32C
STK32C; serine/threonine kinase 32C; serine/threonine-protein kinase 32C; MGC23665; PKE; YANK3; PKE protein kinase; protein kinase (PKE); RP11-140A10.1;
STK38L
serine/threonine kinase 38 like
STK38L; serine/threonine kinase 38 like; serine/threonine-protein kinase 38-like; KIAA0965; NDR2; nuclear Dbf2 related 2; NDR2 protein kinase; nuclear Dbf2-related 2; nuclear Dbf2-related kinase 2;
TREX1
three prime repair exonuclease 1
TREX1; three prime repair exonuclease 1; AGS1, Aicardi Goutieres syndrome 1; DRN3; DNase III; 3 repair exonuclease 1; 3-5 exonuclease TREX1; CRV; AGS1; HERNS; DKFZp434J0310;
UCRC
UQCR10 ubiquinol-cytochrome c reductase, complex III subunit X
QCR9; UCRC; HSPC051; HSPC119; HSPC151; UCCR7.2; cytochrome b-c1 complex subunit 9; OTTHUMP00000199673; OTTHUMP00000199674; complex III subunit 9; complex III subunit X; cytochrome C1, nonheme 7kDa protein; cytochrome c1 non-heme 7 kDa protein; ubiquinol-cytochrome c reductase complex (7.2 kD); ubiquinol-cytochrome c reductase complex 7.2 kDa protein; ubiquinol-cytochrome c reductase, complex III subunit X, 7.2kDa;
UQCRH
ubiquinol-cytochrome c reductase hinge protein
UQCRH; ubiquinol-cytochrome c reductase hinge protein; cytochrome b-c1 complex subunit 6, mitochondrial; QCR6; ubiquinol cytochrome c reductase; complex III subunit VIII; UQCR8; Complex III subunit 6; Cytochrome b c1 complex subunit 6; Cytochrome b c1 complex subunit 6 mitochondrial; Cytochrome c1 non heme 11 kDa protein; MGC111572; Mitochondrial hinge protein; QCR 6; Ubiquinol cytochrome c reductase complex 11 kDa protein; Ubiquinol cytochrome c reductase complex 11 kDa protein mitochondrial; Ubiquinol cytochrome c reductase hinge protein; cytochrome c1 non-heme 11 kDa protein; ubiquinol-cytochrome c reductase complex 11 kDa protein; ubiquinol-cytochrome c reductase, complex III subunit VIII;
WBSCR22
Williams Beuren syndrome chromosome region 22
WBSCR22; Williams Beuren syndrome chromosome region 22; uncharacterized methyltransferase WBSCR22; MGC2022; MGC5140; MGC19709; PP3381; WBMT; HASJ4442; HUSSY 3; HUSSY3; WBS22_HUMAN; Williams Beuren candidate region putative methyltransferase; Williams Beuren syndrome chromosome region 22 protein; Williams-Beuren syndrome chromosomal region 22 protein; Williams-Beuren candidate region putative methyltransferase; HUSSY-3;
C20orf20
chromosome 20 open reading frame 20
C20ORF20; chromosome 20 open reading frame 20; MRG-binding protein; Eaf7; FLJ10914; MRG15BP; MRGBP; MRG(MORF4-related gene)-binding protein; URCC4;
CHD7
chromodomain helicase DNA binding protein 7
CHD7; chromodomain helicase DNA binding protein 7; CRG; HH5; IS3; KAL5; chromodomain-helicase-DNA-binding protein 7; CHARGE association; ATP-dependent helicase CHD7; chromodomain helicase DNA binding protein 7 isoform CRA_e;
D17Wsu104e
DNA segment, Chr 17, Wayne State University 104, expressed
D17WSU104E; DNA segment, Chr 17, Wayne State University 104, expressed; UPF0556 protein C19orf10 homolog; interleukin-25; stromal cell-derived growth factor SF20; Il25; IL-25; Ly6elg;
STK25
serine/threonine kinase 25
STK25; serine/threonine kinase 25; serine/threonine kinase 25 (Ste20, yeast homolog); serine/threonine-protein kinase 25; SOK1; YSK1; SOK-1; ste20-like kinase; Ste20, yeast homolog; ste20/oxidant stress response kinase 1; sterile 20/oxidant stress-respons;
STK32B
serine/threonine kinase 32B
STK32B; serine/threonine kinase 32B; serine/threonine-protein kinase 32B; HSA250839; STK32; STKG6; YANK2; gene for serine/threonine protein kinase;
C14orf129
chromosome 14 open reading frame 129
C14ORF129; chromosome 14 open reading frame 129; GSK3-beta interaction protein; GSK3beta interaction protein; GSKIP; GSKIP_HUMAN; MGC4945; UPF0279; HSPC210;
C16orf53
chromosome 16 open reading frame 53
C16ORF53; chromosome 16 open reading frame 53; PAXIP1-associated protein 1; GAS; glutamate rich coactivator interacting with SRC1/NCOA1; MGC4606; PTIP-associated 1 protein; PTIP-associated protein 1; glutamate-rich coactivator interacting with SRC1/NCOA1;
C10orf81
chromosome 10 open reading frame 81
C10ORF81; chromosome 10 open reading frame 81; PH domain-containing protein C10orf81; bA211N11.2; FLJ23537; PH domain containing protein C10orf81; epididymis luminal protein 185; HEL185; hypothetical protein LOC79949; OTTHUMP00000020508; RP11-211N11.2;
C12orf24
chromosome 12 open reading frame 24
C12ORF24; chromosome 12 open reading frame 24; uncharacterized protein C12orf24; HSU79274; Hypothetical protein LOC29902; Protein predicted by clone 23733; OTTHUMP00000241430; OTTHUMP00000241431;
C13orf31
chromosome 13 open reading frame 31
chromosome 13 open reading frame 31; FLJ38725; DKFZp686D11119; hypothetical protein LOC144811; RP11-5G9.2; OTTHUMP00000178593;
C14orf126
chromosome 14 open reading frame 126
C14ORF126; chromosome 14 open reading frame 126; probable D-tyrosyl-tRNA(Tyr) deacylase 2; MGC9912; Chromosome 14 open reading frame 12; DTD2_HUMAN; FLJ51408;
C16orf35
chromosome 16 open reading frame 35
C16ORF35;chromosome 16 open reading frame 35;C16orf35, chromosome 16 open reading frame 35;CGTHBA;conserved gene telomeric to alpha globin cluster;HS 40;MARE;NPR3;RMD11;-14;Q12980;
C17orf37
chromosome 17 open reading frame 37
chromosome 17 open reading frame 37; HBV XAg-transactivated protein 4; XTP4; RDX12; MGC14832; C35; ORB3; HBV X-transactivated gene 4 protein; Protein C35; protein C17orf37; OTTHUMP00000164348;
C18orf23
chromosome 18 open reading frame 23
chromosome 18 open reading frame 23; FLJ34218; FLJ31435;
C19orf50
chromosome 19 open reading frame 50
C19ORF50; chromosome 19 open reading frame 50; C19orf50, chromosome 19 open reading frame 50; UPF0459 protein C19orf50; FLJ25480; KXDL; MGC2749; Hypothetical protein LOC79036; MST096; MSTP096;
C1orf67
chromosome 1 open reading frame 67
C1ORF67; chromosome 1 open reading frame 67; Coiled coil domain containing protein C1orf67; Hypothetical protein LOC200095; MGC149665; MGC149666; MGC27277; MGC51214;
C21orf2
chromosome 21 open reading frame 2
C21ORF2; chromosome 21 open reading frame 2; uncharacterized protein C21orf2; A2; nuclear encoded mitochondrial protein; YF5; C21orf HUMF09G8.5; Hypothetical protein LOC755; Nuclear encoded mitochondrial protein cDNA A2 YF5; YF 5; YF5/A2; nuclear encoded mitochondrial protein, cDNA A2-YF5;
C2orf62
chromosome 2 open reading frame 62
C2ORF62; chromosome 2 open reading frame 62; uncharacterized protein C2orf62; MGC50811; CB062_HUMAN; Hypothetical gene supported by BC052750; Hypothetical protein LOC375307; OTTHUMP00000164138; Uncharacterized protein C2orf62 homolog;
C4orf43
chromosome 4 open reading frame 43
C4ORF43; chromosome 4 open reading frame 43; UPF0534 protein C4orf43; FLJ11184; FLJ5295; Hypothetical protein FLJ11184; Hypothetical protein LOC55319;
C6orf199
chromosome 6 open reading frame 199
C6ORF199; chromosome 6 open reading frame 199; MGC26954; dJ70A9.1;
C9orf103
chromosome 9 open reading frame 103
C9ORF103; chromosome 9 open reading frame 103; probable gluconokinase; bA522I20.2; Gluconokinase like protein; OTTHUMP00000021547; RP11-522I20.2; Glucokinase like protein; Gluconate kinase; OTTHUMP00000021546; OTTHUMP00000021548; glucokinase-like protein; gluconokinase-like protein;
FLJ23834
CDHR3 cadherin-related family member 3
CDH28; FLJ23834; FLJ43271; MGC133292; MGC133293; cadherin-related family member 3; OTTHUMP00000212237; OTTHUMP00000212239; cadherin-like protein 28;
KIR3DX1
killer cell immunoglobulin-like receptor, three domains, X1
killer cell immunoglobulin-like receptor, three domains, X1; FLJ00060; KIR3DL0; LENG12; leukocyte receptor cluster (LRC) member 12; Leukocyte receptor cluster member 12; KIR3DX1;
ACIN1
apoptotic chromatin condensation inducer 1
ACIN1; apoptotic chromatin condensation inducer 1; ACINUS, apoptotic chromatin condensation inducer in the nucleus; apoptotic chromatin condensation inducer in the nucleus; fSAP152; functional spliceosome associated protein 152; KIAA0670; functional spli;
C14ORF169
chromosome 14 open reading frame 169
C14ORF169; chromosome 14 open reading frame 169; lysine-specific demethylase NO66; FLJ21802; NO66; hsNO66; nucleolar protein 66; MYC-associated protein with JmjC domain; MAPJD;
CHD6
chromodomain helicase DNA binding protein 6
CHD6; chromodomain helicase DNA binding protein 6; chromodomain-helicase-DNA-binding protein 6; CHD5; dJ620E11.1; FLJ22369; KIAA1335; RIGB; ATP dependent helicase CHD6; ATP-dependent helicase CHD6; CHD-6; CHD6_HUMAN; Radiation induced gene B protein; Radiation-induced gene B protein; RP4-620E11.2; OTTHUMP00000031013; helicase C-terminal domain- and SNF2 N-terminal domain-containing protein;
COX18
COX18 cytochrome c oxidase assembly homolog (S. cerevisiae)
COX18; COX18 cytochrome c oxidase assembly homolog (S. cerevisiae); mitochondrial inner membrane protein COX18; FLJ38991; COII; COX2; COX2_HUMAN; COXII; Cytochrome c oxidase II; Cytochrome c oxidase polypeptide II; Cytochrome c oxidase subunit 2; MS405; MS419; MT CO2; MT-CO2; MTCO2; Cox18Hs1 protein; Cox18Hs2 protein; Cox18Hs3 protein; OTTHUMP00000160366; OTTHUMP00000219030; mitochondrial COX18; cytochrome c oxidase assembly protein 18; COX18HS;
COX6A2
cytochrome c oxidase subunit VIa polypeptide 2
COX6A2; cytochrome c oxidase subunit VIa polypeptide 2; cytochrome c oxidase subunit 6A2, mitochondrial; COX VIa-M; cytochrome c oxidase subunit VIA-muscle; cytochrome c oxidase polypeptide VIa-heart; COX6AH; COXVIAH;
CPXCR1
CPX chromosome region, candidate 1
CPXCR1; CPX chromosome region, candidate 1; CPX chromosomal region candidate gene 1 protein; cancer/testis antigen 77; CT77; CPX candidate region 1 protein; CPX chromosomal region candidate gene 1 protein homolog; Gm1143; hypothetical protein LOC53336; OTTHUMP00000023634; OTTHUMP00000023635; RP23-18E5.1;
CYBA
cytochrome b-245, alpha polypeptide
CYBA; cytochrome b-245, alpha polypeptide; p22-PHOX; cytochrome b-245 light chain; p22phox; cytochrome b light chain; p22 phagocyte B-cytochrome; cytochrome b(558) alpha chain; cytochrome b558 subunit alpha; cytochrome b(558) alpha-subunit; cytochrome b, alpha polypeptide; flavocytochrome b-558 alpha polypeptide; neutrophil cytochrome b 22 kDa polypeptide; superoxide-generating NADPH oxidase light chain subunit;
CYBB
cytochrome b-245, beta polypeptide
CYBB; cytochrome b-245, beta polypeptide; CGD; NOX2; AMCBX2; GP91-1; GP91PHOX; p91-PHOX; GP91-PHOX; cytochrome b-245 heavy chain; CGD91-phox; NADPH oxidase 2; p22 phagocyte B-cytochrome; cytochrome b558 subunit beta; cytochrome b(558) subunit beta; neutrophil cytochrome b 91 kDa polypeptide; heme-binding membrane glycoprotein gp91phox; superoxide-generating NADPH oxidase heavy chain subunit;
CYP2C6
cytochrome P450, family 2, subfamily c, polypeptide 6
CYP2C6; cytochrome P450, family 2, subfamily c, polypeptide 6; CYPIIC6; P450 PB1; PB1; PTF 2; PTF2;
CYP3A23/3A1
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1
CYP3A23/3A1; cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1; cytochrome P450 3A1; CP33; CP34; CYP3A; CYP3A1; CYP3A3; CYP3A4; CYPIIIA4; Cytochrome P450 3A4; Cytochrome P450 family 3 subfamily A polypeptide 4; Cytochrome P450 subfamily IIIA polypeptide 3; Cytochrome P450 subfamily IIIA polypeptide 4; cytochrome P450, family 3, subfamily a, polypeptide 1; glucocorticoid inducible P450; HLP; MGC126680; NF 25; NF25; P450 III steroid inducible; P450 PCN(PCNC inducible); P450 PCN1; P450C3; P450PCN1; Quinine 3 monooxygenase; Taurochenodeoxycholate 6 alpha hydroxylase; CYPIIIA1; P450 IIIA; P450-PCN1; cytochrome P450-PCN1; cytochrome P450/6 beta B; cytochrome P-450PCN (PNCN inducible); cytochrome P450, subfamily 3A, polypeptide 3; Cytochrome P450, subfamily IIIA, polypeptide 3; cytochrome P450, family 3, subf; CYP; RL33; cDEX; CYP3A23;
MAEA
macrophage erythroblast attacher
MAEA; macrophage erythroblast attacher; EMP; 1110030D19Rik; Cell proliferation inducing gene 5 protein; Cell proliferation-inducing gene 5 protein; Erythroblast macrophage protein; HLC 10; HLC-10; HLC10; Human lung cancer oncogene 10 protein; Lung cancer related protein 10; MAEA_HUMAN; MGC93683; PIG5; OTTHUMP00000217706; OTTHUMP00000217707; OTTHUMP00000217708; OTTHUMP00000217709; OTTHUMP00000217710; OTTHUMP00000217711; OTTHUMP00000217716; OTTHUMP00000217718; proliferation-inducing gene 5; lung cancer-related protein 10; erythrobl; EMLP;
MAST1
microtubule associated serine/threonine kinase 1
MAST1; microtubule associated serine/threonine kinase 1; microtubule-associated serine/threonine-protein kinase 1; KIAA0973; SAST; syntrophin associated serine/threonine kinase; syntrophin-associated serine/threonine-protein kinase; SAST170;
MEF2BNB-MEF2B
MEF2BNB-MEF2B readthrough
MEF2BNB-MEF2B; MEF2BNB-MEF2B readthrough; myocyte enhancer factor 2B; PRDM3; MADS box transcription enhancer factor 2; MDS1 EVI1; Mef2b; MEF2B_HUMAN; Myocyte specific enhancer factor 2B; Myocyte-specific enhancer factor 2B; RSRFR2; Serum response factor like protein 2; Serum response factor-like protein 2; XMEF2; LOC729991-MEF2B readthrough; LOC729991-MEF2B;
SMARCC1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
SMARCC1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1; Rsc8; SRG3; SWI3; BAF155; CRACC1; SWI/SNF complex subunit SMARCC1; BRG1-associated factor 155; SWI/SNF complex 155 kDa subunit; chromatin remodeling complex BAF155 subunit; mammalian chromatin remodeling complex BRG1-associated factor 155; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1;
CDT1
chromatin licensing and DNA replication factor 1
CDT1; chromatin licensing and DNA replication factor 1; DUP; RIS2; DNA replication factor Cdt1; Double parked, Drosophila, homolog of;
hcp-3
HoloCentric chromosome binding Protein
hcp-3; HoloCentric chromosome binding Protein; HoloCentric chromosome binding Protein family member (hcp-3); H3 3 like sequence MH921; H3 3A; H3 a; H3 b; H3 c; H3 d; H3 f; H3 h; H3 histone family member E pseudogene; H3 i; H3 j; H3 k; H3 l; H33_HUMAN; H3F3; H3f3b; Histone H3 3 pseudogene; Histone H3.3;
BRSK1
BR serine/threonine kinase 1
BRSK1; BR serine/threonine kinase 1; serine/threonine-protein kinase BRSK1; KIAA1811; SAD1 kinase; SAD1 homolog; protein kinase SAD1A; brain-selective kinase 1; SadB kinase short isoform; BR serine/threonine-protein kinase 1; serine/threonine-protein kina;
C14ORF166
chromosome 14 open reading frame 166
C14ORF166; chromosome 14 open reading frame 166; UPF0568 protein C14orf166; CGI 99; CLE; CLE7; LCRP369; RLL motif containing 1; RLLM1; CLE7 homolog; CGI99; CGI-99;
C19ORF2
chromosome 19 open reading frame 2
C19ORF2; chromosome 19 open reading frame 2; unconventional prefoldin RPB5 interactor; FLJ10575; NNX3; PPP1R19; protein phosphatase 1; regulatory subunit 19; RMP; RPB5 mediating protein; URI; RNA polymerase II subunit 5 mediating protein; RPB5-mediating protein; protein phosphatase 1, regulatory subunit 19; RNA polymerase II subunit 5-mediating protein; RNA polymerase II, subunit 5-mediating protein;
C19ORF43
chromosome 19 open reading frame 43
C19ORF43; chromosome 19 open reading frame 43; uncharacterized protein C19orf43; fSAP18; functional spliceosome associated protein 18; MGC2803; My029 protein;
C20ORF3
chromosome 20 open reading frame 3
C20ORF3; chromosome 20 open reading frame 3; adipocyte plasma membrane-associated protein; BSCv; Adipocyte plasma membrane associated protein; apmap; APMAP_HUMAN; BSCv protein; Protein BSCv;
CHD2
chromodomain helicase DNA binding protein 2
CHD2; chromodomain helicase DNA binding protein 2; EEOC; chromodomain-helicase-DNA-binding protein 2; CHD-2; ATP-dependent helicase CHD2;
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
CYP1A1; cytochrome P450, family 1, subfamily A, polypeptide 1; CYP1, cytochrome P450, subfamily I (aromatic compound inducible), polypeptide 1; cytochrome P450 1A1; CP11; P1 450; P450 C; P450DX; AHH; AHRR; Aryl hydrocarbon hydroxylase; CP 11; CP1A1_HUMAN; CYP 1; CYP1; CYPIA1; Cytochrome P1 450 dioxin inducible; Cytochrome P1-450; Cytochrome P1-450 dioxin-inducible; Cytochrome P450 family 1 subfamily A polypeptide 1; Cytochrome P450 form 6; Cytochrome P450 subfamily I (aromatic compound inducible) polypeptide 1; Cytochrome P450 subfamily I aromatic compound inducible polypeptide 1; Cytochrome P450-C; Cytochrome P450-P1; Flavoprotein-linked monooxygenase; Microsomal monooxygenase; P450 form 6; P450 P1; Xenobiotic monooxygenase; OTTHUMP00000183469; cytochrome P1-450, dioxin-inducible; cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1; P1-450; P450-C;
CYP2B6
cytochrome P450, family 2, subfamily B, polypeptide 6
CYP2B6; cytochrome P450, family 2, subfamily B, polypeptide 6; CYP2B, cytochrome P450, family 2, subfamily B , cytochrome P450, subfamily IIB (phenobarbital inducible) , cytochrome P450, subfamily IIB (phenobarbital inducible), polypeptide 6; cytochrome P450 2B6; CPB6; CYPIIB6; 11B1; CP2B6_HUMAN; CPB 6; CYP 2B6; CYP IIB6; CYP2B; CYP2B7; CYP2B7P; Cytochrome P450 family 2 subfamily B; Cytochrome P450 family 2 subfamily B polypeptide 6; Cytochrome P450 IIB1; Cytochrome P450 phenobarbital inducible; Cytochrome P450 subfamily IIB (phenobarbital inducible); Cytochrome P450 subfamily IIB (phenobarbital inducible) polypeptide 6; Cytochrome P450 subfamily IIB polypeptide 6; IIB1; P450; P450 IIB1; P450IIB1; cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6;
CYP4A11
cytochrome P450, family 4, subfamily A, polypeptide 11
CYP4A11; cytochrome P450, family 4, subfamily A, polypeptide 11; CP4Y; CYP4A2; CYP4AII; cytochrome P450 4A11; CYPIVA11; P450HL-omega; 20-HETE synthase; alkane-1 monooxygenase; cytochrome P450HL-omega; cytochrome P-450HK-omega; fatty acid omega-hydroxylase; lauric acid omega-hydroxylase; 20-hydroxyeicosatetraenoic acid synthase; cytochrome P450, subfamily IVA, polypeptide 11;
SMARCC2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2
SMARCC2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2; Rsc8; BAF170; CRACC2; SWI/SNF complex subunit SMARCC2; SWI3-like protein; BRG1-associated factor 170; SWI/SNF complex 170 kDa subunit; chromatin remodeling complex BAF170 subunit; mammalian chromatin remodeling complex BRG1-associated factor 170; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2;
SPTBN1
spectrin, beta, non-erythrocytic 1
SPTBN1; spectrin, beta, non-erythrocytic 1; spectrin beta chain, brain 1; beta-fodrin; beta-G spectrin; beta-spectrin 2; beta-II spectrin; beta-spectrin II; fodrin beta chain; embryonic liver beta-fodrin; spectrin, non-erythroid beta chain 1; ELF; SPTB2;
TARS2
threonyl-tRNA synthetase 2, mitochondrial (putative)
TARS2; threonyl-tRNA synthetase 2, mitochondrial (putative); TARSL1, threonyl tRNA synthetase like 1; threonyl-tRNA synthetase, mitochondrial; FLJ12528; threonine tRNA ligase 2; mitochondrial; Threonine tRNA ligase; ThrRS; TARS 2; TARSL1; Threonyl tRNA synthetase 2, mitochondrial; Threonyl tRNA synthetase like 1; threonine--tRNA ligase; threonyl-tRNA synthetase-like 1; threonine tRNA ligase 2, mitochondrial;
ADAMTS3
ADAM metallopeptidase with thrombospondin type 1 motif, 3
ADAMTS3; ADAM metallopeptidase with thrombospondin type 1 motif, 3; ADAMTS-4; A disintegrin and metalloproteinase with thrombospondin motifs 3; ADAM-TS3; ADAMTS-3; PC II-NP; ADAM-TS 3; zinc metalloendopeptidase; procollagen II N-proteinase; procollagen II amino propeptide-processing enzyme; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 3;
C8orf44-SGK3
C8orf44-SGK3 readthrough
C8ORF44-SGK3;C8orf44-SGK3 readthrough;serine/threonine-protein kinase Sgk3;cytokine-independent survival kinase;serum/glucocorticoid-regulated kinase 3;DKFZp779G0825;
CHD5
chromodomain helicase DNA binding protein 5
CHD5; chromodomain helicase DNA binding protein 5; CHD-5; chromodomain-helicase-DNA-binding protein 5; ATP-dependent helicase CHD5;
Cyp11a1
cytochrome P450, family 11, subfamily A, polypeptide 1
CYP11A1; cytochrome P450, family 11, subfamily A, polypeptide 1; CYP11A; CYPXIA1; P450SCC; cholesterol side-chain cleavage enzyme, mitochondrial; steroid 20-22-lyase; cytochrome P450 11A1; cytochrome P450(scc); cytochrome P450C11A1; cholesterol 20-22 desmolase; cholesterol monooxygenase (side-chain cleaving); cytochrome P450, subfamily XIA (cholesterol side chain cleavage);
CYP2C8
cytochrome P450, family 2, subfamily C, polypeptide 8
CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8; cytochrome P450, subfamily IIC (mephenytoin 4 hydroxylase), polypeptide 8; cytochrome P450 2C8; CPC8; CYPIIC8; Cytochrome P450 family 2 subfamily C polypeptide 8; Cytochrome P450 form 1; Cytochrome P450 IIC2; Cytochrome P450 MP-12; Cytochrome P450 MP-20; Cytochrome P450 subfamily IIC (mephenytoin 4 hydroxylase) polypeptide 8; Flavoprotein linked monooxygenase; Microsomal monooxygenase; MP 12/MP 20; P450 form 1; P450 IIC2; P450 MP 12/MP 20; S mephenytoin 4 hydroxylase; Xenobiotic monooxygenase; s-mephenytoin 4-hydroxylase; flavoprotein-linked monooxygenase; cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 8; MP-12/MP-20;
DISC1
disrupted in schizophrenia 1
DISC1; disrupted in schizophrenia 1; disrupted in schizophrenia 1 protein; SCZD9; C1orf136; FLJ13381; FLJ21640; FLJ25311; FLJ41105; KIAA0457;
KLRC4-KLRK1
KLRC4-KLRK1 readthrough
KLRC4-KLRK1;KLRC4-KLRK1 readthrough;NKG2-D type II integral membrane protein;NK cell receptor D;NKG2-D-activating NK receptor;killer cell lectin-like receptor subfamily K member 1;FLJ17759;FLJ78582;
C14ORF159
chromosome 14 open reading frame 159
C14ORF159; chromosome 14 open reading frame 159; UPF0317 protein C14orf159, mitochondrial; FLJ39975; FLJ20950; FLJ39943; DKFZp686I02128;
ANTXR2
anthrax toxin receptor 2
ANTXR2; anthrax toxin receptor 2; capillary morphogenesis protein 2; CMG 2; CMG2; FLJ31074; ISH; JHF; MGC111533; MGC45856; 2310046B19Rik; ANTR2_HUMAN; AW561899; Capillary morphogenesis gene 2 protein; CMG-2;
C10ORF67
chromosome 10 open reading frame 67
C10ORF67; chromosome 10 open reading frame 67; uncharacterized protein C10orf67; MGC46732; RP11-792P23.2;
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif, 14
ADAMTS14; ADAM metallopeptidase with thrombospondin type 1 motif, 14; A disintegrin and metalloproteinase with thrombospondin motifs 14; ADAM-TS14; ADAMTS-14; ADAM-TS 14; metalloprotease-disintegrin protease; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 14;
ADAMTS15
ADAM metallopeptidase with thrombospondin type 1 motif, 15
ADAMTS15; ADAM metallopeptidase with thrombospondin type 1 motif, 15; A disintegrin and metalloproteinase with thrombospondin motifs 15; ADAM-TS15; ADAMTS-15; ADAM-TS 15; metalloprotease disintegrin 15 with thrombospondin domains; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 15, preproprotein;
C16ORF58
chromosome 16 open reading frame 58
C16ORF58; chromosome 16 open reading frame 58; UPF0420 protein C16orf58; FLJ13868;
SHROOM2
shroom family member 2
SHROOM2; shroom family member 2; apical protein, Xenopus laevis like , apical protein like (Xenopus laevis) , APXL; protein Shroom2; 4832440C16; Ab2-404; Apical like protein; Apical like protein APXL protein; apical protein of Xenopus-like; Apical protein Xenopus laevis like; apical protein, Xenopus laevis-like; apical protein-like; apical protein-like (Xenopus laevis); Apical-like protein; APX homolog of Xenopus; C630003H05Rik; DKFZp781J074; FLJ39277; HSAPXL; Liver regeneration-related protein LRRG167; OTTHUMP00000022887; Protein Apxl; Shrm2; SHRM2_HUMAN; SHROOM 2; APXL;
C21ORF63
chromosome 21 open reading frame 63
C21ORF63; chromosome 21 open reading frame 63; C21orf64, chromosome 21 open reading frame 64; uncharacterized protein C21orf63; B18; B19; PRED34; C21orf64; SUE21;
C10ORF57
chromosome 10 open reading frame 57
C10ORF57; chromosome 10 open reading frame 57; transmembrane protein C10orf57; bA369J21.6; FLJ13263; hypothetical protein LOC80195; OTTHUMP00000019950; OTTHUMP00000019951; OTTHUMP00000019952; OTTHUMP00000019954; RP11-369J21.6;
C10ORF62
chromosome 10 open reading frame 62
C10ORF62; chromosome 10 open reading frame 62; uncharacterized protein C10orf62; bA548K23.1;
C11ORF24
chromosome 11 open reading frame 24
C11ORF24; chromosome 11 open reading frame 24; uncharacterized protein C11orf24; DM4E3;
C11ORF46
chromosome 11 open reading frame 46
C11ORF46; chromosome 11 open reading frame 46; uncharacterized protein C11orf46; FLJ38968; DJ299F11.1; Hypothetical protein LOC120534;
C3ORF64
chromosome 3 open reading frame 64
C3ORF64; chromosome 3 open reading frame 64; uncharacterized glycosyltransferase AER61; AER61; AER61 glycosyltransferase; FLJ33770;
C10ORF137
chromosome 10 open reading frame 137
C10ORF137; chromosome 10 open reading frame 137; erythroid differentiation-related factor 1; DKFZp586F1019; EDRF1; FLJ21617; C10orf137 protein; Erythroid differentiation related factor 1;
C13ORF33
chromosome 13 open reading frame 33
C13ORF33; chromosome 13 open reading frame 33; uncharacterized protein C13orf33; AWMS3; FLJ14834; Activated in W/Wv mouse stomach 3 homolog; CM033_HUMAN; hAWMS3;
ADAMTS9
ADAM metallopeptidase with thrombospondin type 1 motif, 9
ADAMTS9; ADAM metallopeptidase with thrombospondin type 1 motif, 9; A disintegrin and metalloproteinase with thrombospondin motifs 9; ADAM-TS9; ADAMTS-9; ADAM-TS 9; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 9;
C10ORF129
chromosome 10 open reading frame 129
C10ORF129; chromosome 10 open reading frame 129; acyl-coenzyme A synthetase ACSM6, mitochondrial; bA310E22.3; AMP-binding enzyme; ACSM6;
C11ORF2
chromosome 11 open reading frame 2
C11ORF2; chromosome 11 open reading frame 2; C11orf3, chromosome 11 open reading frame 3 , chromosome 11 open reading frame2; protein fat-free homolog; ANG2; ANG3; another new gene 2 protein; FFR; C11orf3; FLJ13879; FLJ36472;
C8ORF33
chromosome 8 open reading frame 33
C8ORF33; chromosome 8 open reading frame 33; UPF0488 protein C8orf33; FLJ20989; Hypothetical protein LOC65265;
C7ORF42
chromosome 7 open reading frame 42
C7ORF42; chromosome 7 open reading frame 42; UPF0458 protein C7orf42; FLJ10099; FLJ13090;
C6ORF118
chromosome 6 open reading frame 118
C6ORF118; chromosome 6 open reading frame 118; bA85G2.1; MGC23884;
C7ORF58
chromosome 7 open reading frame 58
C7ORF58; chromosome 7 open reading frame 58; uncharacterized protein C7orf58; FLJ21986; FLJ26813;
ADAMTS10
ADAM metallopeptidase with thrombospondin type 1 motif, 10
ADAMTS10; ADAM metallopeptidase with thrombospondin type 1 motif, 10; WMS; WMS1; ADAM-TS10; ADAMTS-10; A disintegrin and metalloproteinase with thrombospondin motifs 10; ADAM-TS 10; zinc metalloendopeptidase; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 10;
ADAMTS12
ADAM metallopeptidase with thrombospondin type 1 motif, 12
ADAMTS12; ADAM metallopeptidase with thrombospondin type 1 motif, 12; PRO4389; A disintegrin and metalloproteinase with thrombospondin motifs 12; ADAM-TS12; ADAMTS-12; ADAM-TS 12; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 12;
ADAMTS16
ADAM metallopeptidase with thrombospondin type 1 motif, 16
ADAMTS16; ADAM metallopeptidase with thrombospondin type 1 motif, 16; ADAMTS16s; A disintegrin and metalloproteinase with thrombospondin motifs 16; ADAM-TS16; ADAMTS-16; ADAM-TS 16; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 16;
ADAMTS18
ADAM metallopeptidase with thrombospondin type 1 motif, 18
ADAMTS18; ADAM metallopeptidase with thrombospondin type 1 motif, 18; a disintegrin like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 18 , ADAMTS21; A disintegrin and metalloproteinase with thrombospondin motifs 18; ADAMTS 18; ADAMTS21; EC 3.4.24.; ADAM-TS18; ADAMTS-18; ADAM-TS 18; disintegrin and metalloprotease-like protein; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 18; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 21; KNO2;
ADAMTS19
ADAM metallopeptidase with thrombospondin type 1 motif, 19
ADAMTS19; ADAM metallopeptidase with thrombospondin type 1 motif, 19; A disintegrin and metalloproteinase with thrombospondin motifs 19; ADAM-TS19; ADAMTS-19; ADAM-TS 19; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 19;
ADAMTS20
ADAM metallopeptidase with thrombospondin type 1 motif, 20
ADAMTS20; ADAM metallopeptidase with thrombospondin type 1 motif, 20; GON-1; ADAM-TS20; ADAMTS-20; A disintegrin and metalloproteinase with thrombospondin motifs 20; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 20;
ADAMTS6
ADAM metallopeptidase with thrombospondin type 1 motif, 6
ADAMTS6; ADAM metallopeptidase with thrombospondin type 1 motif, 6; ADAM-TS6; ADAMTS-6; ADAM-TS 6; A disintegrin and metalloproteinase with thrombospondin motifs 6; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 6;
ADAMTS7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
ADAMTS7; ADAM metallopeptidase with thrombospondin type 1 motif, 7; ADAM-TS7; ADAMTS-7; ADAM-TS 7; A disintegrin and metalloproteinase with thrombospondin motifs 7; COMPase; a disintegrin and metalloprotease with thrombospondin motifs-7 preproprotein; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 7;
ALS2CR11
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11
ALS2CR11; amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11; amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein; FLJ25351; Amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 11; FLJ40332;
AMMECR1
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1
AMMECR1; Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1; AMME syndrome candidate gene 1 protein; Alport syndrome mental retardation midface hypoplasia and elliptocytosis chromosomal region gene 1; AMMECR 1; AMMECR1 protein; AMMERC1; OTTHUMP00000023851;
C14ORF180
chromosome 14 open reading frame 180
C14ORF180; chromosome 14 open reading frame 180; C14orf77, chromosome 14 open reading frame 77; transmembrane protein C14orf180; C14orf77; FLJ38594;
C14ORF21
chromosome 14 open reading frame 21
C14ORF21; chromosome 14 open reading frame 21; pumilio domain-containing protein C14orf21; hypothetical protein LOC161424; KIAA2021; Pumilio domain containing protein C14orf21;
C14ORF28
chromosome 14 open reading frame 28
C14ORF28; chromosome 14 open reading frame 28; uncharacterized protein C14orf28; c14_5270; CN028_HUMAN; Dopamine receptor interacting protein 1; Dopamine receptor-interacting protein 1; DRIP 1; DRIP1;
C14ORF37
chromosome 14 open reading frame 37
C14ORF37; chromosome 14 open reading frame 37; uncharacterized protein C14orf37; c14_5376;
C1ORF96
chromosome 1 open reading frame 96
C1ORF96; chromosome 1 open reading frame 96; uncharacterized protein C1orf96; FLJ41471; RP4-803J11.3; FLJ37296;
C12ORF49
chromosome 12 open reading frame 49
C12ORF49; chromosome 12 open reading frame 49; UPF0454 protein C12orf49; FLJ21415; Hypothetical protein LOC79794; UPF0454 protein C12orf49 homolog;
C12ORF50
chromosome 12 open reading frame 50
C12ORF50; chromosome 12 open reading frame 50; uncharacterized protein C12orf50; FLJ35821;
C12ORF53
chromosome 12 open reading frame 53
C12ORF53; chromosome 12 open reading frame 53; uncharacterized protein C12orf53; DKFZp547D2210; PILR-associating neural protein; PANP;
C9ORF100
chromosome 9 open reading frame 100
C9ORF100; chromosome 9 open reading frame 100; vav-like protein C9orf100; FLJ14642; Hypothetical protein LOC84904; MGC44886; RP11 331F9.7; Vav like protein C9orf100; RP11-331F9.7;
C9ORF114
chromosome 9 open reading frame 114
C9ORF114; chromosome 9 open reading frame 114; uncharacterized protein C9orf114; CENP 32; centromere protein 32; HSPC109; CENP-32; MGC29492; DKFZp566D143;
C13ORF26
chromosome 13 open reading frame 26
C13ORF26; chromosome 13 open reading frame 26; uncharacterized protein C13orf26; MGC40178; CM026_HUMAN;
C13ORF30
chromosome 13 open reading frame 30
C13ORF30; chromosome 13 open reading frame 30; uncharacterized protein C13orf30; FLJ40919; CM030_HUMAN; hypothetical protein LOC144809; MGC138442;
C11ORF21
chromosome 11 open reading frame 21
C11ORF21; chromosome 11 open reading frame 21; uncharacterized protein C11orf21;
C9ORF64
chromosome 9 open reading frame 64
C9ORF64; chromosome 9 open reading frame 64; UPF0553 protein C9orf64; MGC10999; CI064_HUMAN; RP11-575L7.5;
C9ORF68
chromosome 9 open reading frame 68
C9ORF68; chromosome 9 open reading frame 68; uncharacterized protein C9orf68; FLJ10058; bA6J24.2; RP11-280I16.2;
C10ORF116
chromosome 10 open reading frame 116
C10ORF116; chromosome 10 open reading frame 116; adipose most abundant gene transcript 2 protein; adipose specific 2; APM2; APM 2; OTTHUMP00000020019; RP11-96C23.4; apM-2;
BOD1
biorientation of chromosomes in cell division 1
BOD1; biorientation of chromosomes in cell division 1; FAM44B, family with sequence similarity 44, member B; biorientation of chromosomes in cell division protein 1; biorientation defective 1; family with sequence similarity 44, member B; FAM44B;
C21ORF7
chromosome 21 open reading frame 7
C21ORF7; chromosome 21 open reading frame 7; TAK1-like protein; HC21ORF7; TAK1L; TAKL; TAKL 1; TAKL 2; TAKL 4; Putative gene TGF beta activated kinase like; TAK1 like; TAK1 like protein; TAK1-like protein 1; TAK1-like protein 2; TAK1-like protein 4; TGF-beta activated kinase; TAKL-1; TAKL-2; TAKL-4;
C14ORF133
chromosome 14 open reading frame 133
C14ORF133; chromosome 14 open reading frame 133; spermatogenesis-defective protein 39 homolog; SPE 39; SPE39; VIPAR; VPS16B; VPS33B interacting protein; apical basolateral polarity regulator; protein spe-39 homolog; VPS33B-interacting protein in polarity;
C14ORF135
chromosome 14 open reading frame 135
C14ORF135; chromosome 14 open reading frame 135; pecanex-like protein C14orf135; HCV F-interacting protein; HCV F protein-binding protein 2; hepatitis C virus F protein-binding protein 2; FBP2; FLJ12799; FLJ38170;
C17ORF48
chromosome 17 open reading frame 48
C17ORF48; chromosome 17 open reading frame 48; manganese-dependent ADP-ribose/CDP-alcohol diphosphatase; MDS006; ADPRibase-Mn; CDP-choline phosphohydrolase; ADP-ribose/CDP-alcohol pyrophosphatase; NBLA03831;
C17ORF49
chromosome 17 open reading frame 49
C17ORF49; chromosome 17 open reading frame 49; chromatin complexes subunit BAP18; MGC49942; Hypothetical protein LOC124944; Uncharacterized potential DNA binding protein C17orf49; BPTF-associated protein of 18 kDa; MLL1/MLL complex subunit C17orf49; BAP18;
C17ORF53
chromosome 17 open reading frame 53
C17ORF53; chromosome 17 open reading frame 53; uncharacterized protein C17orf53; MGC3130; FLJ11594;
C11ORF53
chromosome 11 open reading frame 53
C11ORF53; chromosome 11 open reading frame 53; uncharacterized protein C11orf53; MGC50104; Hypothetical protein LOC341032;
C11ORF54
chromosome 11 open reading frame 54
C11ORF54; chromosome 11 open reading frame 54; ester hydrolase C11orf54; PTD012; LP4947;
C5ORF24
chromosome 5 open reading frame 24
C5ORF24; chromosome 5 open reading frame 24; UPF0461 protein C5orf24; FLJ37562; Hypothetical protein LOC134553;
C5ORF35
chromosome 5 open reading frame 35
C5ORF35; chromosome 5 open reading frame 35; uncharacterized protein C5orf35; MGC33648; C5orf35 chromosome 5 open reading frame 35; Hypothetical protein LOC133383;
C5ORF4
chromosome 5 open reading frame 4
C5ORF4; chromosome 5 open reading frame 4; uncharacterized protein C5orf4; FLJ13758;
C5ORF51
chromosome 5 open reading frame 51
C5ORF51; chromosome 5 open reading frame 51; UPF0600 protein C5orf51; LOC285636; Hypothetical protein LOC285636; UPF0600 protein;
C17ORF56
chromosome 17 open reading frame 56
C17ORF56; chromosome 17 open reading frame 56; uncharacterized protein C17orf56; FLJ31528; DKFZp451M1616; CQ056_HUMAN; Hypothetical protein LOC146705;
C17ORF57
chromosome 17 open reading frame 57
C17ORF57; chromosome 17 open reading frame 57; EF-hand domain-containing protein C17orf57; FLJ40342; Hypothetical protein LOC124989;
C1ORF110
chromosome 1 open reading frame 110
C1ORF110; chromosome 1 open reading frame 110; coiled-coil domain-containing protein C1orf110; MGC48998; Coiled coil domain containing protein C1orf110; FLJ41579; Hypothetical protein LOC339512; RP11-331H2.2;
C1ORF111
chromosome 1 open reading frame 111
C1ORF111; chromosome 1 open reading frame 111; uncharacterized protein C1orf111; HSD20; RP11-565P22.3;
C1ORF122
chromosome 1 open reading frame 122
C1ORF122; chromosome 1 open reading frame 122; uncharacterized protein LOC127687; FLJ45459; ALAESM; FLJ23476; Hypothetical protein LOC127687; Protein ALAESM; Uncharacterized protein C1orf122;
C1ORF127
chromosome 1 open reading frame 127
C1ORF127; chromosome 1 open reading frame 127; uncharacterized protein C1orf127; FLJ37118; FLJ37833; Hypothetical protein LOC148345;
C1ORF129
chromosome 1 open reading frame 129
C1ORF129; chromosome 1 open reading frame 129; uncharacterized protein C1orf129; ARMC11; FLJ23550; armadillo repeat containing 11;
C7ORF43
chromosome 7 open reading frame 43
C7ORF43; chromosome 7 open reading frame 43; uncharacterized protein C7orf43; FLJ10925; DKFZp761G0712;
C7ORF44
chromosome 7 open reading frame 44
C7ORF44; chromosome 7 open reading frame 44; uncharacterized protein C7orf44; FLJ10803; Hypothetical protein LOC55744;
C7ORF50
chromosome 7 open reading frame 50
C7ORF50; chromosome 7 open reading frame 50; uncharacterized protein C7orf50; MGC11257; YCR016W; CG050_HUMAN; Hypothetical protein LOC84310;
C16ORF61
chromosome 16 open reading frame 61
C16ORF61; chromosome 16 open reading frame 61; uncharacterized protein C16orf61; DC13; 2310061C15Rik; Hypothetical protein LOC56942;
C16ORF62
chromosome 16 open reading frame 62
C16ORF62; chromosome 16 open reading frame 62; UPF0505 protein C16orf62; MGC16824; esophageal cancer associated protein; esophageal cancer-associated protein; FLJ21040; DKFZp313M0539; DKFZp434B0212;
C16ORF70
chromosome 16 open reading frame 70
C16ORF70; chromosome 16 open reading frame 70; C16orf6, chromosome 16 open reading frame 6 , LIN10; UPF0183 protein C16orf70; FLJ12076; lin 10; C16orf6; Lin 10 homolog; LIN10; lin-10 homolog; lin-10;
C16ORF71
chromosome 16 open reading frame 71
C16ORF71; chromosome 16 open reading frame 71; uncharacterized protein C16orf71; DKFZp686H2240; FLJ43261;
C16ORF73
chromosome 16 open reading frame 73
C16ORF73; chromosome 16 open reading frame 73; uncharacterized protein C16orf73; MGC35212; gs129; hypothetical protein LOC254528; OTTHUMP00000211672;
C16ORF78
chromosome 16 open reading frame 78
C16ORF78; chromosome 16 open reading frame 78; uncharacterized protein C16orf78; MGC33367; Hypothetical protein LOC123970;
C16ORF87
chromosome 16 open reading frame 87
C16ORF87; chromosome 16 open reading frame 87; UPF0547 protein C16orf87; MGC62018;
C17ORF104
chromosome 17 open reading frame 104
C17ORF104; chromosome 17 open reading frame 104; uncharacterized protein C17orf104; FLJ35848; Uncharacterized protein FLJ35848; Hypothetical protein FLJ35848; Hypothetical protein LOC284071; MGC43301;
C17ORF39
chromosome 17 open reading frame 39
C17ORF39; chromosome 17 open reading frame 39; uncharacterized protein C17orf39; MGC3048;
C17ORF42
chromosome 17 open reading frame 42
C17ORF42; chromosome 17 open reading frame 42; transcription elongation factor, mitochondrial; FLJ22729; Hypothetical protein LOC79736; MGC24674; UPF0629 protein C17orf42; transcription elongation factor of mitochondria; TEFM;
C14ORF177
chromosome 14 open reading frame 177
C14ORF177; chromosome 14 open reading frame 177; putative uncharacterized protein C14orf177; FLJ25773;
C14ORF80
chromosome 14 open reading frame 80
C14ORF80; chromosome 14 open reading frame 80; uncharacterized protein C14orf80; MGC16771;
C15ORF27
chromosome 15 open reading frame 27
C15ORF27; chromosome 15 open reading frame 27; transmembrane protein C15orf27; FLJ38190; FLJ30304;
C15ORF32
chromosome 15 open reading frame 32
C15ORF32; chromosome 15 open reading frame 32; uncharacterized protein C15orf32; FLJ32831; MGC129836; MGC129837;
C15ORF33
chromosome 15 open reading frame 33
C15ORF33; chromosome 15 open reading frame 33; uncharacterized protein C15orf33; FLJ32800; CO033_HUMAN;
C15ORF38
chromosome 15 open reading frame 38
C15ORF38; chromosome 15 open reading frame 38; UPF0552 protein C15orf38; MGC61550; 2610034B18Rik; CO038_HUMAN; Hypothetical protein LOC348110; RIKEN cDNA 2610034B18;
C15ORF39
chromosome 15 open reading frame 39
C15ORF39; chromosome 15 open reading frame 39; chromosome 15 open reading frame 38~Name Same As HGNC:28782; uncharacterized protein C15orf39; DKFZP434H132; FLJ46337; MGC117209;
C15ORF17
chromosome 15 open reading frame 17
C15ORF17; chromosome 15 open reading frame 17; uncharacterized protein C15orf17; FLJ00005; CO017_HUMAN; Hypothetical protein LOC57184;
C15ORF24
chromosome 15 open reading frame 24
C15ORF24; chromosome 15 open reading frame 24; C11orf3; Chromosome 15 hypothetical ATG GTP binding protein; HT022; ORF1 FL1; UPF0480 protein C15orf24; chromosome 15 hypothetical ATG/GTP binding protein; ORF1-FL1;
C15ORF26
chromosome 15 open reading frame 26
C15ORF26; chromosome 15 open reading frame 26; uncharacterized protein C15orf26; FLJ38615; Hypothetical protein LOC161502;
C15ORF41
chromosome 15 open reading frame 41
C15ORF41; chromosome 15 open reading frame 41; uncharacterized protein C15orf41; FLJ22851; HH114; MGC11326; CO041_HUMAN; Hypothetical protein LOC84529; Protein HH114;
C15ORF44
chromosome 15 open reading frame 44
C15ORF44; chromosome 15 open reading frame 44; UPF0464 protein C15orf44; DKFZP564O1664; CO044_HUMAN; Hypothetical protein LOC81556;
C15ORF52
chromosome 15 open reading frame 52
C15ORF52; chromosome 15 open reading frame 52; uncharacterized protein C15orf52; FLJ43339; DKFZp686N1468;
C15ORF62
chromosome 15 open reading frame 62
C15ORF62; chromosome 15 open reading frame 62; uncharacterized protein C15orf62, mitochondrial; LOC643338; uncharacterized protein FLJ75552, mitochondrial;
C16ORF13
chromosome 16 open reading frame 13
C16ORF13; chromosome 16 open reading frame 13; UPF0585 protein C16orf13; MGC13114; CP013_HUMAN; Hypothetical protein LOC84326; JFP2;
C16ORF45
chromosome 16 open reading frame 45
C16ORF45; chromosome 16 open reading frame 45; uncharacterized protein C16orf45; FLJ32618;
C16ORF46
chromosome 16 open reading frame 46
C16ORF46; chromosome 16 open reading frame 46; uncharacterized protein C16orf46; FLJ32702;
C16ORF48
chromosome 16 open reading frame 48
C16ORF48; chromosome 16 open reading frame 48; uncharacterized protein C16orf48; DKFZP434A1319; DAKV6410;
C16ORF5
chromosome 16 open reading frame 5
C16ORF5; chromosome 16 open reading frame 5; LITAF-like protein; CDIP; Cell death inducing protein; Cell death-inducing protein; I1; LITAF like protein; LITFL_HUMAN; Transmembrane protein I1;
C16ORF57
chromosome 16 open reading frame 57
C16ORF57; chromosome 16 open reading frame 57; UPF0406 protein C16orf57; FLJ13154; HVSL motif containing 1; HVSL1; poikiloderma with neutropenia; PN;
C1ORF94
chromosome 1 open reading frame 94
C1ORF94; chromosome 1 open reading frame 94; uncharacterized protein C1orf94; MGC15882;
C1ORF95
chromosome 1 open reading frame 95
C1ORF95; chromosome 1 open reading frame 95; uncharacterized membrane protein C1orf95; DKFZp761P211; Hypothetical protein LOC375057; Spec3 like; RP11-9C4.1;
C21ORF91
chromosome 21 open reading frame 91
C21ORF91; chromosome 21 open reading frame 91; C21orf14, C21orf38, chromosome 21 open reading frame 38; protein EURL homolog; cold sore susceptibility gene 1; CSSG1; early undifferentiated retina and lens; EURL; YG81; C21orf14; C21orf38; DKFZp781D1223;
C22ORF13
chromosome 22 open reading frame 13
C22ORF13; chromosome 22 open reading frame 13; uncharacterized protein C22orf13; MGC1842; CG13760 gene product [Drosophila melanogaster] homolog; LLN4;
C22ORF25
chromosome 22 open reading frame 25
C22ORF25; chromosome 22 open reading frame 25; uncharacterized protein C22orf25; DKFZp761P1121;
C22ORF36
chromosome 22 open reading frame 36
C22ORF36; chromosome 22 open reading frame 36; leucine-rich repeat-containing protein C22orf36; MGC131773; LRC6X_HUMAN;
C2ORF18
chromosome 2 open reading frame 18
C2ORF18; chromosome 2 open reading frame 18; transmembrane protein C2orf18; FLJ20555; ANT2-binding protein; ANT2BP;
C9ORF89
chromosome 9 open reading frame 89
C9ORF89; chromosome 9 open reading frame 89; bcl10-interacting CARD protein; bA370F5.1; MGC11115; Bcl10 interacting protein with CARD protein; BinCARD; Bcl10-interacting protein with CARD;
C9ORF153
chromosome 9 open reading frame 153
C9ORF153; chromosome 9 open reading frame 153; uncharacterized protein C9orf153; bA507D14.1; MGC131702;
C9ORF156
chromosome 9 open reading frame 156
C9ORF156; chromosome 9 open reading frame 156; nef-associated protein 1; HSPC219; NAP1; Nef (lentivirus myristoylated factor) associated protein 1; Nef associated protein 1; RP11 23B15.3; Thioesterase NAP1; vNAP1; RP11-23B15.3;
C20ORF72
chromosome 20 open reading frame 72
C20ORF72; chromosome 20 open reading frame 72; uncharacterized protein C20orf72; bA504H3.4; FLJ14597;
C20ORF79
chromosome 20 open reading frame 79
C20ORF79; chromosome 20 open reading frame 79; uncharacterized protein C20orf79; dJ1068E13.2; HSD22; sterol carrier protein 2 like protein; Hypothetical protein LOC140856; MGC138229; OTTHUMP00000030367; sterol carrier protein 2-like protein;
C10ORF93
chromosome 10 open reading frame 93
C10ORF93; chromosome 10 open reading frame 93; uncharacterized protein LOC255352; bB137A17.3; FLJ25954; C10orf124; CJ093_HUMAN; hypothetical protein LOC255352; RP13 137A17.3; TPR repeat-containing protein C10orf93; RP13-137A17.3;
C10ORF95
chromosome 10 open reading frame 95
C10ORF95; chromosome 10 open reading frame 95; uncharacterized protein C10orf95; FLJ14280;
C11ORF16
chromosome 11 open reading frame 16
C11ORF16; chromosome 11 open reading frame 16; uncharacterized protein C11orf16; Hypothetical protein LOC56673;
C9ORF78
chromosome 9 open reading frame 78
C9ORF78; chromosome 9 open reading frame 78; uncharacterized protein C9orf78; HCA59; Hepatocellular carcinoma associated antigen 59; HSPC220; hepatocellular carcinoma-associated antigen 59; bA409K20.3;
C3ORF62
chromosome 3 open reading frame 62
C3ORF62; chromosome 3 open reading frame 62; uncharacterized protein C3orf62; FLJ43654; MGC23381; MGC61663; MGC62079;
C3ORF67
chromosome 3 open reading frame 67
C3ORF67; chromosome 3 open reading frame 67; uncharacterized protein C3orf67; FLJ42117; FLJ42930; MGC48416; CC067_HUMAN; hypothetical protein LOC200844;
C3ORF70
chromosome 3 open reading frame 70
C3ORF70; chromosome 3 open reading frame 70; UPF0524 protein C3orf70;
C3ORF75
chromosome 3 open reading frame 75
C3ORF75; chromosome 3 open reading frame 75; TMEM103, transmembrane protein 103; elongator complex protein 6 homolog; FLJ20211; UPF0405 protein C3orf75; transmembrane protein 103; angiotonin-transactivated protein 1; TMEM103;
C6ORF201
chromosome 6 open reading frame 201
C6ORF201; chromosome 6 open reading frame 201; uncharacterized protein C6orf201; dJ1013A10.5; CF201_HUMAN; Hypothetical protein LOC404220; MGC87625; Protein MGC87625;
C6ORF223
chromosome 6 open reading frame 223
C6ORF223; chromosome 6 open reading frame 223; uncharacterized protein C6orf223; MGC45491;
C6ORF25
chromosome 6 open reading frame 25
C6ORF25; chromosome 6 open reading frame 25; protein G6b; G6b; NG31; G6B protein; Immunoglobulin receptor; MGC142279; MGC142281;
C21ORF56
chromosome 21 open reading frame 56
C21ORF56; chromosome 21 open reading frame 56; uncharacterized protein C21orf56; MGC99490; DKFZp434N0650;
C3ORF15
chromosome 3 open reading frame 15
C3ORF15; chromosome 3 open reading frame 15; AMY-1-associating protein expressed in testis 1; AAT1; AAT1alpha; MYCBP binding protein; AAT 1; AAT-1; AAT1 alpha; AAT1_HUMAN; AMY 1 associating protein expressed in testis 1; AAT1-alpha; MYCBP-binding protein;
C3ORF17
chromosome 3 open reading frame 17
C3ORF17; chromosome 3 open reading frame 17; uncharacterized protein C3orf17; DKFZP434F2021; NET17; hypothetical protein LOC25871;
C3ORF18
chromosome 3 open reading frame 18
C3ORF18; chromosome 3 open reading frame 18; uncharacterized protein C3orf18; G20;
C6ORF10
chromosome 6 open reading frame 10
C6ORF10; chromosome 6 open reading frame 10; uncharacterized protein C6orf10; TSBP; CF010_HUMAN; Testis specific basic protein;
C2ORF89
chromosome 2 open reading frame 89
C2ORF89; chromosome 2 open reading frame 89; UPF0632 protein C2orf89; CB089_HUMAN;
C10ORF88
chromosome 10 open reading frame 88
C10ORF88; chromosome 10 open reading frame 88; uncharacterized protein C10orf88; Em:AC073585.5; FLJ13490; CJ088_HUMAN; Hypothetical protein LOC80007;
C1ORF87
chromosome 1 open reading frame 87
C1ORF87; chromosome 1 open reading frame 87; uncharacterized protein C1orf87; MGC34837; FLJ44073; LOC127795;
C1ORF93
chromosome 1 open reading frame 93
C1ORF93; chromosome 1 open reading frame 93; prostamide/prostaglandin F synthase; MGC26818; PGFS_HUMAN; Prostamide/PG F synthase; Prostamide/PGF synthase; Uncharacterized protein C1orf93; Uncharacterized protein C1orf93 homolog;
CHAMP1
chromosome alignment maintaining phosphoprotein 1
CHAMP1; chromosome alignment maintaining phosphoprotein 1; C13orf8, chromosome 13 open reading frame 8 , zinc finger protein 828 , ZNF828; zinc finger protein 828; CAMP; CHAMP; chromosome alignment maintaining phosphoprotein; chromosome 13 open reading frame 8; FLJ90413; KIAA1802; Zinc finger protein KIAA1802; chromosome alignment-maintaining phosphoprotein; ZNF828; C13orf8;
C14ORF105
chromosome 14 open reading frame 105
C14ORF105; chromosome 14 open reading frame 105; uncharacterized protein C14orf105; FLJ10650;
C11ORF73
chromosome 11 open reading frame 73
C11ORF73; chromosome 11 open reading frame 73; uncharacterized protein C11orf73; HSPC138; HSPC179; lethal, Chr 7, Rinchik 6; L7RN6; FLJ43020;
C11ORF74
chromosome 11 open reading frame 74
C11ORF74; chromosome 11 open reading frame 74; uncharacterized protein C11orf74; FLJ38678; HEPIS;
C11ORF85
chromosome 11 open reading frame 85
C11ORF85; chromosome 11 open reading frame 85; uncharacterized protein C11orf85; hypothetical protein LOC283129; LOC283129; MGC126364;
C11ORF87
chromosome 11 open reading frame 87
C11ORF87; chromosome 11 open reading frame 87; uncharacterized protein C11orf87; LOC399947; LOH11CR1A; FLJ33767;
C1ORF84
chromosome 1 open reading frame 84
C1ORF84; chromosome 1 open reading frame 84; Hypothetical protein LOC149469; Uncharacterized protein C1orf84; SZT2A; RP11-506B15.1;
C20ORF132
chromosome 20 open reading frame 132
C20ORF132; chromosome 20 open reading frame 132; C20orf131, chromosome 20 open reading frame 131; uncharacterized protein C20orf132; dJ621N11.3; dJ621N11.4; hypothetical protein LOC140699; C20orf131;
C20ORF134
chromosome 20 open reading frame 134
C20ORF134; chromosome 20 open reading frame 134; putative uncharacterized actin family protein C20orf134; CT134_HUMAN; dJ63M2.2;
C20ORF141
chromosome 20 open reading frame 141
C20ORF141; chromosome 20 open reading frame 141; hypothetical protein LOC128653; dJ860F19.4; LOC128653; TMEM239;
C20ORF144
chromosome 20 open reading frame 144
C20ORF144; chromosome 20 open reading frame 144; uncharacterized protein C20orf144; dJ63M2.6; hypothetical protein LOC128864; CT144_HUMAN;
C5ORF20
chromosome 5 open reading frame 20
C5ORF20; chromosome 5 open reading frame 20; dendritic cell nuclear protein 1; DCNP1;
C20ORF194
chromosome 20 open reading frame 194
C20ORF194; chromosome 20 open reading frame 194; uncharacterized protein C20orf194; DKFZp434N061; hypothetical protein LOC25943; MGC117480; MGC141683;
C20ORF195
chromosome 20 open reading frame 195
C20ORF195; chromosome 20 open reading frame 195; uncharacterized protein C20orf195; MGC5356; CT195_HUMAN; hypothetical protein LOC79025;
C20ORF196
chromosome 20 open reading frame 196
C20ORF196; chromosome 20 open reading frame 196; uncharacterized protein C20orf196; FLJ25067; RP4-784N16.1;
C20ORF24
chromosome 20 open reading frame 24
C20ORF24; chromosome 20 open reading frame 24; uncharacterized protein C20orf24; PNAS 11; RIP5; Rab5 interacting protein; rab5-interacting protein; PNAS-11;
C20ORF4
chromosome 20 open reading frame 4
C20ORF4; chromosome 20 open reading frame 4; uncharacterized protein C20orf4; bA234K24.2; DKFZp564N1363; CGI 23; CGI-23;
C21ORF58
chromosome 21 open reading frame 58
C21ORF58; chromosome 21 open reading frame 58; uncharacterized protein C21orf58;
C21ORF62
chromosome 21 open reading frame 62
C21ORF62; chromosome 21 open reading frame 62; C21orf120, chromosome 21 open reading frame 120; uncharacterized protein C21orf62; B37; PRED81; C21orf120;
C2ORF27A
chromosome 2 open reading frame 27A
C2ORF27A; chromosome 2 open reading frame 27A; C2orf27, chromosome 2 open reading frame 27; uncharacterized protein C2orf27; MGC50273; OTTHUMP00000162444; C2orf27; C2orf27B;
C2ORF29
chromosome 2 open reading frame 29
C2ORF29; chromosome 2 open reading frame 29; UPF0760 protein C2orf29; C40; CB029_HUMAN; Hypothetical protein LOC55571;
C2ORF3
chromosome 2 open reading frame 3
C2ORF3; chromosome 2 open reading frame 3; TCF9, transcription factor 9 (binds GC rich sequences); GC-rich sequence DNA-binding factor; DNABF; GC binding factor; GCF; GC rich sequence DNA binding factor; TCF 9; TCF9; Transcription factor 9; TCF-9; GC bindng factor; transcription factor 9 (binds GC-rich sequences);
C2ORF42
chromosome 2 open reading frame 42
C2ORF42; chromosome 2 open reading frame 42; uncharacterized protein C2orf42; FLJ20558;
C2ORF43
chromosome 2 open reading frame 43
C2ORF43; chromosome 2 open reading frame 43; UPF0554 protein C2orf43; FLJ21820; Hypothetical protein LOC60526;
C2ORF47
chromosome 2 open reading frame 47
C2ORF47; chromosome 2 open reading frame 47; uncharacterized protein C2orf47, mitochondrial; DKFZp666A212; FLJ22555; Hhypothetical protein LOC79568;
C2ORF50
chromosome 2 open reading frame 50
C2ORF50; chromosome 2 open reading frame 50; uncharacterized protein C2orf50; FLJ25143; MGC149401; CB050_HUMAN; Hypothetical protein LOC130813;
C2ORF53
chromosome 2 open reading frame 53
C2ORF53; chromosome 2 open reading frame 53; uncharacterized protein C2orf53; MGC44505; Hypothetical protein LOC339779; OTTHUMP00000158509;
C2ORF55
chromosome 2 open reading frame 55
C2ORF55; chromosome 2 open reading frame 55; uncharacterized protein C2orf55; MGC42367; Hypothetical protein LOC343990;
C2ORF56
chromosome 2 open reading frame 56
C2ORF56; chromosome 2 open reading frame 56; protein midA homolog, mitochondrial; MidA; mitochondrial dysfunction protein A homolog; PRO1853;
C2ORF57
chromosome 2 open reading frame 57
C2ORF57; chromosome 2 open reading frame 57; uncharacterized protein C2orf57; MGC35154; Hypothetical protein LOC165100;
C2ORF68
chromosome 2 open reading frame 68
C2ORF68; chromosome 2 open reading frame 68; UPF0561 protein C2orf68; FLJ14112; FLJ35653; MGC131675;
C2ORF69
chromosome 2 open reading frame 69
C2ORF69; chromosome 2 open reading frame 69; UPF0565 protein C2orf69; FLJ38973; hypothetical protein FLJ38973;
C2ORF80
chromosome 2 open reading frame 80
C2ORF80; chromosome 2 open reading frame 80; uncharacterized protein C2orf80; LOC389073;
C10ORF140
chromosome 10 open reading frame 140
C10ORF140; chromosome 10 open reading frame 140; protein DLN-1; DKFZp761J229; DLN 1; DLN1_HUMAN; FLJ45187; DLN-1;
C10ORF46
chromosome 10 open reading frame 46
C10ORF46; chromosome 10 open reading frame 46; uncharacterized protein C10orf46; FLJ40409; MGC33215; Cullin; OTTHUMP00000046870; Uncharacterized protein C10orf46 homolog;
C10ORF47
chromosome 10 open reading frame 47
C10ORF47; chromosome 10 open reading frame 47; uncharacterized protein C10orf47; MGC35403;
C11ORF57
chromosome 11 open reading frame 57
C11ORF57; chromosome 11 open reading frame 57; uncharacterized protein C11orf57; FLJ10726;
C11ORF63
chromosome 11 open reading frame 63
C11ORF63; chromosome 11 open reading frame 63; uncharacterized protein C11orf63; FLJ23554;
C11ORF65
chromosome 11 open reading frame 65
C11ORF65; chromosome 11 open reading frame 65; uncharacterized protein C11orf65; MGC33948;
C11ORF67
chromosome 11 open reading frame 67
C11ORF67; chromosome 11 open reading frame 67; UPF0366 protein C11orf67; CK067; FLJ21035; PTD015; Hypothetical protein LOC28971; MGC3367;
C11ORF71
chromosome 11 open reading frame 71
C11ORF71; chromosome 11 open reading frame 71; uncharacterized protein C11orf71; FLJ20010; C11orf71 chromosome 11 open reading frame 71; CK071_HUMAN; Gm5617; hypothetical protein LOC54494;
C12ORF11
chromosome 12 open reading frame 11
C12ORF11; chromosome 12 open reading frame 11; cell cycle regulator Mat89Bb homolog; FLJ10637; NET48; FLJ10630; Sarcoma antigen NY SAR 95; sarcoma antigen NY-SAR-95;
C12ORF29
chromosome 12 open reading frame 29
C12ORF29; chromosome 12 open reading frame 29; uncharacterized protein C12orf29; DKFZp434N2030; FLJ38158; MGC102978; DKFZp313K0436; DKFZp686L04169;
C12ORF4
chromosome 12 open reading frame 4
C12ORF4; chromosome 12 open reading frame 4; uncharacterized protein C12orf4; FLJ21158; FLJ23899;
C12ORF40
chromosome 12 open reading frame 40
C12ORF40; chromosome 12 open reading frame 40; uncharacterized protein C12orf40; FLJ40126;
C12ORF42
chromosome 12 open reading frame 42
C12ORF42; chromosome 12 open reading frame 42; uncharacterized protein C12orf42; FLJ25323; MGC43592; MGC57409;
C12ORF48
chromosome 12 open reading frame 48
C12ORF48; chromosome 12 open reading frame 48; PARP1-binding protein; FLJ20641; AROM; CL048_HUMAN; PARP 1 binding protein; PARP1 binding protein; PARPBP; UPF0419 protein C12orf48; PARP-1 binding protein;
CECR2
cat eye syndrome chromosome region, candidate 2
CECR2; cat eye syndrome chromosome region, candidate 2; cat eye syndrome critical region protein 2; KIAA1740;
C19ORF55
chromosome 19 open reading frame 55
C19ORF55; chromosome 19 open reading frame 55; uncharacterized protein C19orf55; FLJ30657; Uncharacterized protein C19orf55 homolog;
C19ORF56
chromosome 19 open reading frame 56
C19ORF56; chromosome 19 open reading frame 56; UPF0139 membrane protein C19orf56; PTD008; CS056_HUMAN; Hypothetical protein LOC51398;
C19ORF73
chromosome 19 open reading frame 73
C19ORF73; chromosome 19 open reading frame 73; putative uncharacterized protein C19orf73; FLJ10490; CS073_HUMAN;
C12ORF54
chromosome 12 open reading frame 54
C12ORF54; chromosome 12 open reading frame 54; uncharacterized protein C12orf54; MGC35033; HSD-29; HSD-30;
C12ORF61
chromosome 12 open reading frame 61
C12ORF61; chromosome 12 open reading frame 61; putative uncharacterized protein C12orf61; FLJ25590; CL061_HUMAN;
C12ORF63
chromosome 12 open reading frame 63
C12ORF63; chromosome 12 open reading frame 63; putative uncharacterized protein C12orf63; FLJ44112; CL063_HUMAN;
C12ORF66
chromosome 12 open reading frame 66
C12ORF66; chromosome 12 open reading frame 66; UPF0536 protein C12orf66; FLJ32549; CL066_HUMAN; Hypothetical protein LOC144577;
C12ORF68
chromosome 12 open reading frame 68
C12ORF68; chromosome 12 open reading frame 68; uncharacterized protein C12orf68; LOC387856;
C14ORF118
chromosome 14 open reading frame 118
C14ORF118; chromosome 14 open reading frame 118; uncharacterized protein C14orf118; FLJ10033; FLJ20689; MGC61896;
C18ORF8
chromosome 18 open reading frame 8
C18ORF8; chromosome 18 open reading frame 8; uncharacterized protein C18orf8; colon cancer associated protein Mic1; HsT2591; MIC1; Colon cancer-associated protein Mic1; Mic-1; MIC1_HUMAN;
C19ORF18
chromosome 19 open reading frame 18
C19ORF18; chromosome 19 open reading frame 18; uncharacterized protein C19orf18; MGC41906;
C19ORF21
chromosome 19 open reading frame 21
C19ORF21; chromosome 19 open reading frame 21; uncharacterized protein C19orf21; DKFZp686H18209; hypothetical protein LOC126353;
C19ORF24
chromosome 19 open reading frame 24
C19ORF24; chromosome 19 open reading frame 24; uncharacterized membrane protein C19orf24; FLJ20640; CS024_HUMAN; Hypothetical protein LOC55009;
C19ORF28
chromosome 19 open reading frame 28
C19ORF28; chromosome 19 open reading frame 28; uncharacterized MFS-type transporter C19orf28; MGC20700; PP3501; Hypothetical protein LOC126321; Uncharacterized MFS type transporter C19orf28;
C19ORF45
chromosome 19 open reading frame 45
C19ORF45; chromosome 19 open reading frame 45; uncharacterized protein C19orf45; FLJ35784; CS045_HUMAN; FLJ56642; hypothetical protein LOC374877;
C19ORF46
chromosome 19 open reading frame 46
C19ORF46; chromosome 19 open reading frame 46; nesprin-4; FLJ36445; Hypothetical protein LOC163183;
C19ORF47
chromosome 19 open reading frame 47
C19ORF47; chromosome 19 open reading frame 47; uncharacterized protein C19orf47; FLJ36888; DKFZp686P05129;
C19ORF52
chromosome 19 open reading frame 52
C19ORF52; chromosome 19 open reading frame 52; uncharacterized protein C19orf52;
C19ORF54
chromosome 19 open reading frame 54
C19ORF54; chromosome 19 open reading frame 54; UPF0692 protein C19orf54; FLJ41131; FLJ17063; Hypothetical protein LOC284325; MGC103014;
chp1
chromodomain protein Chp1
chp1; chromodomain protein Chp1; Chp 1; Chromo domain containing protein 1; Chromo domain protein 1; Chromodomain protein 1;
C17ORF59
chromosome 17 open reading frame 59
C17ORF59; chromosome 17 open reading frame 59; uncharacterized protein C17orf59; FLJ20014; PRO2472;
C17ORF64
chromosome 17 open reading frame 64
C17ORF64; chromosome 17 open reading frame 64; uncharacterized protein C17orf64;
C17ORF66
chromosome 17 open reading frame 66
C17ORF66; chromosome 17 open reading frame 66; uncharacterized protein C17orf66; FLJ32830; hypothetical protein LOC256957;
C17ORF74
chromosome 17 open reading frame 74
C17ORF74; chromosome 17 open reading frame 74; uncharacterized protein C17orf74;
C17ORF77
chromosome 17 open reading frame 77
C17ORF77; chromosome 17 open reading frame 77; uncharacterized protein C17orf77; FLJ31882;
C17ORF78
chromosome 17 open reading frame 78
C17ORF78; chromosome 17 open reading frame 78; uncharacterized protein C17orf78; FLJ39647; MGC34759;
C17ORF80
chromosome 17 open reading frame 80
C17ORF80; chromosome 17 open reading frame 80; uncharacterized protein C17orf80; FLJ20721; HLC 8; MIG3; migration inducing protein 3; SPEP1; sperm expressed protein 1; sperm-expressed protein 1; migration-inducing protein 3; lung cancer-related protein 8;
C17ORF81
chromosome 17 open reading frame 81
C17ORF81; chromosome 17 open reading frame 81; dermal papilla-derived protein 6; dermal papilla derived protein 6; DERP6; S phase 2 protein; S-phase 2 protein; MST071; HSPC002; MSTP071;
C20ORF107
chromosome 20 open reading frame 107
C20ORF107; chromosome 20 open reading frame 107; C20orf107, chromosome 20 open reading frame 107; dJ1153D9.4;
C20ORF11
chromosome 20 open reading frame 11
C20ORF11; chromosome 20 open reading frame 11; protein C20orf11; bA305P22.1; FLJ20602; TWA1; CT011_HUMAN; Two hybrid associated protein 1; Two hybrid associated protein 1 with RanBPM; Two hybrid-associated protein 1 with RanBPM;
C20ORF111
chromosome 20 open reading frame 111
C20ORF111; chromosome 20 open reading frame 111; uncharacterized protein C20orf111; dJ1183I21.1; HSPC207; Perit1; peroxide inducible transcript 1; peroxide-inducible transcript 1;
C20ORF112
chromosome 20 open reading frame 112
C20ORF112; chromosome 20 open reading frame 112; C20orf113, chromosome 20 open reading frame 113; uncharacterized protein C20orf112; dJ1184F4.2; dJ1184F4.4; DKFZP566G1424; hypothetical protein LOC140688; C20orf113; CT112_HUMAN;
C1ORF65
chromosome 1 open reading frame 65
C1ORF65; chromosome 1 open reading frame 65; uncharacterized protein C1orf65; FLJ35728; RP11-76K24.1;
C6ORF58
chromosome 6 open reading frame 58
C6ORF58; chromosome 6 open reading frame 58; UPF0762 protein C6orf58; MGC72003;
C6ORF62
chromosome 6 open reading frame 62
C6ORF62; chromosome 6 open reading frame 62; uncharacterized protein C6orf62; DKFZP564G182; FLJ12619; HBV X transactivated protein 12; XTP12; HBV X-transactivated protein 12; HBV XAg-transactivated protein 12; HBV X-transactivated gene 12 protein; dJ30M3.;
C7ORF61
chromosome 7 open reading frame 61
C7ORF61; chromosome 7 open reading frame 61; uncharacterized protein C7orf61; IMAGE:4839025; Hypothetical protein LOC402573;
C7ORF62
chromosome 7 open reading frame 62
C7ORF62; chromosome 7 open reading frame 62; uncharacterized protein C7orf62; MGC26647;
C7ORF64
chromosome 7 open reading frame 64
C7ORF64; chromosome 7 open reading frame 64; UPF0712 protein C7orf64; DKFZp564O0523; HSPC304; Hypothetical protein LOC84060; CG064_HUMAN; DKFZp686D1651; OTTHUMP00000215752;
C9ORF117
chromosome 9 open reading frame 117
C9ORF117; chromosome 9 open reading frame 117; uncharacterized protein C9orf117; RP11-56D16.5;
C9ORF123
chromosome 9 open reading frame 123
C9ORF123; chromosome 9 open reading frame 123; transmembrane protein C9orf123; MGC4730;
C17ORF82
chromosome 17 open reading frame 82
C17ORF82; chromosome 17 open reading frame 82; putative uncharacterized protein C17orf82;
C17ORF97
chromosome 17 open reading frame 97
C17ORF97; chromosome 17 open reading frame 97; uncharacterized protein C17orf97; LOC400566;
C18ORF10
chromosome 18 open reading frame 10
C18ORF10; chromosome 18 open reading frame 10; tubulin polyglutamylase complex subunit 2; DKFZP586M1523; HsT3006; C18orf10 chromosome 18 open reading frame 10; HMFN0601; L17; PGs2; TPGS2_HUMAN;
C18ORF25
chromosome 18 open reading frame 25
C18ORF25; chromosome 18 open reading frame 25; uncharacterized protein C18orf25; MGC12909; ARKadia like 1; ARKL1; CR025_HUMAN; ARKadia-like 1;
C18ORF34
chromosome 18 open reading frame 34
C18ORF34; chromosome 18 open reading frame 34; uncharacterized protein C18orf34; FLJ44050; MGC111498; MGC163407;
C18ORF54
chromosome 18 open reading frame 54
C18ORF54; chromosome 18 open reading frame 54; lung adenoma susceptibility protein 2; MGC33382; LAS2;
C18ORF56
chromosome 18 open reading frame 56
C18ORF56; chromosome 18 open reading frame 56; putative uncharacterized protein C18orf56;
C1ORF100
chromosome 1 open reading frame 100
C1ORF100; chromosome 1 open reading frame 100; uncharacterized protein C1orf100; RP11-518L10.1;
C1ORF131
chromosome 1 open reading frame 131
C1ORF131; chromosome 1 open reading frame 131; uncharacterized protein C1orf131; DKFZp547B1713; CA131_HUMAN; Hypothetical protein LOC128061; OTTHUMP00000036145; OTTHUMP00000036146; RP4-609B14.1;
C1ORF141
chromosome 1 open reading frame 141
C1ORF141; chromosome 1 open reading frame 141; uncharacterized protein C1orf141; MGC48454;
C1ORF144
chromosome 1 open reading frame 144
C1ORF144; chromosome 1 open reading frame 144; UPF0485 protein C1orf144; DKFZp566C0424; putative MAPK activating protein PM20,PM21; putative MAPK-activating protein PM18/PM20/PM22; MGC70432;
C1ORF159
chromosome 1 open reading frame 159
C1ORF159; chromosome 1 open reading frame 159; uncharacterized protein C1orf159; FLJ20584; FLJ21143; FLJ36119; RP11-465B22.4;
C1ORF172
chromosome 1 open reading frame 172
C1ORF172; chromosome 1 open reading frame 172; uncharacterized protein C1orf172; FLJ34633; RP11 344H11.3; RP11-344H11.3;
C1ORF177
chromosome 1 open reading frame 177
C1ORF177; chromosome 1 open reading frame 177; uncharacterized protein C1orf177; FLJ40201;
C1ORF182
chromosome 1 open reading frame 182
C1ORF182; chromosome 1 open reading frame 182; uncharacterized protein C1orf182; SSTK IP; SSTK-interacting protein (SSTK-IP); SIP; SSTK-IP; MGC26877; RP11-443G18.5;
C1ORF183
chromosome 1 open reading frame 183
C1ORF183; chromosome 1 open reading frame 183; uncharacterized protein C1orf183; FLJ31105; CA183_HUMAN;
C1ORF186
chromosome 1 open reading frame 186
C1ORF186; chromosome 1 open reading frame 186; uncharacterized protein C1orf186; FLJ16052;
C1ORF187
chromosome 1 open reading frame 187
C1ORF187; chromosome 1 open reading frame 187; draxin; FLJ34999; dorsal repulsive axon guidance protein; UNQ3119; neucrin; AGPA3119; MGC117222;
C1ORF190
chromosome 1 open reading frame 190
C1ORF190; chromosome 1 open reading frame 190; NF-kappa-B activator C1orf190; FLJ25163; Hypothetical protein LOC541468; Uncharacterized protein C1orf190;
C7ORF23
chromosome 7 open reading frame 23
C7ORF23; chromosome 7 open reading frame 23; MDR1 and mitochondrial taxol resistance associated gene; MGC4175; MM TRAG;
CBX7
chromobox homolog 7
CBX7; chromobox homolog 7; chromobox protein homolog 7; Cbx 7; OTTHUMP00000028984;
CBX8
chromobox homolog 8
CBX8; chromobox homolog 8; chromobox homolog 8 (Drosophila Pc class); chromobox protein homolog 8; HPC3; Pc class 3 homolog (Drosophila); PC3; polycomb 3; RC1; rectachrome 1; Pc class 3 homolog; chromobox homolog 8 (Pc class homolog, Drosophila);
CHD9
chromodomain helicase DNA binding protein 9
CHD9; chromodomain helicase DNA binding protein 9; chromodomain-helicase-DNA-binding protein 9; BC022889; FLJ12178; KIAA0308; A330063D19Rik; mKIAA0308; 1810014J18Rik; 9030205D12Rik; AD-013; AD013; ATP-dependent helicase; chromatin remodeling factor; CReMM; KISH2; PPAR-alpha-interacting complex protein 320 k; PPAR{gamma}-interacting cofactor 320 kDa; PRIC320; CHD-9; proteinx0008; kismet homolog 2; ATP-dependent helicase CHD9; ciprofibrate bound protein p240; chromatin remodeling factor CHROM1; chromatin-remodeling factor CHROM1; chromatin-related mesenchymal modulator; PPAR-alpha-interacting complex protein 320 kDa; peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein;
C1ORF216
chromosome 1 open reading frame 216
C1ORF216; chromosome 1 open reading frame 216; UPF0500 protein C1orf216; FLJ38984; 5730409E04Rik; CA216_HUMAN; hypothetical protein LOC127703;
C1ORF43
chromosome 1 open reading frame 43
C1ORF43; chromosome 1 open reading frame 43; uncharacterized protein C1orf43; DKFZp586G1722; NICE 3; protein NICE-3; HCV NS5A-transactivated protein 4; hepatitis C virus NS5A-transactivated protein 4; NICE-3; S863-3; HSPC012; NS5ATP4; MGC111001;
C1ORF51
chromosome 1 open reading frame 51
C1ORF51; chromosome 1 open reading frame 51; uncharacterized protein C1orf51; BC017397; FLJ25889;
C1ORF52
chromosome 1 open reading frame 52
C1ORF52; chromosome 1 open reading frame 52; UPF0690 protein C1orf52; FLJ44982; gm117; BCL10-associated gene protein; RP11-234D19.1;
C1ORF53
chromosome 1 open reading frame 53
C1ORF53; chromosome 1 open reading frame 53; uncharacterized protein C1orf53; CA053_HUMAN; Hypothetical protein LOC388722;
C1ORF54
chromosome 1 open reading frame 54
C1ORF54; chromosome 1 open reading frame 54; uncharacterized protein C1orf54; FLJ23221; Hypothetical protein LOC79630;
C1ORF55
chromosome 1 open reading frame 55
C1ORF55; chromosome 1 open reading frame 55; UPF0667 protein C1orf55; FLJ35382; dJ671D7.1; RP4-671D7.1;
C1ORF56
chromosome 1 open reading frame 56
C1ORF56; chromosome 1 open reading frame 56; uncharacterized protein C1orf56; FLJ20519; RP11-316M1.9;
C1ORF74
chromosome 1 open reading frame 74
C1ORF74; chromosome 1 open reading frame 74; UPF0739 protein C1orf74; FLJ25078;
CHTOP
chromatin target of PRMT1
CHTOP; chromatin target of PRMT1; C1orf77, chromosome 1 open reading frame 77; chromatin target of PRMT1 protein; DKFZP547E1010; FOP; Friend of Prmt1; small protein rich in arginine and glycine; SRAG; Chromosome 1 open reading frame 77; CHTOP_HUMAN; Friend of PRMT1 protein; MGC131924; MGC86949; OTTHUMP00000035122; OTTHUMP00000035123; Pp7704; RP1 178F15.2; Small arginine- and glycine-rich protein; SRAG-3; SRAG-5; C1orf77; FL-SRAG; RP1-178F15.2;
C20ORF160
chromosome 20 open reading frame 160
C20ORF160; chromosome 20 open reading frame 160; uncharacterized protein C20orf160; dJ310O13.5; FLJ43600;
C20ORF165
chromosome 20 open reading frame 165
C20ORF165; chromosome 20 open reading frame 165; uncharacterized protein C20orf165; dJ337O18.8; CT165_HUMAN; TSG23;
C20ORF173
chromosome 20 open reading frame 173
C20ORF173; chromosome 20 open reading frame 173; uncharacterized protein C20orf173; dJ477O4.4; CT173_HUMAN; FLJ25360; Hypothetical protein LOC140873; MGC138265; MGC138267;
C20ORF177
chromosome 20 open reading frame 177
C20ORF177; chromosome 20 open reading frame 177; uncharacterized protein C20orf177; dJ551D2.5; CT177_HUMAN;
C3ORF23
chromosome 3 open reading frame 23
C3ORF23; chromosome 3 open reading frame 23; uncharacterized protein C3orf23; DKFZp313N0621; CC023_HUMAN; D9Ertd402e; FLJ41686; Hypothetical protein LOC285343; MGC119530; MGC119531; MGC119532; MGC119533; TOAG1; Tolerance associated gene 1; tolerance associated gene-1;
C3ORF24
chromosome 3 open reading frame 24
C3ORF24; chromosome 3 open reading frame 24; uncharacterized protein C3orf24; MGC40179; CC024_HUMAN; HSD19; hypothetical protein LOC115795;
C3ORF33
chromosome 3 open reading frame 33
C3ORF33; chromosome 3 open reading frame 33; uncharacterized protein C3orf33; AC3 33; FLJ31139; AP-1 activity suppressor; E130311K13Rik; MSTP052; OTTHUMP00000212995; RIKEN cDNA E130311K13; AC3-33;
C3ORF37
chromosome 3 open reading frame 37
C3ORF37; chromosome 3 open reading frame 37; UPF0361 protein C3orf37; DC12; CC037_HUMAN; MGC111075;
C3ORF38
chromosome 3 open reading frame 38
C3ORF38; chromosome 3 open reading frame 38; uncharacterized protein C3orf38; MGC26717; FLJ54270; Hypothetical protein LOC285237;
C3ORF39
chromosome 3 open reading frame 39
C3ORF39; chromosome 3 open reading frame 39; uncharacterized glycosyltransferase AGO61; AGO61; FLJ14566; Uncharacterized glycosyltransferase AGO61 precursor; glycosyltransferase;
C3ORF58
chromosome 3 open reading frame 58
C3ORF58; chromosome 3 open reading frame 58; UPF0672 protein C3orf58; MGC33365; DIA1; Golgi protein GoPro49;
C4ORF19
chromosome 4 open reading frame 19
C4ORF19; chromosome 4 open reading frame 19; uncharacterized protein C4orf19; FLJ11017;
C4ORF22
chromosome 4 open reading frame 22
C4ORF22; chromosome 4 open reading frame 22; uncharacterized protein C4orf22; MGC35043;
C4ORF27
chromosome 4 open reading frame 27
C4ORF27; chromosome 4 open reading frame 27; UPF0609 protein C4orf27; FLJ20534; FLJ33423; FLJ42042;
C4ORF32
chromosome 4 open reading frame 32
C4ORF32; chromosome 4 open reading frame 32; uncharacterized protein C4orf32; FLJ39370; CD032_HUMAN;
C4ORF33
chromosome 4 open reading frame 33
C4ORF33; chromosome 4 open reading frame 33; UPF0462 protein C4orf33; FLJ33703; C4orf33 chromosome 4 open reading frame 33; CD033_HUMAN;
C4ORF36
chromosome 4 open reading frame 36
C4ORF36; chromosome 4 open reading frame 36; uncharacterized protein C4orf36; MGC26744;
C4ORF44
chromosome 4 open reading frame 44
C4ORF44; chromosome 4 open reading frame 44; uncharacterized protein C4orf44; LOC345222; CD044_HUMAN; hypothetical protein LOC345222;
C4ORF45
chromosome 4 open reading frame 45
C4ORF45; chromosome 4 open reading frame 45; uncharacterized protein C4orf45; FLJ25371; CD045_HUMAN;
C4ORF46
chromosome 4 open reading frame 46
C4ORF46; chromosome 4 open reading frame 46; uncharacterized protein C4orf46; LOC201725; hypothetical protein LOC201725; Hypothetical protein LOC201725 2;
C4ORF47
chromosome 4 open reading frame 47
C4ORF47; chromosome 4 open reading frame 47; UPF0602 protein C4orf47; LOC441054;
C6ORF64
chromosome 6 open reading frame 64
C6ORF64; chromosome 6 open reading frame 64; uncharacterized protein C6orf64; FLJ11101; DKFZp434H012; Hypothetical protein LOC55776; OTTHUMP00000016342;
C6ORF70
chromosome 6 open reading frame 70
C6ORF70; chromosome 6 open reading frame 70; transmembrane protein C6orf70; dJ266L20.3; FLJ11152;
C6ORF81
chromosome 6 open reading frame 81
C6ORF81; chromosome 6 open reading frame 81; uncharacterized protein C6orf81; FLJ25390; Hypothetical protein LOC221481;
C6ORF97
chromosome 6 open reading frame 97
C6ORF97; chromosome 6 open reading frame 97; coiled-coil domain-containing protein C6orf97; bA282P11.1; FLJ23305; CF097_HUMAN; Coiled coil domain containing protein C6orf97; Hypothetical protein LOC80129; LOC80129;
C7ORF29
chromosome 7 open reading frame 29
C7ORF29; chromosome 7 open reading frame 29; uncharacterized protein C7orf29;
CECR6
cat eye syndrome chromosome region, candidate 6
CECR6; cat eye syndrome chromosome region, candidate 6; cat eye syndrome critical region protein 6; AW048664; Cat eye syndrome chromosome region candidate 6; Cat eye syndrome chromosome region candidate 6 homolog (human); Cat eye syndrome chromosome region candidate 6 homolog; RGD1565302;
C8ORF34
chromosome 8 open reading frame 34
C8ORF34; chromosome 8 open reading frame 34; uncharacterized protein C8orf34; vest 1; VEST1; vestibule 1; protein VEST-1; vestibule-1 protein; VEST-1; FLJ36872; FLJ37331; DKFZp547E186;
C8ORF45
chromosome 8 open reading frame 45
C8ORF45; chromosome 8 open reading frame 45; uncharacterized protein C8orf45; FLJ25692; Minichromosome maintenance complex component like;
C8ORF48
chromosome 8 open reading frame 48
C8ORF48; chromosome 8 open reading frame 48; uncharacterized protein C8orf48; FLJ25402;
C8ORF59
chromosome 8 open reading frame 59
C8ORF59; chromosome 8 open reading frame 59; uncharacterized protein C8orf59; hypothetical protein LOC401466;
C5ORF54
chromosome 5 open reading frame 54
C5ORF54; chromosome 5 open reading frame 54; transposon-derived Buster3 transposase-like protein; Buster3; CE054_HUMAN; Transposon derived Buster3 transposase like protein;
C5ORF55
chromosome 5 open reading frame 55
C5ORF55; chromosome 5 open reading frame 55; uncharacterized protein C5orf55; Hypothetical protein LOC116349;
C5ORF60
chromosome 5 open reading frame 60
C5ORF60; chromosome 5 open reading frame 60; putative uncharacterized protein C5orf60; CE060_HUMAN; FLJ35723; LOC285679; OTTHUMP00000223359;
C6ORF120
chromosome 6 open reading frame 120
C6ORF120; chromosome 6 open reading frame 120; UPF0669 protein C6orf120; bA160E12.4;
C6ORF127
chromosome 6 open reading frame 127
C6ORF127; chromosome 6 open reading frame 127; colipase-like protein C6orf127; dJ510O8.6; CF127_HUMAN; ESP32; Hypothetical protein LOC340204;
C6ORF146
chromosome 6 open reading frame 146
C6ORF146; chromosome 6 open reading frame 146; uncharacterized protein C6orf146; MGC43581; Hypothetical protein LOC222826;
C6ORF174
chromosome 6 open reading frame 174
C6ORF174; chromosome 6 open reading frame 174; uncharacterized protein C6orf174; dJ403A15.3; CF174_HUMAN;
C6ORF192
chromosome 6 open reading frame 192
C6ORF192; chromosome 6 open reading frame 192; MFS-type transporter C6orf192; dJ55C23.6; hypothetical protein LOC116843; Uncharacterized MFS-type transporter C6orf192;
C8ORF76
chromosome 8 open reading frame 76
C8ORF76; chromosome 8 open reading frame 76; uncharacterized protein C8orf76; FLJ14825; Hypothetical protein LOC84933; LOC84933;
C8ORF84
chromosome 8 open reading frame 84
C8ORF84; chromosome 8 open reading frame 84; RPE-spondin; RPE spondin; RPESP; FLJ40021;
C9ORF174
chromosome 9 open reading frame 174
C9ORF174; chromosome 9 open reading frame 174; KIAA1529; uncharacterized protein C9orf174; BDAG1; Behcets Disease Associated Gene 1; DKFZp434I2420; DKFZp686B2031; DKFZp686G1725; FLJ41397; FLJ50036; Hypothetical protein LOC100499483;
C9ORF25
chromosome 9 open reading frame 25
C9ORF25; chromosome 9 open reading frame 25; uncharacterized protein C9orf25; bA573M23.5; FLJ39031; Hypothetical protein LOC203259;
C9ORF3
chromosome 9 open reading frame 3
C9ORF3; chromosome 9 open reading frame 3; aminopeptidase O; AOPEP; AP O; APO; C90RF3; FLJ14675; AP-O; ONPEP;
C9ORF30
chromosome 9 open reading frame 30
C9ORF30; chromosome 9 open reading frame 30; UPF0439 protein C9orf30; MGC17337; CI030; FLJ34973; Hypothetical protein LOC91283; L8; OTTHUMP00000021792;
C9ORF4
chromosome 9 open reading frame 4
C9ORF4; chromosome 9 open reading frame 4; uncharacterized protein C9orf4; CG 6; Brain protein CG 6; Brain protein CG-6; Brain protein CG6; CG6; CI004_HUMAN; CG-6;
C9ORF40
chromosome 9 open reading frame 40
C9ORF40; chromosome 9 open reading frame 40; uncharacterized protein C9orf40; FLJ10110; FLJ25795;
C9ORF43
chromosome 9 open reading frame 43
C9ORF43; chromosome 9 open reading frame 43; uncharacterized protein C9orf43; MGC17358; Hypothetical protein LOC257169; OTTHUMP00000021960;
C9ORF46
chromosome 9 open reading frame 46
C9ORF46; chromosome 9 open reading frame 46; transmembrane protein C9orf46; AD025; FLJ14688; MDS030; uncharacterized hematopoietic stem/progenitor cells protein MDS030; FLJ39176; Hypothetical protein LOC55848; 5033414D02Rik;
C7ORF31
chromosome 7 open reading frame 31
C7ORF31; chromosome 7 open reading frame 31; uncharacterized protein C7orf31;
C9ORF128
chromosome 9 open reading frame 128
C9ORF128; chromosome 9 open reading frame 128; uncharacterized protein C9orf128; CI128_HUMAN;
C9ORF150
chromosome 9 open reading frame 150
C9ORF150; chromosome 9 open reading frame 150; uncharacterized protein C9orf150; bA3L8.2; FLJ38505; MGC46502; similar to DNA segment; Chr 4; Brigham & Womens Genetics 0951 expressed; CI150_HUMAN; FLJ90271; HYST0841;
C9ORF152
chromosome 9 open reading frame 152
C9ORF152; chromosome 9 open reading frame 152; uncharacterized protein C9orf152; bA470J20.2; Hypothetical protein LOC401546;
C9ORF167
chromosome 9 open reading frame 167
C9ORF167; chromosome 9 open reading frame 167; torsin family protein C9orf167; FLJ20245; CI167_HUMAN; RP13-122B23.4;
C9ORF170
chromosome 9 open reading frame 170
C9ORF170; chromosome 9 open reading frame 170; uncharacterized protein C9orf170; FLJ45537; CI170_HUMAN;
C19ORF29
chromosome 19 open reading frame 29
C19ORF29; chromosome 19 open reading frame 29; uncharacterized protein C19orf29; cactin; cactin homolog (Drosophila); fSAPc; functional spliceosome associated protein c; NY REN 24 antigen; NY REN 24; cactin homolog; NY-REN-24 antigen; renal carcinoma anti;
CECR5
cat eye syndrome chromosome region, candidate 5
CECR5; cat eye syndrome chromosome region, candidate 5; cat eye syndrome critical region protein 5;
CYP2D4
cytochrome P450, family 2, subfamily d, polypeptide 4
CYP2D4; cytochrome P450, family 2, subfamily d, polypeptide 4; Cyp2d18; Cyp2d4v1; CYPIID18; cytochrome P450 2d18; cytochrome P450 family 2 subfamily d polypeptide 22; Cytochrome P450 subfamily IID4; Debrisoquine 4 hydroxylase; CYPIID4; P450-DB4; P450-CMF3; P450 2D-29/2D-35; cytochrome P450 2D4; cytochrome P450-DB4; cytochrome P450-CMF3; cytochrome P450 2D-29; cytochrome P450 2D-35; debrisoquine 4-hydroxylase; Cytochrome P450, subfamily IID4; cytochrome P450, subfamily 2D, polypeptide 6; cytochrome P450, subfamily IID, polypeptide 6; cytochrome P450, family 2, subfamily d, polypeptide 22; Cyp2d6; Cyp2d22; Cyp2d4v2;
CYP3A2
cytochrome P450, family 3, subfamily a, polypeptide 2
CYP3A2; cytochrome P450, family 3, subfamily a, polypeptide 2; cytochrome P450 3A2; Cyp3a11; CYPIIIA2; cytochrome P450 family 3 subfamily a polypeptide 11.; P450 6 beta A; P450 PCN2; P450/6 beta A; Testosterone 6 beta hydroxylase; P450-PCN2; P450/6-beta-A; cytochrome P450-PCN2; cytochrome P450/6-beta-A; testosterone 6-beta-hydroxylase; cytochrome P450, family 3, subfamily a, polypeptide 11;
CDYL2
chromodomain protein, Y-like 2
CDYL2; chromodomain protein, Y-like 2; chromodomain Y like protein 2; chromodomain Y-like protein 2; FLJ38866; CDY like 2; CDYL 2; Chromodomain protein Y like 2; CDY-like 2; prostate cancer candidate protein 1, PCCP1; PCCP1;
C11ORF68
chromosome 11 open reading frame 68
C11ORF68; chromosome 11 open reading frame 68; UPF0696 protein C11orf68; BLES03; P5326; protein p5326; basophilic leukemia expressed protein BLES03; basophilic leukemia-expressed protein Bles03;
MT-CO3
mitochondrially encoded cytochrome c oxidase III
MT-CO3; mitochondrially encoded cytochrome c oxidase III; cytochrome c oxidase III , MTCO3; cytochrome c oxidase III; CO3; COIII; COX3; Cytochrome c oxidase polypeptide III; Cytochrome c oxidase subunit 3; COXIII; MS406; MT CO3; MTCO3; cytochrome c oxidase subunit III;
COX7A2L
cytochrome c oxidase subunit VIIa polypeptide 2 like
COX7A2L; cytochrome c oxidase subunit VIIa polypeptide 2 like; cytochrome c oxidase subunit 7A-related protein, mitochondrial; COX7AR; COX7RP; EB1; SIG81; COX7a related protein; Cytochrome c oxidase subunit VIIa related protein, mitochondrial; Estrogen receptor binding CpG island; COX7a-related protein; cytochrome c oxidase subunit VII-related protein; cytochrome c oxidase subunit VIIa-related protein;
CYP2C18
cytochrome P450, family 2, subfamily C, polypeptide 18
CYP2C18; cytochrome P450, family 2, subfamily C, polypeptide 18; CYP2C17, cytochrome P450, subfamily IIC (mephenytoin 4 hydroxylase), polypeptide 18; cytochrome P450 2C18; CPCI; CYP2C; P450IIC17; CYP2C 18; (S) mephenytoin hydroxylase associated cytochrome P450; CYP2C17; CYPIIC18; Cytochrome P450 family 2 subfamily C polypeptide 18; Cytochrome P450 subfamily IIC (mephenytoin 4 hydroxylase) polypeptide 17; Cytochrome P450 subfamily IIC (mephenytoin 4 hydroxylase) polypeptide 18; Flavoprotein linked monooxygenase; Microsomal monooxygenase; Unspecific monooxygenase; cytochrome P450-6B/29C; flavoprotein-linked monooxygenase; (S)-mephenytoin hydroxylase associated cytochrome P450; cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 17; cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 18; P450-6B/29C;
CBX4
chromobox homolog 4
CBX4; chromobox homolog 4; chromobox homolog 4 (Drosophila Pc class); E3 SUMO-protein ligase CBX4; hPC2; NBP16; NS5ATP1 binding protein 16; Pc class 2 homolog (Drosophila); PC2; Pc class 2 homolog; polycomb 2 homolog; NS5ATP1-binding protein 16; chromobox;
C9ORF9
chromosome 9 open reading frame 9
C9ORF9; chromosome 9 open reading frame 9; uncharacterized protein C9orf9; Rsb66 homolog; FLJ26879;
C9ORF82
chromosome 9 open reading frame 82
C9ORF82; chromosome 9 open reading frame 82; uncharacterized protein C9orf82; FLJ13657; RP11-337A23.1;
CYP3A43
cytochrome P450, family 3, subfamily A, polypeptide 43
CYP3A43; cytochrome P450, family 3, subfamily A, polypeptide 43; cytochrome P450, subfamily IIIA, polypeptide 43; cytochrome P450 3A43; Cytochrome P450 family 3 subfamily A polypeptide 43; Cytochrome P450 polypeptide 43; Cytochrome P450 subfamily IIIA polypeptide 43; MGC119315; MGC119316;
CYP4B1
cytochrome P450, family 4, subfamily B, polypeptide 1
CYP4B1; cytochrome P450, family 4, subfamily B, polypeptide 1; cytochrome P450, subfamily IVB, polypeptide 1; cytochrome P450 4B1; CP4B1_HUMAN; CYPIVB1; Cytochrome P450-HP; P450HP; microsomal monooxygenase; P-450HP;
CYP2U1
cytochrome P450, family 2, subfamily U, polypeptide 1
CYP2U1; cytochrome P450, family 2, subfamily U, polypeptide 1; cytochrome P450 2U1; CP2U1_HUMAN; CYP2U 1; EC 1.14.14.1; P450TEC;
CYP2W1
cytochrome P450, family 2, subfamily W, polypeptide 1
CYP2W1; cytochrome P450, family 2, subfamily W, polypeptide 1; cytochrome P450 2W1; FLJ20359; MGC34287; CYPIIW1;
CYP39A1
cytochrome P450, family 39, subfamily A, polypeptide 1
CYP39A1; cytochrome P450, family 39, subfamily A, polypeptide 1; cytochrome P450, subfamily XXXIX (oxysterol 7 alpha hydroxylase), polypeptide 1; 24-hydroxycholesterol 7-alpha-hydroxylase; hCYP39A1; cytochrome P450 39A1; oxysterol 7alpha-hydroxylase; oxys;
CYP2D1
cytochrome P450, family 2, subfamily d, polypeptide 1
CYP2D1; cytochrome P450, family 2, subfamily d, polypeptide 1; cytochrome P450 2D1; CPD6; CYP2D; Cyp2d9; CYPIID6; Cytochrome P450 2D6; Debrisoquine 4 hydroxylase; P450 DB1; xenobiotic monooxygenase; CYPIID1; P450-DB1; P450-UT-7; P450-CMF1A; cytochrome P450-DB1; cytochrome P450-UT-7; cytochrome P450-CMF1A; debrisoquine 4-hydroxylase; cytochrome P450, family 2, subfamily d, polypeptide 9;
COX7B
cytochrome c oxidase subunit VIIb
COX7B; cytochrome c oxidase subunit VIIb; cytochrome c oxidase subunit 7B, mitochondrial; mitochondrial; COX7B_HUMAN; Cytochrome c oxidase chain VIIb; Cytochrome c oxidase polypeptide VIIb; Cytochrome c oxidase subunit 7B; Cytochrome c oxidase subunit 7B mitochondrial; cytochrome-c oxidase chain VIIb;
COX7B2
cytochrome c oxidase subunit VIIb2
COX7B2; cytochrome c oxidase subunit VIIb2; cytochrome c oxidase subunit 7B2, mitochondrial; CX7B2_HUMAN; Cytochrome c oxidase polypeptide VIIb2; Cytochrome c oxidase subunit 7B2 mitochondrial; MGC102754;
CYP2R1
cytochrome P450, family 2, subfamily R, polypeptide 1
CYP2R1; cytochrome P450, family 2, subfamily R, polypeptide 1; vitamin D 25-hydroxylase; Cytochrome P450 2R1; Cytochrome P450 family 2 R1; Cytochrome P450 family 2 subfamily R polypeptide 1; EC 1.14.13.15; MGC4663; Vitamin D 25 hydroxylase; OTTHUMP00000231476; cytochrome P450, family 2, R1;
CHRFAM7A
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion
CHRFAM7A; CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion; CHRNA7-FAM7A fusion protein; CHRNA7 DR1; D 10; Alpha 7 neuronal nicotinic acetylcholine receptor FAM7A hybrid; CHRNA7 (cholinergic receptor nicotinic alpha 7 exons 5 10) and FAM7A (family with sequence similarity 7A exons A E) fusion; CHRNA7; CHRNA7 FAM7A fusion; CHRNA7 FAM7A fusion protein; D10; HGNC:15781; MGC120482; MGC120483; alpha-7 nicotinic cholinergic receptor subunit; alpha 7 neuronal nicotinic acetylcholine receptor-FAM7A hybrid; CHRNA7 (cholinergic receptor, nicotinic, alpha polypeptide 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion; D-10; CHRNA7-DR1;
CIT
citron (rho-interacting, serine/threonine kinase 21)
CIT; citron (rho-interacting, serine/threonine kinase 21); citron Rho-interacting kinase; CRIK; KIAA0949; STK21; serine/threonine-protein kinase 21;
CXORF58
chromosome X open reading frame 58
CXORF58; chromosome X open reading frame 58; putative uncharacterized protein CXorf58; FLJ25444;
CXORF64
chromosome X open reading frame 64
CXORF64; chromosome X open reading frame 64; uncharacterized protein CXorf64; LOC100130613; CX064_HUMAN;
CXORF66
chromosome X open reading frame 66
CXORF66; chromosome X open reading frame 66; uncharacterized protein CXorf66; RP11 35F15.2; Hypothetical protein LOC347487; RP11-35F15.2;
CYP26C1
cytochrome P450, family 26, subfamily C, polypeptide 1
CYP26C1; cytochrome P450, family 26, subfamily C, polypeptide 1; cytochrome P450 26C1; FLJ45301;
CYP27A1
cytochrome P450, family 27, subfamily A, polypeptide 1
CYP27A1; cytochrome P450, family 27, subfamily A, polypeptide 1; CYP27, cytochrome P450, subfamily XXVIIA (steroid 27 hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1; sterol 26-hydroxylase, mitochondrial; cerebrotendinous xanthomatosis; CP27; CTX; Sterol 26 hydroxylase; Sterol 27 hydroxylase; Vitamin D(3) 25hydroxylase; CYP; CYP27; Cytochrome P450 27 mitochondrial; cytochrome P450 27; sterol 27-hydroxylase; cytochrome P-450C27/25; vitamin D(3) 25-hydroxylase; cholestanetriol 26-monooxygenase; 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase; 5-beta-cholestane-3-alpha, 7-alpha, 12-alpha-triol 26-hydroxylase; 5-beta-cholestane-3-alpha, 7-alpha, 12-alpha-triol 27-hydroxylase; cytochrome P450, subfamily XXVIIA (steroid 27-hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1;
CYP2S1
cytochrome P450, family 2, subfamily S, polypeptide 1
CYP2S1; cytochrome P450, family 2, subfamily S, polypeptide 1; cytochrome P450, subfamily IIS, polypeptide 1; cytochrome P450 2S1; CYPIIS1; cytochrome P540, subfamily IIS, polypeptide 1; cytochrome P450 family member predicted from ESTs;
CYP2C11
cytochrome P450, subfamily 2, polypeptide 11
CYP2C11; cytochrome P450, subfamily 2, polypeptide 11; cytochrome P450 2C11; CP2CB_RAT; Cyp2c; CYP2CII; CYPIIC11; Cytochrome P-450(M-1); Cytochrome P450-UT-2; Cytochrome P450-UT-A; Cytochrome P450H; P450 UT A; P450H; UT2; UT-2; P450-UT-A; P-450(M-1); cytochrome P450, 2c29; cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase);
CYP4V2
cytochrome P450, family 4, subfamily V, polypeptide 2
CYP4V2; cytochrome P450, family 4, subfamily V, polypeptide 2; cytochrome P450 4V2; CYP4AH1; BCD; CYP4V 2; Retina CYP4V2;
CYP4X1
cytochrome P450, family 4, subfamily X, polypeptide 1
CYP4X1; cytochrome P450, family 4, subfamily X, polypeptide 1; cytochrome P450 4X1; MGC40051; CYPIVX1;
CYP4Z1
cytochrome P450, family 4, subfamily Z, polypeptide 1
CYP4Z1; cytochrome P450, family 4, subfamily Z, polypeptide 1; cytochrome P450 4Z1; CYP4A20; CP4Z1_HUMAN; CYPIVZ1; Cytochrome P450 family 4 subfamily Z polypeptide 1;
CYP11B1
cytochrome P450, family 11, subfamily B, polypeptide 1
CYP11B1; cytochrome P450, family 11, subfamily B, polypeptide 1; CYP11B, cytochrome P450, subfamily XIB (steroid 11 beta hydroxylase), polypeptide 1; cytochrome P450 11B1, mitochondrial; CPN1; FHI; P450C11; CYP11B; CYPXIB1; Cytochrome p450 XIB1; P 450C11; S11BH; Steroid 11 beta hydroxylase; Steroid 11 beta monooxygenase; cytochrome P450C11; cytochrome P-450c11; steroid 11-beta-hydroxylase; steroid 11-beta-monooxygenase; cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 1;
CYP19A1B
cytochrome P450, family 19, subfamily A, polypeptide 1b
CYP19A1B; cytochrome P450, family 19, subfamily A, polypeptide 1b; AroB; Aromatase B; Brain aromatase; Cyp19; CYP19a2; Cyp19b; Cytochrome P450 aromatase; Cytochrome P450, 19b; P450aromB; Zgc:92614;
C20ORF54
chromosome 20 open reading frame 54
C20ORF54; chromosome 20 open reading frame 54; riboflavin transporter 2; bA371L19.1; hRFT2; hypothetical protein LOC113278; BVVLS; C20orf54provided by HGNC; MGC10698; RFT2;
COX10
COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase (yeast)
COX10; COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase (yeast); COX10 (yeast) homolog, cytochrome c oxidase assembly protein (heme A: farnesyltransferase); protoheme IX farnesyltransferase, mitochondrial; mitochondrial; 2410004F01Rik; AU042636; COX10_HUMAN; Cytochrome c oxidase assembly protein; Cytochrome c oxidase subunit X; Heme A farnesyltransferase; Heme O synthase; OTTMUSP00000006085; Protoheme IX farnesyltransferase; Protoheme IX farnesyltransferase, mitochondrial precursor; RP23-78H18.1; heme A: farnesyltransferase;
COX11
COX11 cytochrome c oxidase assembly homolog (yeast)
COX11; COX11 cytochrome c oxidase assembly homolog (yeast); COX11 (yeast) homolog, cytochrome c oxidase assembly protein; cytochrome c oxidase assembly protein COX11, mitochondrial; COX11P; cytochrome c oxidase assembly protein COX11; cytochrome c oxidase subunit 11; COX11 homolog; COX11 homolog, cytochrome c oxidase assembly protein (yeast); COX11 homolog, cytochrome c oxidase assembly protein;
CYP4F12
cytochrome P450, family 4, subfamily F, polypeptide 12
CYP4F12; cytochrome P450, family 4, subfamily F, polypeptide 12; cytochrome P450, subfamily IVF, polypeptide 12; cytochrome P450 4F12; CYPIVF12; F22329_1;
CYP4F2
cytochrome P450, family 4, subfamily F, polypeptide 2
CYP4F2; cytochrome P450, family 4, subfamily F, polypeptide 2; cytochrome P450, subfamily IVF, polypeptide 2; leukotriene-B(4) omega-hydroxylase 1; CYPIVF2; cytochrome P450 4F2; cytochrome P450-LTB-omega; leukotriene-B4 20-monooxygenase; leukotriene B4 om;
CYP4F22
cytochrome P450, family 4, subfamily F, polypeptide 22
CYP4F22; cytochrome P450, family 4, subfamily F, polypeptide 22; cytochrome P450 4F22; FLJ39501; CP4FN_HUMAN; FLJ 39501; LI3; cytochrome P450, family 2, subfamily E, polypeptide 2 homolog;
CXORF21
chromosome X open reading frame 21
CXORF21; chromosome X open reading frame 21; uncharacterized protein CXorf21; FLJ11577; Hypothetical protein LOC80231; 5430427O19Rik;
CXORF26
chromosome X open reading frame 26
CXORF26; chromosome X open reading frame 26; UPF0368 protein Cxorf26; MGC874; 2610029G23Rik;
CXORF30
chromosome X open reading frame 30
CXORF30; chromosome X open reading frame 30; putative uncharacterized protein CXorf30; OTTHUMG00000021353; CX030_HUMAN; RP11-87M18.1;
CXORF38
chromosome X open reading frame 38
CXORF38; chromosome X open reading frame 38; uncharacterized protein CXorf38; MGC39350; CX038_HUMAN; Hypothetical protein LOC159013;
CXORF48
chromosome X open reading frame 48
CXORF48; chromosome X open reading frame 48; uncharacterized protein CXorf48; cancer/testis antigen 55; CT55; FLJ20527; Hypothetical protein LOC54967; Tumor antigen BJ HCC 20; tumor antigen BJ-HCC-20; BRCA2-interacting protein; BJHCC20A; RP13-565O16.1;
CXORF56
chromosome X open reading frame 56
CXORF56; chromosome X open reading frame 56; UPF0428 protein CXorf56; FLJ22965;
CYB5R1
cytochrome b5 reductase 1
CYB5R1; cytochrome b5 reductase 1; NAD(P)H:quinone oxidoreductase type 3, polypeptide A2 , NQO3A2; NADH-cytochrome b5 reductase 1; humb5R2; b5R.1; B5R1; EC 1.6.2.2; NAD; NAD(P)H:quinone oxidoreductase type 3 polypeptide A2; NAD(P)H:quinone oxidoreductase type 3, polypeptide A2; NADH cytochrome b5 reductase 1; NB5R1_HUMAN; NQO3A2; UNQ3049/PRO9865;
CYB5RL
cytochrome b5 reductase-like
CYB5RL; cytochrome b5 reductase-like; NADH-cytochrome b5 reductase-like; LOC606495; 2810410C14Rik; EC 1.6.2.2; FLJ00377; mFLJ00377; NB5R5_HUMAN; RP23-97J2.4; OTTHUMP00000232139;
CYP27B1
cytochrome P450, family 27, subfamily B, polypeptide 1
CYP27B1; cytochrome P450, family 27, subfamily B, polypeptide 1; cytochrome P450, subfamily XXVIIB (25 hydroxyvitamin D 1 alpha hydroxylase), polypeptide 1 , PDDR, VDD1; 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial; 1alpha(OH)ase; 25 Hydroxyvita;
CYP27C1
cytochrome P450, family 27, subfamily C, polypeptide 1
CYP27C1; cytochrome P450, family 27, subfamily C, polypeptide 1; cytochrome P450 27C1; FLJ16008; Cytochrome P450 family 27 subfamily C polypeptide 1; Cytochrome P450 family 27 subfamily C polypeptide 13; cytochrome P450, family 27, subfamily C, polypeptide 13;
CYP2A13
cytochrome P450, family 2, subfamily A, polypeptide 13
CYP2A13; cytochrome P450, family 2, subfamily A, polypeptide 13; cytochrome P450, subfamily IIA (phenobarbital inducible), polypeptide 13; cytochrome P450 2A13; CPAD; CYP2A; CYPIIA13; cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 13;
CYP2A7
cytochrome P450, family 2, subfamily A, polypeptide 7
CYP2A7; cytochrome P450, family 2, subfamily A, polypeptide 7; cytochrome P450, subfamily IIA (phenobarbital inducible), polypeptide 7; cytochrome P450 2A7; CYP2A; CP2A7_HUMAN; CPA7; CPAD; CYP2A 7; CYPIIA7; Cytochrome P450 IIA4; P450 IIA4; cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 7; P450-IIA4;
CYP20A1
cytochrome P450, family 20, subfamily A, polypeptide 1
CYP20A1; cytochrome P450, family 20, subfamily A, polypeptide 1; cytochrome P450 20A1; CYP M; CP20A_HUMAN; Cytochrome P450 monooxygenase; MGC22229; CYP-M;
CYP21A2
cytochrome P450, family 21, subfamily A, polypeptide 2
CYP21A2; cytochrome P450, family 21, subfamily A, polypeptide 2; CYP21, CYP21B, cytochrome P450, subfamily XXIA (steroid 21 hydroxylase, congenital adrenal hyperplasia), polypeptide 2; steroid 21-hydroxylase; CA21H; CAH1; CPS1; P450c21B; Steroid 21 monooxygenase; CYP21; CYP21B; P450 C21; P450 C21B; Steroid 21 hydroxylase; CYP21A 2; Cytochrome P450 21; 21-OHase; cytochrome P450 XXI; cytochrome P450-C21B; steroid 21-monooxygenase; cytochrome P450, subfamily XXIA (steroid 21-hydroxylase, congenital adrenal hyperplasia), polypeptide 2;
CYP4F8
cytochrome P450, family 4, subfamily F, polypeptide 8
CYP4F8; cytochrome P450, family 4, subfamily F, polypeptide 8; cytochrome P450, subfamily IVF, polypeptide 8; cytochrome P450 4F8; CPF8; Microsomal monooxygenase; Polypeptide 8; flavoprotein-linked monooxygenase; CYPIVF8;
CYBRD1
cytochrome b reductase 1
CYBRD1; cytochrome b reductase 1; DCYTB; ferric chelate reductase 3; FLJ23462; FRRS3; CYBR 1; CYBR1; CYBR1_HUMAN; CYBRD 1; DKFZp564E227; Duodenal cytochrome b; Ferric-chelate reductase 3;
CYB5B
cytochrome b5 type B (outer mitochondrial membrane)
CYB5B; cytochrome b5 type B (outer mitochondrial membrane); cytochrome b5 type B; CYB5 M; CYB5M; OMB5; Type 2 cyt b5; type 2 cyt-b5; outer mitochondrial membrane cytochrome b5; cytochrome b5 outer mitochondrial membrane isoform; CYB5-M; CYPB5M;
CYP17A1
cytochrome P450, family 17, subfamily A, polypeptide 1
CYP17A1; cytochrome P450, family 17, subfamily A, polypeptide 1; CYP17, cytochrome P450, subfamily XVII (steroid 17 alpha hydroxylase), adrenal hyperplasia; steroid 17-alpha-hydroxylase/17,20 lyase; CPT7; P450C17; S17AH; Steroid 17 alpha monooxygenase; 20 lyase; CP17A_HUMAN; CYP17; CYPXVII; Cytochrome P450 17A1; Cytochrome P450 family 17; Cytochrome P450 family 17 subfamily A polypeptide 1; Cytochrome p450 XVIIA1; Cytochrome p450, subfamily XVII (steroid 17 alpha hydroxylase) adrenal hyperplasia; Cytochrome P450-C17; Cytochrome P450c17; OTTHUMP00000020382; P450 C17; Steroid 17 alpha hydroxylase/17,20 lyase; Steroid 17-alpha-hydroxylase/17; Steroid 17-alpha-monooxygenase; cytochrome P450, subfamily XVII (steroid 17-alpha-hydroxylase), adrenal hyperplasia;
CYP2C23
cytochrome P450, family 2, subfamily c, polypeptide 23
CYP2C23; cytochrome P450, family 2, subfamily c, polypeptide 23; cytochrome P450 2C23; Arachidonic acid epoxygenase; CYPIIC23;
CYP4A22
cytochrome P450, family 4, subfamily A, polypeptide 22
CYP4A22; cytochrome P450, family 4, subfamily A, polypeptide 22; cytochrome P450 4A22; CYPIVA22; Cytochrome P450 4A22K; Cytochrome P450 family 4 subfamily A polypeptide 22; Fatty acid omega hydroxylase; Lauric acid omega hydroxylase; RP1 18D14.1; fatty acid omega-hydroxylase; lauric acid omega-hydroxylase;
CYP4F13
cytochrome P450, family 4, subfamily f, polypeptide 13
CYP4F13; cytochrome P450, family 4, subfamily f, polypeptide 13; Cytochrome P450 family 4 subfamily f polypeptide 13; P450 CYP4F13; cytochrome P450 CYP4F13; leukotriene B4 omega hydroxylase; cytochrome P450,subfamily IVF, polypeptide 13; Cypf13; 0610030I10Rik;
EPB49
erythrocyte membrane protein band 4.9 (dematin)
EPB49; erythrocyte membrane protein band 4.9 (dematin); dematin; DMT; FLJ78462; FLJ98848;
EPB41L4A
erythrocyte membrane protein band 4.1 like 4A
EPB41L4A; erythrocyte membrane protein band 4.1 like 4A; band 4.1-like protein 4A; NBL4; Band 4.1 like protein 4A; EPB41L4; FLJ38738; erythrocyte protein band 4.1-like 4;
EPB41L5
erythrocyte membrane protein band 4.1 like 5
EPB41L5; erythrocyte membrane protein band 4.1 like 5; band 4.1-like protein 5; BE37; FLJ12957; KIAA1548; YMO1;
EPB41L2
erythrocyte membrane protein band 4.1-like 2
EPB41L2; erythrocyte membrane protein band 4.1-like 2; band 4.1-like protein 2; 4.1 G; D10Ertd398e; NBL2; OTTHUMP00000040262; 4.1G; AW555191; Band 4.1 like protein 2; DKFZp781D1972; DKFZp781H1755; E41L2_HUMAN; Erythrocyte membrane protein band 4.1 like 2; Erythrocyte membrane protein band 4.1 like protein 2; Generally expressed protein 4.1; OTTHUMP00000017197; OTTHUMP00000233453; OTTHUMP00000233454; OTTHUMP00000233488; OTTHUMP00000233489; OTTHUMP00000233490; OTTHUMP00000233519; OTTHUMP00000233520; OTTHUMP00000233521; OTTHUMP00000233522; OTTHUMP00000233653; erythrocyte membrane protein band 4.1 like-protein 2; 4.1-G;
DSCC1
defective in sister chromatid cohesion 1 homolog (S. cerevisiae)
DSCC1; defective in sister chromatid cohesion 1 homolog (S. cerevisiae); sister chromatid cohesion protein DCC1; DCC1; defective in sister chromatid cohesion homolog 1 (S. cerevisiae); hDCC1; MGC5528; DCC1_HUMAN; Defective in sister chromatid cohesion 1 homolog; Defective in sister chromatid cohesion protein 1 homolog;
C6ORF94
chromosome 6 open reading frame 94
C6ORF94; chromosome 6 open reading frame 94; FAM164B, family with sequence similarity 164, member B; protein FAM164B; dJ468K18.5; F164B_HUMAN; Family with sequence similarity 164, member B; Hypothetical protein LOC153918; FAM164B;
FYTTD1
forty-two-three domain containing 1
FYTTD1; forty-two-three domain containing 1; UAP56-interacting factor; DKFZp761B1514; UAP56 interacting factor; UIF; Forty two three domain containing 1; Forty two three domain containing protein 1; Forty-two-three domain-containing protein 1; FYTTD 1; OTTHUMP00000208028; OTTHUMP00000208031; OTTHUMP00000208032; Protein 40 2 3; Protein 40-2-3; UIF_HUMAN;
C10ORF28
chromosome 10 open reading frame 28
C10ORF28; chromosome 10 open reading frame 28; growth inhibition and differentiation-related protein 88; GIDRP86; PSORT; putative mitochondrial space protein 32.1; growth inhibition and differentiation related protein 86; GIDRP88; FLJ25458; FLJ37160;
C14ORF1
chromosome 14 open reading frame 1
C14ORF1; chromosome 14 open reading frame 1; probable ergosterol biosynthetic protein 28; ERG28; NET51;
ETS2
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
ETS2; v-ets erythroblastosis virus E26 oncogene homolog 2 (avian); v ets avian erythroblastosis virus E26 oncogene homolog 2; protein C-ets-2; C ets 2 protein; ETS2_HUMAN; ETS2IT1; Oncogene ETS2; v ets avian erythroblastosis virus E2 oncogene homolog 2; V ets erythroblastosis virus E26 oncogene homolog 2; oncogene ETS-2; v-ets avian erythroblastosis virus E2 oncogene homolog 2; v-ets avian erythroblastosis virus E26 oncogene homolog 2;
C19ORF40
chromosome 19 open reading frame 40
C19ORF40; chromosome 19 open reading frame 40; FAAP24; Fanconi anemia-associated protein of 24 kDa; Fanconi anemia-associated protein, 24 kDa;
C5ORF64
chromosome 5 open reading frame 64
C5ORF64; chromosome 5 open reading frame 64; uncharacterized protein C5orf64; FLJ37543; FLJ37543 hypothetical protein FLJ37543; FLJ45901; Hypothetical protein FLJ37543; Hypothetical protein LOC285668; MGC138187; MGC138213; Uncharacterized protein FLJ37543;
SGK494
uncharacterized serine/threonine-protein kinase SgK494
SGK494; uncharacterized serine/threonine-protein kinase SgK494; MGC39533; Sugen kinase 494; Uncharacterized serine/threonine protein kinase SgK494;
C2ORF63
chromosome 2 open reading frame 63
C2ORF63; chromosome 2 open reading frame 63; uncharacterized protein C2orf63; FLJ31438; Hypothetical protein LOC130162;
C17ORF70
chromosome 17 open reading frame 70
C17ORF70; chromosome 17 open reading frame 70; FAAP100; Fanconi anemia-associated protein of 100 kDa; Fanconi anemia-associated protein, 100kDa; Fanconi anemia core complex 100 kDa subunit; Fanconi anemia associated protein 100 kDa subunit;
HP1BP3
heterochromatin protein 1, binding protein 3
HP1BP3; heterochromatin protein 1, binding protein 3; heterochromatin protein 1-binding protein 3; HP1 BP74; OTTHUMP00000002720; HP1BP 3; MGC28927; MGC43701; MGC72624; OTTHUMP00000002717; OTTHUMP00000002719; Protein HP1 BP74; RP5 930J4.3; HP1-BP74; OTTHUMP00000002716; RP5-930J4.3;
C10ORF54
chromosome 10 open reading frame 54
C10ORF54; chromosome 10 open reading frame 54; platelet receptor Gi24; B7 H5; GI24; SISP1; stress induced secreted protein 1; GI24_HUMAN; PP2135; UNQ730/PRO1412; B7-H5;
HR
hair growth associated
HR; hair growth associated; AU; MUHH; ALUNC; MUHH1; HSA277165; protein hairless; hairless homolog;
C19ORF38
chromosome 19 open reading frame 38
C19ORF38; chromosome 19 open reading frame 38; protein HIDE1; HIDE1; Highly expressed in immature dendritic cell transcript 1;
C22ORF31
chromosome 22 open reading frame 31
C22ORF31; chromosome 22 open reading frame 31; uncharacterized protein C22orf31; bK747E2.1; HS747E2A;
HRASLS
HRAS-like suppressor
HRASLS; HRAS-like suppressor; H REV107; HRASLS1; HREV107 protein related protein; phospholipase A; H-REV107 protein-related protein; A-C1; HSD28; H-REV107;
HRASLS2
HRAS-like suppressor 2
HRASLS2; HRAS-like suppressor 2; FLJ20556; HRAS like suppressor 2; PLA1 2 2; PLA1/2-2;
HRASLS5
HRAS-like suppressor family, member 5
HRASLS5; HRAS-like suppressor family, member 5; HRAS-like suppressor 5; HRLP5; H-rev107-like protein 5; lecithin-retinol acyltransferase (LRAT)-like protein-1; calcium-independent phosphatidylethanolamine N-acyltransferase; RLP1; iNAT;
C19ORF33
chromosome 19 open reading frame 33
C19ORF33; chromosome 19 open reading frame 33; immortalization up-regulated protein; H2RSP; IMUP; IMUP 1; IMUP 2; HAI 2 related small protein; Hepatocyte growth factor activator inhibitor type 2 related small protein; Immortalization up regulated protein; Immortalization upregulated protein; MGC39135; MGC75180; HAI-2 related small protein; HAI-2-related small protein; immortalization-upregulated protein; hepatocyte growth factor activator inhibitor type 2-related small protein; IMUP-1; IMUP-2;
KTI12
KTI12 homolog, chromatin associated
KTI12; KTI12 homolog, chromatin associated (S. cerevisiae); protein KTI12 homolog; MGC20419; SBBI81; TOT4; RP11-91A18.3;
UHRF1BP1L
UHRF1 binding protein 1-like
UHRF1BP1L; UHRF1 binding protein 1-like; UHRF1-binding protein 1-like; KIAA0701; Hypothetical protein DKFZp686A1736; Hypothetical protein LOC23074; UH1BL_HUMAN; UHRF1 binding protein 1 like; UHRF1 (ICBP90) binding protein 1-like;
KIR3DL2
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 3DL2; CD158K; cl 5; nkat4; nkat4a; nkat4b; CD158 antigen like family member K; CD158 antigen-like family member K; KI3L2_HUMAN; Killer cell immunoglobulin like receptor 3DL2; killer cell immunoglobulin like receptor KIR3DL2; Killer cell immunoglobulin like receptor, three domains, long cytoplasmic tail, 2; KIR antigen 3DL2; Kirl2; MHC class I NK cell receptor; Natural killer associated transcript 4; natural killer cell inhibitory receptor; Natural killer-associated transcript 4; NK associated transcript 4; NK associated transcript 4A, included; NK associated transcript 4B, included; NKAT-4; p140; p70 natural killer cell receptor clone CL 5; p70 natural killer cell receptor clone CL-5; p70 NK receptor CL 5; p70 NK receptor CL-5; killer Ig receptor; p70 killer cell inhibitory receptor; killer cell immunoglobulin-like receptor KIR3DL2;
LOC727787
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like
LOC727787; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 2 like; LOC727787|-|-;
MAST4
microtubule associated serine/threonine kinase family member 4
MAST4; microtubule associated serine/threonine kinase family member 4; microtubule-associated serine/threonine-protein kinase 4; KIAA0303; Microtubule associated serine/threonine protein kinase member 4;
C19ORF6
chromosome 19 open reading frame 6
C19ORF6; chromosome 19 open reading frame 6; membralin; ASBABP1; aspecific BCL2 ARE binding protein 1; MBRL; MGC4022; aspecific BCL2 ARE-binding protein 1; R32184_3;
MAST3
microtubule associated serine/threonine kinase 3
MAST3; microtubule associated serine/threonine kinase 3; microtubule-associated serine/threonine-protein kinase 3; KIAA0561;
MCM10
minichromosome maintenance complex component 10
MCM10; minichromosome maintenance complex component 10; MCM10 minichromosome maintenance deficient 10 (S. cerevisiae); protein MCM10 homolog; CNA43; DNA43; PRO2249; FLJ31133; HsMCM10; MCM10 minichromosome maintenance deficient 10; MCM10_HUMAN; Minichromosome maintenance protein 10 isoform 1; homolog of yeast MCM10;
C5ORF41
chromosome 5 open reading frame 41
C5ORF41; chromosome 5 open reading frame 41; UPF0474 protein C5orf41; adult retina protein; Hypothetical protein; luman-recruiting factor; LRF;
C20ORF201
chromosome 20 open reading frame 201
C20ORF201; chromosome 20 open reading frame 201; uncharacterized protein C20orf201; CT201_HUMAN; bA299N6.3;
C20ORF203
chromosome 20 open reading frame 203
C20ORF203; chromosome 20 open reading frame 203; uncharacterized protein C20orf203; FLJ33706; alugen;
C5ORF39
chromosome 5 open reading frame 39
C5ORF39; chromosome 5 open reading frame 39; annexin-2 receptor; Annexin 2 receptor; Annexin II receptor; AX2R; AXIIR;
C10ORF96
chromosome 10 open reading frame 96
C10ORF96; chromosome 10 open reading frame 96; UPF0628 protein C10orf96; MGC35062;
MCM9
minichromosome maintenance complex component 9
MCM9; minichromosome maintenance complex component 9; C6orf61, chromosome 6 open reading frame 61 , MCMDC1, minichromosome maintenance deficient domain containing 1; DNA replication licensing factor MCM9; dJ329L24.3; FLJ20170; MGC35304; C6orf61; hMCM9; MCMDC1; Mini-chromosome maintenance deficient 9; Mini-chromosome maintenance deficient domain-containing protein 1; minichromosome maintenance deficient domain containing 1; dJ329L24.1;
C7ORF49
chromosome 7 open reading frame 49
C7ORF49; chromosome 7 open reading frame 49; modulator of retrovirus infection homolog; FLJ22450; FLJ27285; MGC5242; modulator of retrovirus infection; MRI;
C1ORF35
chromosome 1 open reading frame 35
C1ORF35; chromosome 1 open reading frame 35; multiple myeloma tumor-associated protein 2; MGC4174; MMTAG2; multiple myeloma tumor associated protein 2; multiple myeloma transforming 2; hMMTAG2;
MUB
mushroom-body expressed
MUB; mushroom-body expressed; CG7437 gene product from transcript CG7437-RA; CG7437-PA isoform A; Cg7437-pb isoform b; CG7437-PC isoform C; Mushroom body expressed; Nucleic acid binding protein; mushroom-body expressed, isoform A; CG7437-PA; mub-PA; mushroom bodies; mushroom-body expressed, isoform B; CG7437-PB; mub-PB; mushroom-body expressed, isoform C; CG7437-PC; mub-PC; mushroom-body expressed, isoform D; CG7437-PD; mub-PD; mushroom-body expressed, isoform E; CG7437-PE; mub-PE; anon-WO0172774.33; anon-WO0172774.35; anon-WO0172774.36; anon-WO0172774.37; CG7437; Dmel\CG7437; l(3)04093; l(3)j6B10; l(3)j8B3;
MT-CYB
mitochondrially encoded cytochrome b
MT-CYB; mitochondrially encoded cytochrome b; cytochrome b , MTCYB; cytochrome b; COB; CYTB; UQCR3; Complex III subunit 3; Complex III subunit III; Cytochrome b c1 complex subunit 3; MTCYB; Ubiquinol cytochrome c reductase complex cytochrome b subunit; TAA stop codon is completed by the addition of 3 A residues to the mRNA;
C4ORF49
chromosome 4 open reading frame 49
C4ORF49; chromosome 4 open reading frame 49; uncharacterized protein C4orf49; OSAP; ovary specific acidic protein; CD049_HUMAN; Corneal endothelium-specific protein 1; GS3582; Ovary-specific acidic protein; mitochondria-localized glutamic acid-rich protein; hypoxia up-regulated mitochondrial movement regulator; HUMMR; MGARP; CESP-1;
C14ORF49
chromosome 14 open reading frame 49
C14ORF49; chromosome 14 open reading frame 49; nesprin-3; FLJ25605; NET53; MGC75267; Nesprin 3; SYNE3_HUMAN; OTTHUMP00000246622; OTTHUMP00000246623;
NPNT
nephronectin
NPNT; nephronectin; preosteoblast EGF-like repeat protein with MAM domain; Nctn; POEM; AA682063; AI314031; 1110009H02Rik;
NELF
nasal embryonic LHRH factor
NELF; nasal embryonic LHRH factor; nasal embryonic luteinizing hormone-releasing hormone factor; RP11-48C7.1; MGC125369;
NPHP1
nephronophthisis 1 (juvenile) homolog (human)
NPHP1; nephronophthisis 1 (juvenile) homolog (human); nephrocystin-1; JBTS4; Juvenile nephronophthisis 1 protein; Nephrocystin 1; NPH1; SLSN1;
C1ORF63
chromosome 1 open reading frame 63
C1ORF63; chromosome 1 open reading frame 63; UPF0471 protein C1orf63; DJ465N24.2.1; Hypothetical protein LOC57035; RP3 465N24.4; NPD014; RP3-465N24.4;
NFE2L3
nuclear factor (erythroid-derived 2)-like 3
NFE2L3; nuclear factor (erythroid-derived 2)-like 3; nuclear factor erythroid 2-related factor 3; Nrf3; erythroid derived 2; like 3; NF-E2-related factor 3; NF2L3_HUMAN; NFE2-related factor 3; Nuclear factor; nuclear factor, erythroid derived 2, like 3; nuclear factor-erythroid 2-related factor 3; nuclear factor-erythroid 2 p45-related factor 3;
C12ORF75
chromosome 12 open reading frame 75
C12ORF75; chromosome 12 open reading frame 75; overexpressed in colon carcinoma 1 protein; OCC 1; overexpressed in colon carcinoma-1; AGD3; OCC1; OCC-1; MGC148100; MGC149157;
OXA1L
oxidase (cytochrome c) assembly 1-like
OXA1L; oxidase (cytochrome c) assembly 1-like; mitochondrial inner membrane protein OXA1L; MGC133129; OXA1; Hsa; OXA1 like protein; Oxa1hs; Oxidase (cytochrome c) assembly 1 like; Oxidase assembly 1 like protein; OXA1-like protein; oxidase assembly 1-like protein;
C5ORF13
chromosome 5 open reading frame 13
C5ORF13; chromosome 5 open reading frame 13; neuronal protein 3.1; D4S114; P311; PRO1873; PTZ17; Protein p311;
CAF1
Chromatin assembly factor 1 subunit
CAF1; Chromatin assembly factor 1 subunit; CG4236 gene product from transcript CG4236-RA; Caf 1; CAF-1 P55 subunit; CAF1 p55 subunit; CAF1A; CAF1P55; chaf1b; Chromatin assembly factor 1 p55 subunit; Chromatin assembly factor 1 p60 subunit; dCAF1; Human chromatin assembly factor-I p55 subunit; Nucleosome remodeling factor 55 kDa subunit; NURF 55; NURF-55; p55; Probable histone binding protein Caf1; chromatin assembly factor 1 subunit, isoform A; CG4236-PA; Caf1-PA; nucleosome remodeling factor; chromatin assembly Factor-1; chromatin associated factor-1 subunit; Nurf55/CAF1; nucleosome remodeling factor - 55kD; dCAF-1-p180; chromatin assembly factor 1 subunit, isoform B; CG4236-PB; Caf1-PB; 154659_at; 55; caf-1; caf1 p55; CAF1-55; Caf1/p55; CG4236; d-CAF1; dCAF-1; dCAF-1 p55; Dmel\CG4236; dNURF; MSI1/RbAp48/CAC3/LIN-53; Nurf; Nurf55; p55/NURF-55; p55CAF1; RbAp48;
F2RL2
coagulation factor II (thrombin) receptor-like 2
F2RL2; coagulation factor II (thrombin) receptor-like 2; PAR3; PAR-3; proteinase-activated receptor 3; thrombin receptor-like 2; protease-activated receptor 3; proteinase-activated receptor-3; Coagulation factor II receptor-like 2 (protease-actovated receptor 3);
PSTPIP2
proline-serine-threonine phosphatase interacting protein 2
PSTPIP2; proline-serine-threonine phosphatase interacting protein 2; proline-serine-threonine phosphatase-interacting protein 2; Macrophage actin associated tyrosine phosphorylated protein; Macrophage actin-associated tyrosine-phosphorylated protein; MAYP; Proline serine threonine phosphatase interacting protein 2; OTTHUMP00000202182; OTTHUMP00000202254; PEST phosphatase-interacting protein 2;
eba-165
erythrocyte binding antigen-165
eba-165; erythrocyte binding antigen-165; erythrocyte binding antigen putative;
C9ORF102
chromosome 9 open reading frame 102
C9ORF102; chromosome 9 open reading frame 102; C9orf102, chromosome 9 open reading frame 102; FLJ37706; RAD26L; SR278; RP11-346B7.2;
SMC4
structural maintenance of chromosomes 4
SMC4; structural maintenance of chromosomes 4; SMC4 (structural maintenance of chromosomes 4, yeast) like 1 , SMC4 structural maintenance of chromosomes 4 like 1 (yeast) , SMC4L1; structural maintenance of chromosomes protein 4; CAP C; hCAP C; SMC protein 4; XCAP-C homolog; chromosome-associated polypeptide C; SMC4 structural maintenance of chromosomes 4-like 1; CAPC; CAP-C; SMC-4; SMC4L1; hCAP-C;
RCC2
regulator of chromosome condensation 2
RCC2; regulator of chromosome condensation 2; protein RCC2; TD 60; RCC1-like protein TD-60; telophase disk protein of 60 kDa; TD-60; KIAA1470; DKFZp762N0610;
SMARCAL1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
SMARCAL1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1; ATP driven annealing helicase; HARP; HepA related protein; HHARP; SMARCA like Protein 1; Sucrose nonfermenting protein 2 like 1; SWI/SNF Related; SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily A like protein 1; HepA-related protein; SMARCA-like protein 1; ATP-driven annealing helicase; sucrose nonfermenting protein 2-like 1;
SMARCD1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1
SMARCD1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1; BAF60A; CRACD1; Rsc6p; Swp73-like protein; BRG1-asso;
C10ORF27
chromosome 10 open reading frame 27
C10ORF27; chromosome 10 open reading frame 27; protein SPATIAL; FLJ32820; spatial; Stromal protein associated with thymii and lymph node homolog; stromal protein associated with thymii and lymph nodes;
NIM1
serine/threonine-protein kinase NIM1
NIM1; serine/threonine-protein kinase NIM1; Hypothetical protein LOC167359; Hypothetical protein MGC42105; NIM1_HUMAN;
C22ORF42
chromosome 22 open reading frame 42
C22ORF42; chromosome 22 open reading frame 42; uncharacterized protein C22orf42; dJ90G24.6; Hypothetical protein LOC150297; LOC150297; Uncharacterized protein LOC150297; RP1-127L4.6;
C13ORF27
chromosome 13 open reading frame 27
C13ORF27; chromosome 13 open reading frame 27; uncharacterized protein C13orf27; Hypothetical protein LOC93081;
C11ORF58
chromosome 11 open reading frame 58
C11ORF58; chromosome 11 open reading frame 58; small acidic protein; SMAP; IMAGE145052; MGC117265; DKFZp686N0232;
SMARCA1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
SMARCA1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1; SWI; ISWI; SWI2; SNF2L; SNF2L1; SNF2LB; SNF2LT; NURF140; probable global transcription activator SNF2L1; SNF2-like 1; ATP-dependent helicase SMARCA1; sucrose nonfermenting 2-like protein 1; nucleosome-remodeling factor subunit SNF2L; global transcription activator homologous sequence;
SPTBN5
spectrin, beta, non-erythrocytic 5
SPTBN5; spectrin, beta, non-erythrocytic 5; spectrin beta chain, brain 4; beta V spectrin; BSPECV; HUBSPECV; HUSPECV; brain 4; non-erythroid beta chain 4; Beta-V spectrin; Spectrin; Spectrin beta chain; Spectrin, non-erythroid beta chain 4; SPTBN4; SPTN5_HUMAN;
SMARCAD1
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1
SMARCAD1; SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1; DKFZp762K2015; ETL1; KIAA1122; ATP dependent helicase 1; ATP-dependent helicase 1; hHEL1; SMRCD_HUMAN; OTTHUMP00000161594; OTTHUMP00000161595; OTTHUMP00000219301; OTTHUMP00000219302; HEL1; ADERM;
STYXL1
serine/threonine/tyrosine interacting-like 1
STYXL1; serine/threonine/tyrosine interacting-like 1; dual specificity phosphatase 24 (putative) , DUSP24; serine/threonine/tyrosine-interacting-like protein 1; MK STYX; Dual specificity phosphatase inhibitor MK STYX; Dual specificity protein phosphatase 24; DUSP24; Map kinase phosphatase like protein MK STYX; MKSTYX; Serine/threonine/tyrosine interacting like protein 1; dual specificity phosphatase 24 (putative); map kinase phosphatase-like protein MK-STYX; dual specificity phosphatase inhibitor MK-STYX; MK-STYX;
SMC5
Structural Maintenance Of Chromosomes 5
SMC5; Structural maintenance of chromosomes 5-like 1; Structural maintenance of chromosomes 5; SMC5L1; KIAA0594; FLJ22116; HGNC:20465; Structural maintenance of chromosomes protein 5; hSMC 5; SMC-5; hSMC5; OTTHUMP00000063367; SMC 5; SMC 5 structural maintenance of chromosomes 5 like 1; SMC5 L1; SMC5 protein; SMC5 structural maintenance of chromosomes 5 like 1; Structural maintenance of chromosomes 5 like 1; SMC protein 5; SMC5 structural maintenance of chromosomes 5-like 1 (yeast);
SMCHD1
structural maintenance of chromosomes flexible hinge domain containing 1
SMCHD1; structural maintenance of chromosomes flexible hinge domain containing 1; structural maintenance of chromosomes flexible hinge domain-containing protein 1; SMC hinge domain-containing protein 1;
SMCR7
Smith-Magenis syndrome chromosome region, candidate 7
SMCR7; Smith-Magenis syndrome chromosome region, candidate 7; mitochondrial dynamic protein MID49; MGC23130; MiD49; mitochondrial dynamic protein of 49 kDa; Smith-Magenis syndrome chromosomal region candidate gene 7 protein;
C1ORF116
chromosome 1 open reading frame 116
C1ORF116; chromosome 1 open reading frame 116; specifically androgen-regulated gene protein; FLJ36507; MGC2742; MGC4309; SARG; specifically androgen regulated gene; specifically androgen-regulated protein; DKFZp666H2010;
MAU2
MAU2 sister chromatid cohesion factor
MAU2; MAU2 sister chromatid cohesion factor; SCC4; MAU2L; mau-2; KIAA0892; MAU2 chromatid cohesion factor homolog; protein MAU-2; sister chromatid cohesion 4; cohesin loading complex subunit SCC4 homolog;
TINAG
tubulointerstitial nephritis antigen
TINAG; tubulointerstitial nephritis antigen; TIN AG; TIN-Ag; TIN1; TIN2; TINAG_HUMAN;
TINAGL1
tubulointerstitial nephritis antigen-like 1
TINAGL1; tubulointerstitial nephritis antigen-like 1; LCN7, lipocalin 7 , TINAG like 1; tubulointerstitial nephritis antigen-like; ARG1; LIECG3; P3ECSL; TINAGRP; Androgen regulated gene 1; GIS5; Glucocorticoid inducible protein 5; Glucocorticoid inducible protein; LCN7; Lipocalin 7; Lipocalin7; OLRG 2; OLRG2; Oxidized LDL responsive gene 2; Oxidized LDL responsive gene 2 protein; TIN Ag related protein; TIN Ag RP; TINAG like 1; TINAGL 1; TINAGL; Tubulointerstitial nephritis antigen like 1; Tubulointerstitial nephritis antigen like; Tubulointerstitial nephritis antigen related protein; OLRG-2; TIN-Ag-RP; TINAG-like 1; TIN Ag-related protein; androgen-regulated gene 1; oxidized-LDL responsive gene 2; glucocorticoid-inducible protein 5; tubulointerstitial nephritis antigen-related protein;
TBXA2R
thromboxane A2 receptor
TBXA2R; thromboxane A2 receptor; Prostanoid TP receptor; TP receptor; TXA2 R; TXA2R; TXA2-R; BDPLT13;
THNSL2
threonine synthase-like 2
THNSL2; threonine synthase-like 2 (S. cerevisiae); threonine synthase-like 2; FLJ10916; secreted osteoclastogenic factor of activated T cells; secreted osteoclastogenic factor of activated T-cells; THS2; TSH2; SOFAT; FLJ35504;
TARSL2
threonyl-tRNA synthetase-like 2
TARSL2; threonyl-tRNA synthetase-like 2; probable threonyl-tRNA synthetase 2, cytoplasmic; FLJ25005; Threonine tRNA ligase; threonyl tRNA synthetase like 2; Threonyl-tRNA synthetase-like protein 2; ThrRS; OTTHUMP00000194834; threonine--tRNA ligase;
SS18L2
synovial sarcoma translocation gene on chromosome 18-like 2
SS18L2; synovial sarcoma translocation gene on chromosome 18-like 2; SS18-like protein 2; KIAA iso; SYT homolog 2; SS18 like protein 2; Synovial sarcoma translocation gene on chromosome 18 like 2; KIAA-iso;
STK11IP
serine/threonine kinase 11 interacting protein
STK11IP; serine/threonine kinase 11 interacting protein; serine/threonine-protein kinase 11-interacting protein; KIAA1898; LIP1; LKB1 interacting protein; LKB1IP; STK11IP1; LKB1 interacting protein 1; LKB1-interacting protein 1; S11IP_HUMAN; STK11 interacting protein; serine/threonine kinase 11-interacting protein;
STN7
serine/threonine-protein kinase SNT7
STN7; serine/threonine-protein kinase SNT7; SNT7; Stt7 homolog; STT7 HOMOLOG STN7; STT7 homolog STN7 (STN7); FUNCTIONS IN: protein kinase activity, kinase activity; INVOLVED IN: regulation of photosynthesis, light reaction, circadian rhythm; LOCATED IN: chloroplast; EXPRESSED IN: 25 plant structures; EXPRESSED DURING: 15 growth stages; CONTAINS InterPro DOMAIN/s: Protein kinase, ATP binding site (InterPro:IPR017441), Protein kinase, catalytic domain (InterPro:IPR000719), Serine/threonine-protein kinase-like domain (InterPro:IPR017442), Protein kinase-like domain (InterPro:IPR011009), Serine/threonine-protein kinase, active site (InterPro:IPR008271); BEST Arabidopsis thaliana protein match is: cyclin-dependent kinase B1; 2 (TAIR:AT2G38620.2); Has 29571 Blast hits to 29413 proteins in 1565 species: Archae - 57; Bacteria - 3753; Metazoa - 11524; Fungi - 3757; Plants - 4496; Viruses - 50; Other Eukaryotes - 5934 (source: NCBI BLink).; T6L1.2; T6L1_2;
STK35
serine/threonine kinase 35
STK35; serine/threonine kinase 35; serine/threonine-protein kinase 35; bA550O8.2; CLIK1; CLP 36 interacting kinase; CLIK-1; CLP-36 interacting kinase; CLP-36-interacting kinase 1; PDLIM1-interacting kinase 1; serine threonine kinase 35 long form; serine/t;
STK36
serine/threonine kinase 36
STK36; serine/threonine kinase 36; serine/threonine kinase 36 (fused homolog, Drosophila); serine/threonine-protein kinase 36; FU; fused homolog (Drosophila); KIAA1278; Fused homolog; Serine/threonine kinase 36, fused homolog; OTTHUMP00000164096; OTTHUMP00000164097; OTTHUMP00000206456;
STYX
serine/threonine/tyrosine interacting protein
STYX; serine/threonine/tyrosine interacting protein; serine/threonine/tyrosine-interacting protein; Protein tyrosine phosphatase like protein; protein tyrosine phosphatase-like protein;
SS18L1
synovial sarcoma translocation gene on chromosome 18-like 1
SS18L1; synovial sarcoma translocation gene on chromosome 18-like 1; calcium-responsive transactivator; KIAA0693; SS18; SS18-like protein 1; SSXT; synovial sarcoma translocation; SYT homolog 1; CREST; LP2261;
TDH
L-threonine dehydrogenase
TDH; L-threonine dehydrogenase; L-threonine 3-dehydrogenase, mitochondrial; Inactive L threonine 3 dehydrogenase mitochondrial; FLJ25033; L threonine dehydrogenase; SDR14E1P;
C2ORF51
chromosome 2 open reading frame 51
C2ORF51; chromosome 2 open reading frame 51; protein TSC21; FLJ25369; TSC21; testis-specific conserved protein of 21 kDa;
UQCRC1
ubiquinol-cytochrome c reductase core protein I
UQCRC1; ubiquinol-cytochrome c reductase core protein I; cytochrome b-c1 complex subunit 1, mitochondrial; D3S3191; QCR1; UQCR1; mitochondrial; Complex III subunit 1; Core protein I; Cytochrome b c1 complex subunit 1, mitochondrial; Cytochrome b-c1 complex subunit 1; OTTHUMP00000164820; QCR1_HUMAN; Ubiquinol cytochrome c reductase core protein I; Ubiquinol-cytochrome-c reductase complex core protein 1;
DCT
dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2)
DCT; dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2); TYRP2; L-dopachrome tautomerase; L dopachrome tautomerase; Dopachrome delta isomerase; Dopachrome tautomerase; Dopachrome tautomerase dopachrome delta isomerase, tyrosine related protein 2; DT; EC 5.3.3.12; L dopachrome Delta isomerase; L-dopachrome Delta-isomerase; TRP 2; TRP-2; TRP2; Tyrosinase related protein 2; Tyrosinase-related protein 2; TYRP2_HUMAN; OTTHUMP00000018553; dopachrome delta-isomerase;
C7ORF11
chromosome 7 open reading frame 11
C7ORF11; chromosome 7 open reading frame 11; TTD non-photosensitive 1 protein; non photosensitive 1; ORF20; tricothiodystrophy; TTDN1; ABHS; TTD nonphotosensitive 1 protein; Russell-Silver syndrome region;
C3ORF52
chromosome 3 open reading frame 52
C3ORF52; chromosome 3 open reading frame 52; TPA-induced transmembrane protein; FLJ23186; TPA induced trans membrane protein; TTMP; TPA induced trans-membrane protein; novel endoplasmic reticulum transmembrane protein;
UQCRQ
ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa
UQCRQ; ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa; cytochrome b-c1 complex subunit 8; complex III subunit 8; QCR8; QP C; ubiquinol cytochrome c reductase; complex III subunit VII; UQCR7; complex III subunit VIII; low molecular mass;
VTI1A
vesicle transport through interaction with t-SNAREs homolog 1A (yeast)
VTI1A; vesicle transport through interaction with t-SNAREs homolog 1A (yeast); vesicle transport through interaction with t-SNAREs homolog 1A; MVti1; Vti1 rp2; SNARE Vti1a beta protein; Vesicle transport through interaction with tSNAREs homolog 1A (yeast); SNARE Vti1a-beta protein; vesicle transport v-SNARE protein Vti1-like 2; VTI1RP2; Vti1-rp2;
VTI1B
vesicle transport through interaction with t-SNAREs homolog 1B (yeast)
VTI1B; vesicle transport through interaction with t-SNAREs homolog 1B (yeast); vesicle transport through interaction with t-SNAREs homolog 1B; VTI2; HGNC:17793; V SNARE; Vesicle associated soluble NSF attachment protein receptor; Vesicle transport through interaction with t SNAREs 1B; Vesicle transport through interaction with t SNAREs homolog 1B (yeast); Vesicle transport v-SNARE protein Vti1-like 1; VTI1; VTI1 like; Vti1 rp1; Vti1-rp1; VTI1B_HUMAN; VTI1L; VTI1L1; vesicle-associated soluble NSF attachment protein receptor; v-SNARE; VTI1-LIKE;
WBSCR16
Williams-Beuren syndrome chromosome region 16
WBSCR16; Williams-Beuren syndrome chromosome region 16; Williams-Beuren syndrome chromosomal region 16 protein; 5730496C04Rik; MGC44931; AU019812; DKFZp434D0421; MGC189739; RCC1-like G exchanging factor-like protein; WBS16_HUMAN;
WBSCR27
Williams Beuren syndrome chromosome region 27
WBSCR27; Williams Beuren syndrome chromosome region 27; Williams-Beuren syndrome chromosomal region 27 protein; MGC40131;
CYB5D2
cytochrome b5 domain containing 2
CYB5D2; cytochrome b5 domain containing 2; neuferricin; MGC32124; cytochrome b5 domain-containing protein 2;
EPB41L4B
erythrocyte membrane protein band 4.1 like 4B
EPB41L4B; erythrocyte membrane protein band 4.1 like 4B; band 4.1-like protein 4B; EHM2; FERM-containing protein CG1; CG1; FLJ21596; DKFZp761N1814;
C11H16ORF80
chromosome 11 open reading frame, human C16orf80
C11H16ORF80; chromosome 11 open reading frame, human C16orf80; UPF0468 protein C16orf80 homolog; C16orf80; Chromosome 16 open reading frame 80; EVORF; fSAP23; Functional spliceosome-associated protein 23; Gene Trap Locus 3; GTL3; transcription factor 2B; Transcription factor IIB;
KIR3DS1
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
KIR3DS1;killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1;killer cell immunoglobulin-like receptor 3DS1;nkat10;NKAT-10;killer Ig receptor;MHC class I NK cell receptor;natural killer-associated transcript 10;killer cell immunoglobulin-like receptor KIR3DS1;KIR-G1;NKAT10;CD158E2;KIR-123FM;MGC119726;MGC119728;MGC125316;
anthrax PA
Bacillus anthracis protective antigen
anthrax PA; Anthrax Protective Antigen; Anthrax toxins translocating protein; Bacillus anthracis Protective Antigen; PA 83; PA; PA83; Pag; PagA; Protective antigen;
F2RL1
coagulation factor II (thrombin) receptor-like 1
F2RL1;coagulation factor II (thrombin) receptor-like 1;3538;ENSG00000164251;PAR2;GPR11;5q13;proteinase-activated receptor 2;proteinase-activated receptor 2;PAR-2;thrombin receptor-like 1;G protein-coupled receptor-11;G-protein coupled receptor 11;protease-activated receptor 2;proteinase-activated receptor-2;coagulation factor II receptor-like 1;
UQCC
ubiquinol-cytochrome c reductase complex chaperone
UQCC; ubiquinol-cytochrome c reductase complex chaperone; BFZB; CBP3; C20orf44;
COMMD3-BMI1
COMMD3-BMI1 readthrough
COMMD3-BMI1;COMMD3-BMI1 readthrough;chromosome: 10;DKFZp434I153;COMMD3-BMI1 read-through protein;COMMD3-BMI1 read-through protein;
C15orf55
chromosome 15 open reading frame 55
C15ORF55;chromosome 15 open reading frame 55;29919;ENSG00000184507;NUT;15q14;MGC138683, MGC138684, DKFZp434O192;protein NUT;protein NUT;nuclear protein in testis;
NFE2L1
nuclear factor (erythroid-derived 2)-like 1
NFE2L1;nuclear factor (erythroid-derived 2)-like 1;7781;ENSG00000082641;NRF1;TCF11;LCR-F1;17q21.3;FLJ00380;nuclear factor erythroid 2-related factor 1;nuclear factor erythroid 2-related factor 1;TCF-11;NFE2-related factor 1;NF-E2-related factor 1;transcription factor HBZ17;transcription factor LCR-F1;locus control region-factor 1;nuclear factor, erythroid derived 2, like 1;transcription factor 11 (basic leucine zipper type);
C8orf86
chromosome 8 open reading frame 86
C8ORF86;chromosome 8 open reading frame 86;33774;ENSG00000196166;8p11.22;FLJ43582;uncharacterized protein C8orf86;uncharacterized protein C8orf86;
C1orf229
chromosome 1 open reading frame 229
C1ORF229;chromosome 1 open reading frame 229;33759;ENSG00000221953;1q44;FLJ45717;putative uncharacterized protein C1orf229;putative uncharacterized protein C1orf229;
C20orf78
chromosome 20 open reading frame 78
C20ORF78;chromosome 20 open reading frame 78;16210;ENSG00000149443;dJ1068E13.1;20p11.23;putative uncharacterized protein C20orf78;putative uncharacterized protein C20orf78;
C17orf105
chromosome 17 open reading frame 105
C17ORF105;chromosome 17 open reading frame 105;37241;ENSG00000231256;17q21.31;FLJ43829;uncharacterized protein C17orf105;uncharacterized protein C17orf105;
C17orf108
chromosome 17 open reading frame 108
C17ORF108;chromosome 17 open reading frame 108;27314;ENSG00000232859;HSD24;17q11.2;UPF0631 protein C17orf108;UPF0631 protein C17orf108;
C9orf172
chromosome 9 open reading frame 172
C9ORF172;chromosome 9 open reading frame 172;37284;ENSG00000232434;9q34.3;uncharacterized protein C9orf172;uncharacterized protein C9orf172;
C1orf228
chromosome 1 open reading frame 228
C1ORF228;chromosome 1 open reading frame 228;34345;ENSG00000198520;p40;NCRNA00082;1p34.1;MGC33556;uncharacterized protein C1orf228;uncharacterized protein C1orf228;
NME1-NME2
NME1-NME2 readthrough
NME1-NME2;NME1-NME2 readthrough;33531;ENSG00000011052;NMELV;NM23-LV;17q21.3;FLJ93990;NME1-NME2 protein;NME1-NME2 protein;NME1-NME2 readthrough transcript;EC 2.7.4.6;
SCLT1
sodium channel and clathrin linker 1
SCLT1;sodium channel and clathrin linker 1;26406;ENSG00000151466;CAP1A;CAP-1A;hCAP-1A;4q28.2;FLJ30655, FLJ36042, MGC70542;sodium channel and clathrin linker 1;sodium channel and clathrin linker 1;sodium channel-associated protein 1;
SEMA5B
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and s
SEMA5B;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B;10737;ENSG00000082684;SemG;SEMAG;3q21.1;FLJ10372, KIAA1445;semaphorin-5B;semaphorin-5B;
SLC4A2
solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1) [ H
SLC4A2;solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1);11028;ENSG00000164889;AE2;HKB3;BND3L;NBND3;EPB3L1;7q36.1;FLJ59028;anion exchange protein 2;anion exchange protein 2;AE 2;anion exchanger 2 type a;anion exchanger 2 type b1;anion exchanger 2 type b2;solute carrier family 4 member 2;non-erythroid band 3-like protein;
SMCR8
Smith-Magenis syndrome chromosome region, candidate 8
SMCR8;Smith-Magenis syndrome chromosome region, candidate 8;17921;ENSG00000176994;17p11.2;FLJ34716, FLJ60657;Smith-Magenis syndrome chromosomal region candidate gene 8 protein;Smith-Magenis syndrome chromosomal region candidate gene 8 protein;
THBS3
thrombospondin 3
THBS3;thrombospondin 3;11787;ENSG00000169231;TSP3;1q21;MGC119564, MGC119565;thrombospondin-3;thrombospondin-3;
THSD4
thrombospondin, type I, domain containing 4
THSD4;thrombospondin, type I, domain containing 4;25835;ENSG00000187720;ADAMTSL6;FVSY9334;PRO34005;ADAMTSL-6;15q23;FLJ13710;thrombospondin type-1 domain-containing protein 4;thrombospondin type-1 domain-containing protein 4;ADAMTS-like protein 6;A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6;
UHRF1BP1
UHRF1 binding protein 1
UHRF1BP1;UHRF1 binding protein 1;21216;ENSG00000065060;ICBP90;C6orf107;dJ349A12.1;RP3-349A12.1;6p21;FLJ20302;UHRF1-binding protein 1;UHRF1-binding protein 1;ICBP90 binding protein 1;ICBP90-binding protein 1;UHRF1 (ICBP90) binding protein 1;ubiquitin-like containing PHD and RING finger domains 1-binding protein 1;
WBSCR17
Williams-Beuren syndrome chromosome region 17
WBSCR17;Williams-Beuren syndrome chromosome region 17;16347;ENSG00000185274;GALNT16;GALNT20;GALNTL3;7q11.23;DKFZp434I2216, DKFZp761D2324;putative polypeptide N-acetylgalactosaminyltransferase-like protein 3;putative polypeptide N-acetylgalactosaminyltransferase-like protein 3;galNAc-T-like protein 3;pp-GalNAc-transferase 20;pp-GaNTase-like protein 3;polypeptide GalNAc transferase-like protein 3;polypeptide N-acetylgalactosaminyltransferase WBSCR17;williams-Beuren syndrome chromosomal region 17 protein;protein-UDP acetylgalactosaminyltransferase-like protein 3;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like 3;UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16;EC 2.4.1.41;
CYB561D2
cytochrome b-561 domain containing 2
CYB561D2;cytochrome b-561 domain containing 2;30253;ENSG00000114395;101F6;TSP10;3p21.3;cytochrome b561 domain-containing protein 2;cytochrome b561 domain-containing protein 2;putative tumor suppressor 101F6;putative tumor suppressor protein 101F6;
C10orf107
chromosome 10 open reading frame 107
C10ORF107;chromosome 10 open reading frame 107;28678;ENSG00000183346;bA63A2.1;10q21.2;MGC44593;uncharacterized protein C10orf107;uncharacterized protein C10orf107;
CYB561
cytochrome b-561
CYB561;cytochrome b-561;2571;ENSG00000008283;FRRS2;17q23.3;cytochrome b561;cytochrome b561;ferric-chelate reductase 2;
Stk30
serine/threonine kinase 30
STK30;serine/threonine kinase 30;ENSMUSG00000056458;MOK;Rage;RAGE1;12 F1;12;MGC46883, MGC107277;MAPK/MAK/MRK overlapping kinase;MAPK/MAK/MRK overlapping kinase;T/STK 30;MOK protein kinase;renal tumor antigen;MAPK/MAK/MRK/ overlapping kinase;EC 2.7.11.22;
C14orf2
chromosome 14 open reading frame 2
C14ORF2;chromosome 14 open reading frame 2;1188;ENSG00000156411;MP68;PLPM;14q32.33;6.8 kDa mitochondrial proteolipid;6.8 kDa mitochondrial proteolipid;
COX19
COX19 cytochrome c oxidase assembly homolog (S. cerevisiae)
COX19;COX19 cytochrome c oxidase assembly homolog (S. cerevisiae);28074;ENSG00000240230;7p22.3;MGC104475;cytochrome c oxidase assembly protein COX19;cytochrome c oxidase assembly protein COX19;hCOX19;
C14orf166B
chromosome 14 open reading frame 166B
C14ORF166B;chromosome 14 open reading frame 166B;23346;ENSG00000100565;14q24.3;uncharacterized protein C14orf166B;uncharacterized protein C14orf166B;
C19orf44
chromosome 19 open reading frame 44
C19ORF44;chromosome 19 open reading frame 44;26141;ENSG00000105072;19p13.11;FLJ21742, FLJ22492;uncharacterized protein C19orf44;uncharacterized protein C19orf44;
C19orf57
chromosome 19 open reading frame 57
C19ORF57;chromosome 19 open reading frame 57;28153;ENSG00000132016;19p13.12;MGC11271, MGC149720;uncharacterized protein C19orf57;uncharacterized protein C19orf57;pre-T/NK cell-associated protein 3B3;pre-T/NK cell associated protein (3B3);
C19orf59
chromosome 19 open reading frame 59
C19ORF59;chromosome 19 open reading frame 59;27291;ENSG00000183019;MCEMP1;19p13.2;MGC132456;mast cell-expressed membrane protein 1;mast cell-expressed membrane protein 1;
C19orf60
chromosome 19 open reading frame 60
C19ORF60;chromosome 19 open reading frame 60;26098;ENSG00000006015;19p13.11;FLJ20850, FLJ30108, FLJ34606, FLJ37391;uncharacterized protein C19orf60;uncharacterized protein C19orf60;
C19orf66
chromosome 19 open reading frame 66
C19ORF66;chromosome 19 open reading frame 66;25649;ENSG00000130813;19p13.2;FLJ11286, FLJ40743;UPF0515 protein C19orf66;UPF0515 protein C19orf66;
C19orf70
chromosome 19 open reading frame 70
C19ORF70;chromosome 19 open reading frame 70;33702;ENSG00000174917;P117;QIL1;19p13.3;protein QIL1;protein QIL1;
C20orf26
chromosome 20 open reading frame 26
C20ORF26;chromosome 20 open reading frame 26;15872;ENSG00000089101;dJ1002M8.3;dJ1178H5.4;20p11.23;DKFZp434K156;uncharacterized protein C20orf26;uncharacterized protein C20orf26;
C10orf111
chromosome 10 open reading frame 111
C10ORF111;chromosome 10 open reading frame 111;28582;ENSG00000176236;bA455B2.4;10p13;MGC35468;uncharacterized protein C10orf111;uncharacterized protein C10orf111;
C10orf113
chromosome 10 open reading frame 113
C10ORF113;chromosome 10 open reading frame 113;31447;ENSG00000204683;bA165O3.1;10p12.31;putative uncharacterized protein C10orf113;putative uncharacterized protein C10orf113;
C10orf118
chromosome 10 open reading frame 118
C10ORF118;chromosome 10 open reading frame 118;24349;ENSG00000165813;10q25.3;FLJ10188, FLJ35301, MGC118918, MGC129699;uncharacterized protein C10orf118;uncharacterized protein C10orf118;CTCL tumor antigen L14-2;CTCL tumor antigen HD-CL-01/L14-2;
C10orf12
chromosome 10 open reading frame 12
C10ORF12;chromosome 10 open reading frame 12;23420;ENSG00000155640;10q24.1;FLJ13022, DKFZp564P1916;uncharacterized protein C10orf12;uncharacterized protein C10orf12;
C10orf120
chromosome 10 open reading frame 120
C10ORF120;chromosome 10 open reading frame 120;25707;ENSG00000183559;bA318C4.1;10q26.13;uncharacterized protein C10orf120;uncharacterized protein C10orf120;
C10orf128
chromosome 10 open reading frame 128
C10ORF128;chromosome 10 open reading frame 128;27274;ENSG00000204161;10q11.23;putative uncharacterized protein C10orf128;putative uncharacterized protein C10orf128;
C10orf32
chromosome 10 open reading frame 32
C10ORF32;chromosome 10 open reading frame 32;23516;ENSG00000166275;RP11-753C18.6;10q24.32;FLJ40752, MGC27171, DKFZp686B2219;UPF0693 protein C10orf32;UPF0693 protein C10orf32;
C10orf35
chromosome 10 open reading frame 35
C10ORF35;chromosome 10 open reading frame 35;23519;ENSG00000171224;10q22.1;uncharacterized protein C10orf35;uncharacterized protein C10orf35;
C10orf53
chromosome 10 open reading frame 53
C10ORF53;chromosome 10 open reading frame 53;27421;ENSG00000178645;10q11.23;FLJ60598;UPF0728 protein C10orf53;UPF0728 protein C10orf53;
C10orf55
chromosome 10 open reading frame 55
C10ORF55;chromosome 10 open reading frame 55;31008;ENSG00000222047;bA417O11.3;10q22.2;uncharacterized protein C10orf55;uncharacterized protein C10orf55;
C10orf68
chromosome 10 open reading frame 68
C10ORF68;chromosome 10 open reading frame 68;25779;ENSG00000150076;dJ1104A8.1;RP11-479G22.1;10p11.22;FLJ13031, MGC149767;uncharacterized protein C10orf68;uncharacterized protein C10orf68;
C10orf71
chromosome 10 open reading frame 71
C10ORF71;chromosome 10 open reading frame 71;26973;ENSG00000177354;10q11.23;FLJ45913;uncharacterized protein C10orf71;uncharacterized protein C10orf71;
C10orf90
chromosome 10 open reading frame 90
C10ORF90;chromosome 10 open reading frame 90;26563;ENSG00000154493;FATS;bA422P15.2;RP11-422P15.2;10q26.2;FLJ32938;centrosomal protein C10orf90;centrosomal protein C10orf90;fragile-site associated tumor suppressor homolog;
C10orf91
chromosome 10 open reading frame 91
C10ORF91;chromosome 10 open reading frame 91;27275;ENSG00000180066;bA432J24.4;RP11-432J24.4;10q26.3;uncharacterized protein C10orf91;uncharacterized protein C10orf91;
C11orf1
chromosome 11 open reading frame 1
C11ORF1;chromosome 11 open reading frame 1;1163;ENSG00000137720;11q23.1;FLJ23499;UPF0686 protein C11orf1;UPF0686 protein C11orf1;
C11orf10
chromosome 11 open reading frame 10
C11ORF10;chromosome 11 open reading frame 10;1164;ENSG00000134825;11q12.2;UPF0197 transmembrane protein C11orf10;UPF0197 transmembrane protein C11orf10;
C11orf34
chromosome 11 open reading frame 34
C11ORF34;chromosome 11 open reading frame 34;30053;ENSG00000188771;PLET1;11q23.1;placenta-expressed transcript 1 protein;placenta-expressed transcript 1 protein;placenta expressed transcript 1;
C11orf45
chromosome 11 open reading frame 45
C11ORF45;chromosome 11 open reading frame 45;28584;ENSG00000174370;11q24.3;FLJ43646, MGC35558;putative uncharacterized protein C11orf45;putative uncharacterized protein C11orf45;
C11orf48
chromosome 11 open reading frame 48
C11ORF48;chromosome 11 open reading frame 48;28351;ENSG00000162194;11q12.3;MGC2477;uncharacterized protein C11orf48;uncharacterized protein C11orf48;
C11orf49
chromosome 11 open reading frame 49
C11ORF49;chromosome 11 open reading frame 49;28720;ENSG00000149179;11p11.2;MGC4707, FLJ22210;UPF0705 protein C11orf49;UPF0705 protein C11orf49;
C11orf52
chromosome 11 open reading frame 52
C11ORF52;chromosome 11 open reading frame 52;30531;ENSG00000149300;11q23.1;FLJ25219, MGC14839, MGC131888;uncharacterized protein C11orf52;uncharacterized protein C11orf52;
C11orf70
chromosome 11 open reading frame 70
C11ORF70;chromosome 11 open reading frame 70;28188;ENSG00000137691;11q22.1;MGC13040;uncharacterized protein C11orf70;uncharacterized protein C11orf70;
C11orf80
chromosome 11 open reading frame 80
C11ORF80;chromosome 11 open reading frame 80;26197;ENSG00000173715;11q13.2;FLJ22531;putative uncharacterized protein C11orf80;putative uncharacterized protein C11orf80;
C11orf84
chromosome 11 open reading frame 84
C11ORF84;chromosome 11 open reading frame 84;25115;ENSG00000168005;11q13.1;DKFZp762N0114;uncharacterized protein C11orf84;uncharacterized protein C11orf84;hypothetical protein BC007540;
C11orf86
chromosome 11 open reading frame 86
C11ORF86;chromosome 11 open reading frame 86;34442;ENSG00000173237;11q13.2;FLJ22675;uncharacterized protein C11orf86;uncharacterized protein C11orf86;
C11orf9
chromosome 11 open reading frame 9
C11ORF9;chromosome 11 open reading frame 9;1181;ENSG00000124920;MRF;Ndt80;11q12-q13.1;KIAA0954, MGC10781;myelin gene regulatory factor;myelin gene regulatory factor;
C12orf23
chromosome 12 open reading frame 23
C12ORF23;chromosome 12 open reading frame 23;28281;ENSG00000151135;12q23.3;FLJ11721, FLJ13959, MGC17943;UPF0444 transmembrane protein C12orf23;UPF0444 transmembrane protein C12orf23;
C12orf43
chromosome 12 open reading frame 43
C12ORF43;chromosome 12 open reading frame 43;25719;ENSG00000157895;12q;FLJ12448;uncharacterized protein C12orf43;uncharacterized protein C12orf43;
C12orf45
chromosome 12 open reading frame 45
C12ORF45;chromosome 12 open reading frame 45;28628;ENSG00000151131;12q23.3;MGC40397;uncharacterized protein C12orf45;uncharacterized protein C12orf45;
C12orf52
chromosome 12 open reading frame 52
C12ORF52;chromosome 12 open reading frame 52;25925;ENSG00000139405;RITA;12q24.13;FLJ14827;RBPJ-interacting and tubulin-associated protein;RBPJ-interacting and tubulin-associated protein;RBP-J interacting and tubulin associated;
C12orf60
chromosome 12 open reading frame 60
C12ORF60;chromosome 12 open reading frame 60;28726;ENSG00000182993;12p12.3;FLJ31651, MGC47869;uncharacterized protein C12orf60;uncharacterized protein C12orf60;
C12orf70
chromosome 12 open reading frame 70
C12ORF70;chromosome 12 open reading frame 70;34448;ENSG00000165935;12p11.23;uncharacterized protein C12orf70;uncharacterized protein C12orf70;
C12orf71
chromosome 12 open reading frame 71
C12ORF71;chromosome 12 open reading frame 71;34452;ENSG00000214700;12p11.23;uncharacterized protein C12orf71;uncharacterized protein C12orf71;hCG1794298;
C12orf73
chromosome 12 open reading frame 73
C12ORF73;chromosome 12 open reading frame 73;34450;ENSG00000204954;12q23.3;FLJ13975, DKFZp547P055;uncharacterized protein C12orf73;uncharacterized protein C12orf73;
C14orf101
chromosome 14 open reading frame 101
C14ORF101;chromosome 14 open reading frame 101;20185;ENSG00000070269;14q22.3;FLJ20392;UPF0679 protein C14orf101;UPF0679 protein C14orf101;
C14orf43
chromosome 14 open reading frame 43
C14ORF43;chromosome 14 open reading frame 43;19853;ENSG00000156030;LSR68;c14_5541;C14orf117;14q24.3;FLJ00335;uncharacterized protein C14orf43;uncharacterized protein C14orf43;
C14orf45
chromosome 14 open reading frame 45
C14ORF45;chromosome 14 open reading frame 45;19855;ENSG00000119636;14q24.3;FLJ23189;uncharacterized protein C14orf45;uncharacterized protein C14orf45;
C14orf93
chromosome 14 open reading frame 93
C14ORF93;chromosome 14 open reading frame 93;20162;ENSG00000100802;14q11.2;FLJ12154;uncharacterized protein C14orf93;uncharacterized protein C14orf93;
C15orf23
chromosome 15 open reading frame 23
C15ORF23;chromosome 15 open reading frame 23;30767;ENSG00000128944;SKAP;HSD11;TRAF4AF1;15q15.1;FLJ14502, MGC141728, MGC141729;small kinetochore-associated protein;small kinetochore-associated protein;kinastrin;TRAF4 associated factor 1;TRAF4-associated factor 1;putative TRAF4-associated factor 1;small kinetochore associated protein;kinetochore-localized astrin-binding protein;
C15orf43
chromosome 15 open reading frame 43
C15ORF43;chromosome 15 open reading frame 43;28520;ENSG00000167014;15q21.1;MGC33951;uncharacterized protein C15orf43;uncharacterized protein C15orf43;
C15orf53
chromosome 15 open reading frame 53
C15ORF53;chromosome 15 open reading frame 53;33796;ENSG00000175779;15q14;FLJ35695, MGC148119;uncharacterized protein C15orf53;uncharacterized protein C15orf53;
C15orf57
chromosome 15 open reading frame 57
C15ORF57;chromosome 15 open reading frame 57;28295;ENSG00000128891;CCDC32;15q15.1;FLJ25915, MGC20481;uncharacterized protein C15orf57;uncharacterized protein C15orf57;coiled-coil domain containing 32;
C15orf59
chromosome 15 open reading frame 59
C15ORF59;chromosome 15 open reading frame 59;33753;ENSG00000205363;15q24.1;MGC131524;UPF0583 protein C15orf59;UPF0583 protein C15orf59;
C16orf79
chromosome 16 open reading frame 79
C16ORF79;chromosome 16 open reading frame 79;28309;ENSG00000182685;16p13.3;MGC21830;chromosome 16 open reading frame 79;chromosome 16 open reading frame 79;BRICHOS domain-containing protein C16orf79;
C16orf80
chromosome 16 open reading frame 80
C16ORF80;chromosome 16 open reading frame 80;29523;ENSG00000070761;GTL3;EVORF;fSAP23;16q21;UPF0468 protein C16orf80;UPF0468 protein C16orf80;gene trap locus 3;transcription factor IIB;functional spliceosome-associated protein 23;
C16orf88
chromosome 16 open reading frame 88
C16ORF88;chromosome 16 open reading frame 88;34404;ENSG00000103550;FAM191A;101F10.1;16p12.3;protein C16orf88;protein C16orf88;testis-specific gene 118 protein;family with sequence similarity 191, member A;
C17orf47
chromosome 17 open reading frame 47
C17ORF47;chromosome 17 open reading frame 47;26844;ENSG00000181013;17q22;FLJ40121;uncharacterized protein C17orf47;uncharacterized protein C17orf47;
C17orf58
chromosome 17 open reading frame 58
C17ORF58;chromosome 17 open reading frame 58;27568;ENSG00000186665;17q24.2;MGC138278;UPF0450 protein C17orf58;UPF0450 protein C17orf58;
C17orf67
chromosome 17 open reading frame 67
C17ORF67;chromosome 17 open reading frame 67;27900;ENSG00000214226;17q22;uncharacterized protein C17orf67;uncharacterized protein C17orf67;
C17orf99
chromosome 17 open reading frame 99
C17ORF99;chromosome 17 open reading frame 99;34490;ENSG00000187997;UNQ464;17q25.3;FLJ50084;uncharacterized protein C17orf99;uncharacterized protein C17orf99;GLPG464;
C18orf26
chromosome 18 open reading frame 26
C18ORF26;chromosome 18 open reading frame 26;26808;ENSG00000178690;DYNAP;18q21.2;FLJ39106;uncharacterized protein C18orf26;uncharacterized protein C18orf26;dynactin-associated protein;
C18orf32
chromosome 18 open reading frame 32
C18ORF32;chromosome 18 open reading frame 32;31690;ENSG00000177576;18q21.1;FLJ23458;UPF0729 protein C18orf32;UPF0729 protein C18orf32;putative NFkB activating protein;putative NF-kappa-B-activating protein 200;
C18orf62
chromosome 18 open reading frame 62
C18ORF62;chromosome 18 open reading frame 62;27598;ENSG00000206026;18q23;MGC126049;putative uncharacterized protein C18orf62;putative uncharacterized protein C18orf62;
C19orf26
chromosome 19 open reading frame 26
C19ORF26;chromosome 19 open reading frame 26;28617;ENSG00000099625;DOS;19p13.3;MGC40084;protein Dos;protein Dos;downstream of Stk11;
C19orf42
chromosome 19 open reading frame 42
C19ORF42;chromosome 19 open reading frame 42;28419;ENSG00000214046;19p13.11;MGC2747;UPF0608 protein C19orf42;UPF0608 protein C19orf42;
C1orf105
chromosome 1 open reading frame 105
C1ORF105;chromosome 1 open reading frame 105;29591;ENSG00000180999;RP1-106H8.1;1q24.3;uncharacterized protein C1orf105;uncharacterized protein C1orf105;
C1orf106
chromosome 1 open reading frame 106
C1ORF106;chromosome 1 open reading frame 106;25599;ENSG00000163362;1q32.1;FLJ10901, MGC125608;uncharacterized protein C1orf106;uncharacterized protein C1orf106;
C1orf109
chromosome 1 open reading frame 109
C1ORF109;chromosome 1 open reading frame 109;26039;ENSG00000116922;1p34.3;FLJ20508;uncharacterized protein C1orf109;uncharacterized protein C1orf109;
C1orf112
chromosome 1 open reading frame 112
C1ORF112;chromosome 1 open reading frame 112;25565;ENSG00000000460;RP1-97P20.1;1q24.2;FLJ10706, FLJ13470, MGC130018, MGC130019;uncharacterized protein C1orf112;uncharacterized protein C1orf112;
C1orf114
chromosome 1 open reading frame 114
C1ORF114;chromosome 1 open reading frame 114;28051;ENSG00000117477;RP1-206D15.2;1q24;FLJ25846;uncharacterized protein C1orf114;uncharacterized protein C1orf114;
C1orf123
chromosome 1 open reading frame 123
C1ORF123;chromosome 1 open reading frame 123;26059;ENSG00000162384;RP5-1024G6.3;1p32.3;FLJ20580;UPF0587 protein C1orf123;UPF0587 protein C1orf123;
C1orf158
chromosome 1 open reading frame 158
C1ORF158;chromosome 1 open reading frame 158;28567;ENSG00000157330;RP11-474O21.4;1p36.21;MGC35194, DKFZp686C0236;uncharacterized protein C1orf158;uncharacterized protein C1orf158;
C1orf162
chromosome 1 open reading frame 162
C1ORF162;chromosome 1 open reading frame 162;28344;ENSG00000143110;1p13.2;MGC24133;transmembrane protein C1orf162;transmembrane protein C1orf162;
C1orf168
chromosome 1 open reading frame 168
C1ORF168;chromosome 1 open reading frame 168;27295;ENSG00000187889;RP4-758N20.2;1p32.2;FLJ43208;uncharacterized protein C1orf168;uncharacterized protein C1orf168;
C1orf173
chromosome 1 open reading frame 173
C1ORF173;chromosome 1 open reading frame 173;25346;ENSG00000178965;RP11-653A5.1;1p31.1;MGC90412, DKFZp547I048, DKFZp761G1720, DKFZp781L0319;uncharacterized protein C1orf173;uncharacterized protein C1orf173;
C1orf174
chromosome 1 open reading frame 174
C1ORF174;chromosome 1 open reading frame 174;27915;ENSG00000198912;RP13-531C17.2;1p36.32;UPF0688 protein C1orf174;UPF0688 protein C1orf174;
C1orf192
chromosome 1 open reading frame 192
C1ORF192;chromosome 1 open reading frame 192;32325;ENSG00000188931;1q23.3;UPF0740 protein C1orf192;UPF0740 protein C1orf192;
C1orf194
chromosome 1 open reading frame 194
C1ORF194;chromosome 1 open reading frame 194;32331;ENSG00000179902;1p13.3;uncharacterized protein C1orf194;uncharacterized protein C1orf194;
C1orf198
chromosome 1 open reading frame 198
C1ORF198;chromosome 1 open reading frame 198;25900;ENSG00000119280;1q42.2;FLJ14525, FLJ16283, FLJ38847, MGC10710, DKFZp667D152;uncharacterized protein C1orf198;uncharacterized protein C1orf198;
C1orf21
chromosome 1 open reading frame 21
C1ORF21;chromosome 1 open reading frame 21;15494;ENSG00000116667;PIG13;1q25;uncharacterized protein C1orf21;uncharacterized protein C1orf21;proliferation-inducing protein 13;cell proliferation-inducing gene 13 protein;
C1orf27
chromosome 1 open reading frame 27
C1ORF27;chromosome 1 open reading frame 27;24299;ENSG00000157181;ODR4;TTG1;odr-4;1q25;FLJ20505;protein odr-4 homolog;protein odr-4 homolog;hODR-4;LAG1-interacting protein;odorant response abnormal 4;transactivated by transforming growth factor beta protein 1;transactivated by recombinant transforming growth factor beta;EC 1.1.1.14;
C1orf61
chromosome 1 open reading frame 61
C1ORF61;chromosome 1 open reading frame 61;30780;ENSG00000125462;CROC4;1q22;FLJ38303;protein CROC-4;protein CROC-4;contingent replication of cDNA 4;transcriptional activator of the c fos promoter;transcriptional activator of the c-fos promoter;
C1orf64
chromosome 1 open reading frame 64
C1ORF64;chromosome 1 open reading frame 64;28339;ENSG00000183888;ERRF;RP11-5P18.4;1p36.13;MGC24047;uncharacterized protein C1orf64;uncharacterized protein C1orf64;ER-related factor;
C1orf68
chromosome 1 open reading frame 68
C1ORF68;chromosome 1 open reading frame 68;29468;ENSG00000198854;LEP7;XP32;1q21.3;skin-specific protein 32;skin-specific protein 32;skin-specific protein (xp32);
C1orf85
chromosome 1 open reading frame 85
C1ORF85;chromosome 1 open reading frame 85;29436;ENSG00000198715;NCU-G1;1q22;MGC31963;lysosomal protein NCU-G1;lysosomal protein NCU-G1;kidney predominant protein NCU-G1;
C1orf86
chromosome 1 open reading frame 86
C1ORF86;chromosome 1 open reading frame 86;26428;ENSG00000162585;FP7162;RP11-181G12.3;1p36.33;FLJ30256, FLJ31031, FLJ36608, FLJ43456, FLJ46660, MGC120153;uncharacterized protein C1orf86;uncharacterized protein C1orf86;
C20orf151
chromosome 20 open reading frame 151
C20ORF151;chromosome 20 open reading frame 151;16144;ENSG00000130701;20q13.33;uncharacterized protein C20orf151;uncharacterized protein C20orf151;
C20orf152
chromosome 20 open reading frame 152
C20ORF152;chromosome 20 open reading frame 152;16145;ENSG00000149646;dJ954P9.1;20q11.23;MGC138880;uncharacterized protein C20orf152;uncharacterized protein C20orf152;
C20orf166
chromosome 20 open reading frame 166
C20ORF166;chromosome 20 open reading frame 166;16159;ENSG00000174407;dJ353C17.1;20q13.33;FLJ32423, MGC129808;uncharacterized protein C20orf166;uncharacterized protein C20orf166;
C22orf15
chromosome 22 open reading frame 15
C22ORF15;chromosome 22 open reading frame 15;15558;ENSG00000169314;N27C7-3;22q11.23;FLJ36561;uncharacterized protein C22orf15;uncharacterized protein C22orf15;protein N27C7-3;
C22orf23
chromosome 22 open reading frame 23
C22ORF23;chromosome 22 open reading frame 23;18589;ENSG00000128346;EVG1;dJ1039K5.6;22q13.1;FLJ32787;UPF0193 protein EVG1;UPF0193 protein EVG1;
C22orf28
chromosome 22 open reading frame 28
C22ORF28;chromosome 22 open reading frame 28;26935;ENSG00000100220;FAAP;HSPC117;DJ149A16.6;RP1-149A16.6;22q12;tRNA-splicing ligase RtcB homolog;tRNA-splicing ligase RtcB homolog;ankyrin repeat domain 54;focal adhesion-associated protein;EC 6.5.1.3;
C22orf29
chromosome 22 open reading frame 29
C22ORF29;chromosome 22 open reading frame 29;26112;ENSG00000215012;22q11.21;FLJ21125;uncharacterized protein C22orf29;uncharacterized protein C22orf29;
C22orf32
chromosome 22 open reading frame 32
C22ORF32;chromosome 22 open reading frame 32;25055;ENSG00000183172;DDDD;dJ186O1.1;22q13.2;UPF0466 protein C22orf32, mitochondrial;UPF0466 protein C22orf32, mitochondrial;
C2orf44
chromosome 2 open reading frame 44
C2ORF44;chromosome 2 open reading frame 44;26157;ENSG00000163026;PP384;2p23.3;FLJ21945;WD repeat-containing protein C2orf44;WD repeat-containing protein C2orf44;
C2orf65
chromosome 2 open reading frame 65
C2ORF65;chromosome 2 open reading frame 65;25183;ENSG00000159374;D6Mm5e;2p13.1;FLJ44410;uncharacterized protein C2orf65;uncharacterized protein C2orf65;
C2orf66
chromosome 2 open reading frame 66
C2ORF66;chromosome 2 open reading frame 66;33809;ENSG00000187944;UNQ6411;2q33.1;hypothetical protein LOC401027;hypothetical protein LOC401027;IIDS6411;uncharacterized protein C2orf66;
C2orf72
chromosome 2 open reading frame 72
C2ORF72;chromosome 2 open reading frame 72;27418;ENSG00000204128;2q37.1;uncharacterized protein C2orf72;uncharacterized protein C2orf72;
C2orf76
chromosome 2 open reading frame 76
C2ORF76;chromosome 2 open reading frame 76;27017;ENSG00000186132;AIM29;2q14.2;MGC104437;UPF0538 protein C2orf76;UPF0538 protein C2orf76;
C2orf83
chromosome 2 open reading frame 83
C2ORF83;chromosome 2 open reading frame 83;25344;ENSG00000042304;2q36.3;folate transporter-like protein C2orf83;folate transporter-like protein C2orf83;
C3orf20
chromosome 3 open reading frame 20
C3ORF20;chromosome 3 open reading frame 20;25320;ENSG00000131379;3p25.1;DKFZp434N1817;uncharacterized protein C3orf20;uncharacterized protein C3orf20;
C3orf26
chromosome 3 open reading frame 26
C3ORF26;chromosome 3 open reading frame 26;28666;ENSG00000184220;3q12.1;MGC4308;uncharacterized protein C3orf26;uncharacterized protein C3orf26;
C4orf21
chromosome 4 open reading frame 21
C4ORF21;chromosome 4 open reading frame 21;25654;ENSG00000138658;4q25;FLJ11331, FLJ33237, FLJ44066, DKFZp313L226, DKFZp434C0927;prematurely terminated mRNA decay factor-like;prematurely terminated mRNA decay factor-like;
C4orf3
chromosome 4 open reading frame 3
C4ORF3;chromosome 4 open reading frame 3;19225;ENSG00000164096;4q26;uncharacterized protein C4orf3;uncharacterized protein C4orf3;HCV F-transactivated protein 1;hepatitis C virus F protein-transactivated protein 1;
C4orf40
chromosome 4 open reading frame 40
C4ORF40;chromosome 4 open reading frame 40;33193;ENSG00000187533;4q13.3;uncharacterized protein C4orf40;uncharacterized protein C4orf40;
C5orf15
chromosome 5 open reading frame 15
C5ORF15;chromosome 5 open reading frame 15;20656;ENSG00000113583;KCT2;HTGN29;5q31.1;keratinocyte-associated transmembrane protein 2;keratinocyte-associated transmembrane protein 2;keratinocytes associated transmembrane protein 2;
C5orf22
chromosome 5 open reading frame 22
C5ORF22;chromosome 5 open reading frame 22;25639;ENSG00000082213;5p13.3;FLJ11193, FLJ23805, MGC33010, DKFZp667N066;UPF0489 protein C5orf22;UPF0489 protein C5orf22;
C5orf34
chromosome 5 open reading frame 34
C5ORF34;chromosome 5 open reading frame 34;24738;ENSG00000172244;5p12;FLJ32363, MGC46448;uncharacterized protein C5orf34;uncharacterized protein C5orf34;
C5orf44
chromosome 5 open reading frame 44
C5ORF44;chromosome 5 open reading frame 44;25828;ENSG00000113597;5q12.3;FLJ13611, FLJ26957, MGC48585;UPF0533 protein C5orf44;UPF0533 protein C5orf44;
C5orf48
chromosome 5 open reading frame 48
C5ORF48;chromosome 5 open reading frame 48;33767;ENSG00000196900;5q23.2;FLJ27505, MGC163367, MGC163369;uncharacterized protein C5orf48;uncharacterized protein C5orf48;
C6orf106
chromosome 6 open reading frame 106
C6ORF106;chromosome 6 open reading frame 106;21215;ENSG00000196821;FP852;dJ391O22.4;RP3-391O22.4;6p21.31;MGC4614, FLJ22195, FLJ32402;uncharacterized protein C6orf106;uncharacterized protein C6orf106;
C6orf130
chromosome 6 open reading frame 130
C6ORF130;chromosome 6 open reading frame 130;21257;ENSG00000124596;dJ34B21.3;6p21.1;FLJ17636, MGC19570;O-acetyl-ADP-ribose deacetylase C6orf130;O-acetyl-ADP-ribose deacetylase C6orf130;
C6orf132
chromosome 6 open reading frame 132
C6ORF132;chromosome 6 open reading frame 132;21288;ENSG00000188112;bA7K24.2;6p21.1;FLJ90086;uncharacterized protein C6orf132;uncharacterized protein C6orf132;
C6orf15
chromosome 6 open reading frame 15
C6ORF15;chromosome 6 open reading frame 15;13927;ENSG00000204542;STG;6p21.3;uncharacterized protein C6orf15;uncharacterized protein C6orf15;taste bud-specific protein;
C6orf162
chromosome 6 open reading frame 162
C6ORF162;chromosome 6 open reading frame 162;21401;ENSG00000111850;dJ102H19.2;6q15-q16.1;DKFZp586E1923;UPF0708 protein C6orf162;UPF0708 protein C6orf162;
C6orf163
chromosome 6 open reading frame 163
C6ORF163;chromosome 6 open reading frame 163;21403;ENSG00000203872;6q15;uncharacterized protein C6orf163;uncharacterized protein C6orf163;
C6orf165
chromosome 6 open reading frame 165
C6ORF165;chromosome 6 open reading frame 165;21405;ENSG00000213204;dJ382I10.1;6q15;FLJ25974, FLJ46091;UPF0704 protein C6orf165;UPF0704 protein C6orf165;
C6orf195
chromosome 6 open reading frame 195
C6ORF195;chromosome 6 open reading frame 195;21600;ENSG00000164385;bA145H9.2;RP11-145H9.2;6p25.2;FLJ31934, MGC120321, MGC120322, MGC120323;uncharacterized protein C6orf195;uncharacterized protein C6orf195;
C6orf222
chromosome 6 open reading frame 222
C6ORF222;chromosome 6 open reading frame 222;33769;ENSG00000189325;6p21.31;DKFZp779B1540;uncharacterized protein C6orf222;uncharacterized protein C6orf222;
C6orf225
chromosome 6 open reading frame 225
C6ORF225;chromosome 6 open reading frame 225;33858;ENSG00000203778;6q21;DKFZp586F0922;UPF0731 protein C6orf225;UPF0731 protein C6orf225;
C6orf57
chromosome 6 open reading frame 57
C6ORF57;chromosome 6 open reading frame 57;20957;ENSG00000154079;6q13;MGC104225;UPF0369 protein C6orf57;UPF0369 protein C6orf57;
C6orf89
chromosome 6 open reading frame 89
C6ORF89;chromosome 6 open reading frame 89;21114;ENSG00000198663;6p21.2;FLJ25357, MGC126060, MGC126061, MGC126062;bombesin receptor-activated protein C6orf89;bombesin receptor-activated protein C6orf89;amfion;
C8orf58
chromosome 8 open reading frame 58
C8ORF58;chromosome 8 open reading frame 58;32233;ENSG00000241852;8p21;FLJ34715;uncharacterized protein C8orf58;uncharacterized protein C8orf58;
C8orf74
chromosome 8 open reading frame 74
C8ORF74;chromosome 8 open reading frame 74;32296;ENSG00000171060;8p23.1;uncharacterized protein C8orf74;uncharacterized protein C8orf74;
C9orf11
chromosome 9 open reading frame 11
C9ORF11;chromosome 9 open reading frame 11;1359;ENSG00000120160;AFAF;EQTN;equatorin;9p21;acrosome formation-associated factor;acrosome formation-associated factor;acrosome formation associated factor;
C9orf116
chromosome 9 open reading frame 116
C9ORF116;chromosome 9 open reading frame 116;28435;ENSG00000160345;PIERCE1;RbEST47;RP11-426A6.4;9q34.3;FLJ13945, MGC29761;UPF0691 protein C9orf116;UPF0691 protein C9orf116;pierce 1;p53-induced expression in RB-null cells protein 1;p53-induced expression 1 in Rb−/−cells;
C9orf131
chromosome 9 open reading frame 131
C9ORF131;chromosome 9 open reading frame 131;31418;ENSG00000174038;9p13.3;FLJ00273, MGC41945;uncharacterized protein C9orf131;uncharacterized protein C9orf131;
C9orf135
chromosome 9 open reading frame 135
C9ORF135;chromosome 9 open reading frame 135;31422;ENSG00000204711;9q21.12;uncharacterized protein C9orf135;uncharacterized protein C9orf135;
C9orf139
chromosome 9 open reading frame 139
C9ORF139;chromosome 9 open reading frame 139;31426;ENSG00000180539;9q34.3;FLJ36268, FLJ42909;uncharacterized protein C9orf139;uncharacterized protein C9orf139;
C7orf25
chromosome 7 open reading frame 25
C7ORF25;chromosome 7 open reading frame 25;21703;ENSG00000136197;7p14.1;MGC2821, FLJ21167;UPF0415 protein C7orf25;UPF0415 protein C7orf25;
C7orf34
chromosome 7 open reading frame 34
C7ORF34;chromosome 7 open reading frame 34;21750;ENSG00000165131;ctm-1;7q34;uncharacterized protein C7orf34;uncharacterized protein C7orf34;MSSP-binding protein CTM-1;
C7orf41
chromosome 7 open reading frame 41
C7ORF41;chromosome 7 open reading frame 41;25457;ENSG00000180354;Ells1;7p14.3;FLJ25903;UPF0452 protein C7orf41;UPF0452 protein C7orf41;protein Ells1;
C7orf45
chromosome 7 open reading frame 45
C7ORF45;chromosome 7 open reading frame 45;29580;ENSG00000165120;7q32.2;FLJ40316;uncharacterized protein C7orf45;uncharacterized protein C7orf45;
C7orf53
chromosome 7 open reading frame 53
C7ORF53;chromosome 7 open reading frame 53;22036;ENSG00000181016;7q31.1;FLJ39575, MGC42850, MGC161427, MGC163440;coiled-coil domain-containing transmembrane protein C7orf53;coiled-coil domain-containing transmembrane protein C7orf53;
C7orf57
chromosome 7 open reading frame 57
C7ORF57;chromosome 7 open reading frame 57;22247;ENSG00000164746;7p12.3;uncharacterized protein C7orf57;uncharacterized protein C7orf57;
C7orf59
chromosome 7 open reading frame 59
C7ORF59;chromosome 7 open reading frame 59;33772;ENSG00000188186;7q22.1;MGC163425, MGC163431;UPF0539 protein C7orf59;UPF0539 protein C7orf59;
C7orf60
chromosome 7 open reading frame 60
C7ORF60;chromosome 7 open reading frame 60;26475;ENSG00000164603;7q31.1;FLJ31818;UPF0532 protein C7orf60;UPF0532 protein C7orf60;
C8orf40
chromosome 8 open reading frame 40
C8ORF40;chromosome 8 open reading frame 40;25166;ENSG00000176209;8p11.21;UPF0697 protein C8orf40;UPF0697 protein C8orf40;
C8orf4
chromosome 8 open reading frame 4
C8ORF4;chromosome 8 open reading frame 4;1357;ENSG00000176907;TC1;TC-1;8p11.2;MGC22806;uncharacterized protein C8orf4;uncharacterized protein C8orf4;human thyroid cancer 1;thyroid cancer protein 1;
C8orf42
chromosome 8 open reading frame 42
C8ORF42;chromosome 8 open reading frame 42;26951;ENSG00000180190;Tdrp;Inm01;8p23.3;FLJ44221, DKFZp686J15216;uncharacterized protein C8orf42;uncharacterized protein C8orf42;testis development-related protein;
C8orf44
chromosome 8 open reading frame 44
C8ORF44;chromosome 8 open reading frame 44;25646;ENSG00000213865;8q13.1;FLJ11267;putative uncharacterized protein C8orf44;putative uncharacterized protein C8orf44;
C8orf47
chromosome 8 open reading frame 47
C8ORF47;chromosome 8 open reading frame 47;26823;ENSG00000177459;8q22.2;FLJ39553;uncharacterized protein C8orf47;uncharacterized protein C8orf47;
C9orf16
chromosome 9 open reading frame 16
C9ORF16;chromosome 9 open reading frame 16;17823;ENSG00000171159;EST00098;9q34.1;MGC4639, FLJ12823;UPF0184 protein C9orf16;UPF0184 protein C9orf16;
C9orf163
chromosome 9 open reading frame 163
C9ORF163;chromosome 9 open reading frame 163;26718;ENSG00000196366;RP11-413M3.11;9q34.3;FLJ36779;uncharacterized protein C9orf163;uncharacterized protein C9orf163;
C9orf169
chromosome 9 open reading frame 169
C9ORF169;chromosome 9 open reading frame 169;30529;ENSG00000197191;9q34.3;MGC59937;UPF0574 protein C9orf169;UPF0574 protein C9orf169;
C9orf37
chromosome 9 open reading frame 37
C9ORF37;chromosome 9 open reading frame 37;23395;ENSG00000203993;9q34.3;uncharacterized protein C9orf37;uncharacterized protein C9orf37;AD038;
C9orf57
chromosome 9 open reading frame 57
C9ORF57;chromosome 9 open reading frame 57;27037;ENSG00000204669;RP11-346E17.3;9q21.13;uncharacterized protein C9orf57;uncharacterized protein C9orf57;
C9orf50
chromosome 9 open reading frame 50
C9ORF50;chromosome 9 open reading frame 50;23677;ENSG00000179058;9q34.11;FLJ35803;uncharacterized protein C9orf50;uncharacterized protein C9orf50;
C9orf66
chromosome 9 open reading frame 66
C9ORF66;chromosome 9 open reading frame 66;26436;ENSG00000183784;RP11-59O6.1;9p24.3;FLJ31158;uncharacterized protein C9orf66;uncharacterized protein C9orf66;
C9orf84
chromosome 9 open reading frame 84
C9ORF84;chromosome 9 open reading frame 84;26535;ENSG00000165181;9q31.3;FLJ32779, FLJ44067, MGC43661;uncharacterized protein C9orf84;uncharacterized protein C9orf84;
C9orf91
chromosome 9 open reading frame 91
C9ORF91;chromosome 9 open reading frame 91;24513;ENSG00000157693;RP11-402G3.2;9q32;FLJ38045, MGC129868, MGC129869, DKFZp547P234;transmembrane protein C9orf91;transmembrane protein C9orf91;
CHD1L
chromodomain helicase DNA binding protein 1-like
CHD1L;chromodomain helicase DNA binding protein 1-like;1916;ENSG00000131778;ALC1;CHDL;1q12;FLJ22530;chromodomain-helicase-DNA-binding protein 1-like;chromodomain-helicase-DNA-binding protein 1-like;amplified in liver cancer 1;amplified in liver cancer protein 1;EC 3.6.4.12;
CLTCL1
clathrin, heavy chain-like 1
CLTCL1;clathrin, heavy chain-like 1;2093;ENSG00000070371;CLTD;CHC22;CLH22;CLTCL;22q11.21;FLJ36032;clathrin heavy chain 2;clathrin heavy chain 2;CLH-22;Clathrin, heavy polypeptide D;clathrin, heavy polypeptide-like 1;clathrin heavy chain on chromosome 22;
CXorf61
chromosome X open reading frame 61
CXORF61;chromosome X open reading frame 61;33494;ENSG00000204019;CT83;KKLC1;KK-LC-1;RP3-452H17.2;Xq23;FLJ20611, FLJ22913;kita-kyushu lung cancer antigen 1;kita-kyushu lung cancer antigen 1;cancer/testis antigen 83;
CYB561D1
cytochrome b-561 domain containing 1
CYB561D1;cytochrome b-561 domain containing 1;26804;ENSG00000174151;RP5-831G13.3;1p13.3;FLJ39035, FLJ44753, MGC138204;cytochrome b561 domain-containing protein 1;cytochrome b561 domain-containing protein 1;
BOD1L1
biorientation of chromosomes in cell division 1-like 1
BOD1L1;biorientation of chromosomes in cell division 1-like 1;31792;ENSG00000038219;BOD1L;FAM44A;4p16.1;FLJ33215, KIAA1327;biorientation of chromosomes in cell division protein 1-like 1;biorientation of chromosomes in cell division protein 1-like 1;family with sequence similarity 44, member A;
BOD1L
biorientation of chromosomes in cell division 1-like
FAM44A; AI853319; mKIAA1327; A230054D04Rik;
CDY1
chromodomain protein, Y-linked, 1
CDY1; Chromodomain protein Y chromosome 1; Chromodomain protein Y linked 1; Testis specific chromodomain protein Y protein 1; Testis specific chromodomain prote; Chromodomain protein Y chromosome 1; Chromodomain protein Y linked 1; Testis specific chromodomain protein Y protein 1; Testis specific chromodomain protein Y pr;
C2orf27B
C2orf27A chromosome 2 open reading frame 27A [ Homo sapiens ]
C2ORF27A; chromosome 2 open reading frame 27A; C2orf27, chromosome 2 open reading frame 27; uncharacterized protein C2orf27; MGC50273; OTTHUMP00000162444; C2orf27; C2orf27B;
COX7C
COX7C cytochrome c oxidase subunit VIIc [ Homo sapiens ]
COX7C; COX7C_HUMAN; Cytochrome c oxidase polypeptide VIIc; Cytochrome c oxidase subunit 7C; mitochondrial; cytochrome-c oxidase chain VIIc;
Cyp2c12
cytochrome P450, family 2, subfamily c, polypeptide 12
Cyp2c40; P450pb1; RATP4515B2; RATP4515B8;
Cyp2c29
cytochrome P450, family 2, subfamily c, polypeptide 29
AHOH; Ah-2; Ahh-1; Cyp2c; AHOHase; P450-2C; AI159681; AI196010;
D10Bwg1379e
DNA segment, Chr 10, Brigham & Womens Genetics 1379 expressed
Arfgef3; mKIAA1244; 9630004D11; B930094H20Rik;
D10Wsu52e
DNA segment, Chr 10, Wayne State University 52, expressed
FAAP; HSPC117; AI255213; AI463255;
D15Ertd621e
DNA segment, Chr 15, ERATO Doi 621, expressed
SKIN; Fam91a1; AV220772; BC033609; mKIAA0493;
D16Ertd472e
DNA segment, Chr 16, ERATO Doi 472, expressed
Eurl; 1700010I10Rik; 2310009O17Rik; E330003K22Rik;
D4Bwg0951e
DNA segment, Chr 4, Brigham & Womens Genetics 0951 expressed
Lurap1l; AV077978; AV175137; WI-13707; bM350F23.1; 1110029A09Rik; RP24-318C20.1;
D5Ertd579e
DNA segment, Chr 5, ERATO Doi 579, expressed
Kiaa0232; mKIAA0232; 9030221A05Rik; A930018H20Rik;
D6Wsu116e
DNA segment, Chr 6, Wayne State University 116, expressed
Fam21; A130095H06; C530005J20Rik;
KIR3DL3
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
KIR44; KIRC1; CD158Z; KIR3DL7;
MCMBP
MCMBP minichromosome maintenance complex binding protein [ Homo sapiens ]
C10orf119; chromosome 10 open reading frame 119; MCM-binding protein; MCM-BP; mcmbp; MCMBP_HUMAN; Mini-chromosome maintenance complex-binding protein; Minichromosome maintenance complex binding protein;
UQCR10
ubiquinol-cytochrome c reductase, complex III subunit X
QCR9; UCRC; HSPC051; HSPC119; HSPC151; UCCR7.2; cytochrome b-c1 complex subunit 9; OTTHUMP00000199673; OTTHUMP00000199674; complex III subunit 9; complex III subunit X; cytochrome C1, nonheme 7kDa protein; cytochrome c1 non-heme 7 kDa protein; ubiquinol-cytochrome c reductase complex (7.2 kD); ubiquinol-cytochrome c reductase complex 7.2 kDa protein; ubiquinol-cytochrome c reductase, complex III subunit X, 7.2kDa; UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X;
C16orf89
C16orf89 chromosome 16 open reading frame 89 [ Homo sapiens ]
C16orf89; CP089_HUMAN; UNQ904/PRO1925; UPF0764 protein C16orf89; chromosome 16 open reading frame 89;
C5orf45
C5orf45 chromosome 5 open reading frame 45 [ Homo sapiens ]
Chromosome 5 open reading frame 45; DKFZp686L2452; LOC51149; MGC65027; MGC78537; UPF0544 protein C5orf45; C5ORF45;
C6orf211
C6orf211 chromosome 6 open reading frame 211 [ Homo sapiens ]
C6orf211; CF211_HUMAN; chromosome 6 open reading frame 211; UPF0364 protein C6orf211;
CXorf27
CXorf27 chromosome X open reading frame 27 [ Homo sapiens ]
1700054O13Rik; Chromosome X open reading frame 27; CXorf27; HIP17; Huntingtin interacting protein M; Huntingtin yeast partner M; Huntingtin-interacting protein M; HYPM; HYPM_HUMAN;
Cox16
COX16 COX16 cytochrome c oxidase assembly homolog (S. cerevisiae) [ Homo sapiens (human) ]
HSPC203; C14orf112; cytochrome c oxidase assembly protein; COX16 homolog, mitochondrial; cytochrome c oxidase assembly factor; COX16 cytochrome c oxidase assembly homolog (S. cerevisiae); cytochrome c oxidase assembly protein COX16 homolog, mitochondrial; chromosome 14 open reading frame;
Coa3
cytochrome c oxidase assembly factor 3
COA3; cytochrome c oxidase assembly factor 3; CCDC56; HSPC009; MITRAC12;
Cox7a2
COX7A2 cytochrome c oxidase subunit VIIa polypeptide 2 (liver) [ Homo sapiens ]
COX7A2; COX7AL; COX7AL1; COXVIIa L; COXVIIAL; CX7A2_HUMAN; Cytochrome c oxidase polypeptide 7A2 mitochondrial; Cytochrome c oxidase polypeptide VIIa liver/heart; Cytochrome c oxidase subunit 7A2; Cytochrome c oxidase subunit 7A2 mitochondrial; Cytochrome c oxidase subunit VIIa polypeptide 2; Cytochrome c oxidase subunit VIIa-L; Cytochrome c oxidase subunit VIIa-liver/heart; Cytochrome c oxidase subunit VIIaL; Hepatic cytochrome c oxidase chain VIIa; MGC118950; MGC118951; MGC118952; MGC126875; MGC126877; mitochondrial; VIIAL;
CYP2F1
CYP2F1 cytochrome P450, family 2, subfamily F, polypeptide 1 [ Homo sapiens ]
CYPIIF1; Cytochrome P450 2F1; cytochrome P450, family 2, subfamily F, polypeptide 1; EC=1.14.14.1; flavoprotein-linked monooxygenase; microsomal monooxygenase; EC 1.14.14.1; xenobiotic monooxygenase;
CYP51A1
CYP51A1 cytochrome P450, family 51, subfamily A, polypeptide 1 [ Homo sapiens ]
CP51; CP51A_HUMAN; CYP51; CYP51A1; CYPLI; Cytochrome P450 51; Cytochrome P450 51A1; Cytochrome P450-14DM; Cytochrome P45014DM; Cytochrome P450LI; Lanosterol 14-alpha demethylase; LDM; P450 14DM; P450L1; Sterol 14-alpha demethylase;
RGD1309594
similar to RIKEN cDNA 1810043G02; DNA segment, Chr 10, Johns Hopkins University 13, expressed
C11orf42
C11orf42?chromosome 11 open reading frame 42 [?Homo sapiens?(human) ]
C11orf42; Chromosome 11 open reading frame 42; CK042_HUMAN; Hypothetical protein LOC160298; MGC34805; OTTHUMP00000164534; Uncharacterized protein C11orf42;
C12orf65
C12orf65 chromosome 12 open reading frame 65 [ Homo sapiens (human) ]
C12orf65; chromosome 12 open reading frame 65; CL065_HUMAN; COXPD7; mitochondrial; Probable peptide chain release factor C12orf65; probable peptide chain release factor C12orf65, mitochondrial; SPG55;
C15orf48
C15orf48 chromosome 15 open reading frame 48 [ Homo sapiens (human) ]
C15orf48; FLJ22645; FOAP-11; MGC32925; NMES1; NMES1_HUMAN; Normal mucosa of esophagus-specific gene 1 protein; Protein FOAP-11;
CXorf22
CXorf22 chromosome X open reading frame 22 [ Homo sapiens (human) ]
chromosome X open reading frame 22; CX022_HUMAN; CXorf22; MGC34831; Uncharacterized protein CXorf22;
CYP2B7P1
CYP2B7P1 cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1 [ Homo sapiens (human) ]
CYP2B; CYP2B7; CYP2B7P; cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1;
DHRS12
DHRS12 dehydrogenase/reductase (SDR family) member 12 [ Homo sapiens (human) ]
dehydrogenase/reductase (SDR family) member 12; SDR40C1; FLJ13639; dehydrogenase/reductase SDR family member 12; short chain dehydrogenase/reductase family 40C, member 1; EC 1.1.-.-; DHRS12;
Protective antigen of anthrax toxin
Protective antigen of anthrax toxin
anthrax PA; Anthrax Protective Antigen; Anthrax toxins translocating protein; Bacillus anthracis Protective Antigen; PA 83; PA; PA83; Pag; PagA; Protective antigen;
High-Throughput Screening
Creative BioMart offers a unique combination of target class and cell biology expertise to provide services tailored to your requirements. Our platforms offer high-throughput screening and high-content profiling using standard cell models, human primary cells or disease-related cell lines. Based ...
High-throughput Protein Production
Creative BioMart's professional team can help accelerate your project by providing high-throughput protein production services of up to 1,000 variants within 30 working days. We provide one-stop high-throughput protein production services, including gene synthesis, mutagenesis, subcloning, pilot-sca...
A New Feature of Cell Division: the Interactions among Chromosome, Telomere and Cell Division
The yellow part refers to telomeres, the protective caps on the ends of chromosomes, moving to the outer edge of a cell's nucleus (the blue part) The constant new replacing old and impaired contributes to our life maintenance and growth. You may feel at sea by reading the first sentence, well...
The Chromosome Structure of a RNA Antitoxin Complex and Its Altruistic Mechanism
A new research reveals how some bacterial cells keep a 'suicide complex' ready to hand. In the journal Proceedings of the National Academy of Sciences, you will find an article which talks about some bacterial cells carry a molecular 'suicide complex' to kill themselves in the event of le...
Christmas Presentation for Customers from Creative BioMart
At the time of giving and sharing with wishes of all joys in the Christmas season, Creative BioMart is going to present customers its precious Cell Line Development service. Usingproprietary technologies, such as codon optimization and vector design technologies, Creative BioMart offers Ready...
Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
As usual, Cleveland Clinic will pick out some groundbreaking pharmaceutics that may make big difference for healthcare industry in their late development stages. This year who will be picked by Cleveland? According to internal news, Gilead's sofosbuvir, Novartis heart drugs serelaxin as well as Phar...
Creative BioMart Updates New Product—Thrombin
Creative BioMart will update its products on a daily basis. This time, the thrombin is on the shelf and intended customers are accessible to purchase and inquire related information by contacting out experts. Or some of necessary information can be found on our official we...
Conference on 2013 Chromosomal-related
We are delight to introduce that our peer company Abcam will held the Chromatin, Replication and Chromosomal Stability 2013 conference to promote industry advance. The following are the related information: When From June 17 to June 19, 2013 Where Biotech Research Innovation Center (BRI...
Christmas Sale 2023
Wishing you the Joy and Wonder of Christmas. May you and your family enjoy the season filled with love and happiness in your home. May all your dreams come true this year and the coming ones. What we offer?20% off for products and 10% off for services on Creative BioMart When does this discoun...
Merry Christmas and Happy New Year
Merry Christmas and Happy New Year！ A sincere thanks to you for showing full faith in us and believing in us. We value our relationship, in which we achieved so much. In the coming year, we will strive to strengthen this bond even more. From the entire team at Creative BioMart, we wish yo...
Merry Christmas and Happy New Year
Merry Christmas and Happy New Year！ Its in the spirit of the holiday that we extend our huge thanks to cherished customer like you. Thanks for being so patient and supportive. And we will endeavor to exceed your expectations in the coming year. May your Christmas season be filled with peac...
Merry Christmas and Happy New Year
Holiday Sale Hi everyone! Looking for great holiday gifts at a killer price? The holiday season is officially upon us, and were helping you treat yourself with three weeks of deals on Creative BioMart. We've got holiday deals that will bring you amazing savings on protein products and services. B...
Christmas and New Year Promotion
Holiday Sale As the year comes to a close, we are glad to inform and share with you that it has been an incredible year of profits and profitable relationships. We thank you for your continued patronage, and wish you a Merry Christmas and a very happy new year! In order to appreciate your ...
Merry Christmas and Happy New Year 2017
Merry Christmas and Happy New Year！ We would like to take the opportunity during the holiday season to express our sincere gratitude for you as our cherished customer. None of our achievements would have been possible without you and your unwavering support. May our professional relationship st...
Fast Chromatin Immunoprecipitation Assay
1. Introduction The chromatin immunoprecipitation assay (ChIP assay) has greatly facilitated the expansion of our knowledge of the proteinDNA interactions involved in regulating gene expression, DNA repair, and cell division. The function of the assay is that it gives a researcher the ability to ...
Chromatin Immunoprecipitation (ChIP)
Chromatin Immunoprecipitation (ChIP) principle and introduction Chromatin immunoprecipitation (ChIP) has become an important and popular method for the study of DNA-protein interactions. During the ChIP experiment, protein complexes that interact with DNA are cross-linked to their binding sites...
Protocol of Immobilized Metal Affinity Chromatography
In addition to the enrichment of phosphorylated proteins, phosphorylated peptides can also be enriched. There are many ways to enrich phosphorylated peptides. Immobilized metal affinity chromatography (IMAC) was first proposed by Porath in 1975. After decades of development, it has become the most p...
Guide for Enrichment of Phosphorylated Peptides by Strong Cation Exchange Chromatography
The most commonly used method for the enrichment of phosphorylated peptides is the solid-phase metal ion affinity chromatography (IMAC) described earlier. Although IMAC is relatively simple and fast in application, strong cation exchange chromatography has shown more superior effectiveness in large-...
Guide for Mass Spectrometry Identification of Samples Separated by Liquid Chromatography
As one of the most powerful separation and analysis technologies in the field of chemistry, liquid chromatography (LC) has developed rapidly since the 1970s. Both in terms of fundamental chromatography theory and instrument performance, it has been greatly improved and improved. LC exhibits high sep...
What is HRAS Protein
See All HRAS Products The official full name of HRAS, Harvey Rat Sarcoma Viral Oncogene Homolog, may sound complex, but its significance lies in its role as a member of the Ras protein family. Synonyms for HRAS include H-Ras, HRAS1, and c-H-ras, reflecting its various names in scientific literature....
What is THRA Protein
See All THRA Protein Products What is THRA Protein? The THRA protein, or Thyroid Hormone Receptor Alpha, a member of the nuclear receptor superfamily, governs the cellular response to thyroid hormones. Structurally, THRA comprises distinct domains - an N-terminal A/B domain, a DNA-binding domain (...
